source,citation,relation,ID,title,authors,journal,year,fulltext_online_link,fulltext_location
10.1001~jama.283.8.1016,"Sullivan KM, Monto AS, Longini IM. Estimates of the US health impact of influenza. Am J Public Health. 1993;83:1712-1716.",references,10.2105/AJPH.83.12.1712,Estimates of the US health impact of influenza,"[[u'K', u'M', u'Sullivan'], [u'A', u'S', u'Monto'], [u'I', u'M', u'Longini']]",American Journal of Public Health,1993,[u'http://www.ajph.org/cgi/doi/10.2105/AJPH.83.12.1712'],./output/10.1001~jama.283.8.1016/10.2105~AJPH.83.12.1712
10.2105/AJPH.83.12.1712,"Monto, A., McKimm-Breschkin, J., Macken, C., et. al, Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.01339-05,Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use,"[['Arnold', 'S.', 'Monto'], ['J.', 'L.', 'McKimm-Breschkin'], ['Catherine', '', 'Macken'], ['Alan', 'W.', 'Hampson'], ['Alan', '', 'Hay'], ['Alexander', '', 'Klimov'], ['Masato', '', 'Tashiro'], ['Robert', 'G.', 'Webster'], ['Michelle', '', 'Aymard'], ['Frederick', 'G.', 'Hayden'], ['Maria', '', 'Zambon']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/doi/10.1128/AAC.01339-05', u'http://aac.asm.org/cgi/reprint/50/7/2395.pdf']"
10.2105/AJPH.83.12.1712,"Weycker, D., Edelsberg, J., Halloran, M., et. al, Population-wide benefits of routine vaccination of children against influenza, Vaccine, 2005",cited-by,10.1016/j.vaccine.2004.08.044,Population-wide benefits of routine vaccination of children against influenza,"[['Derek', '', 'Weycker'], ['John', '', 'Edelsberg'], ['M.', 'Elizabeth', 'Halloran'], ['Ira', 'M.', 'Longini'], ['Azhar', '', 'Nizam'], ['Vincent', '', 'Ciuryla'], ['Gerry', '', 'Oster']]",Vaccine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X04006784', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X04006784']"
10.2105/AJPH.83.12.1712,"Neuzil, K., Hohlbein, C., Zhu, Y., , Illness Among Schoolchildren During Influenza Season Effect on School Absenteeism, Parental Absenteeism From Work, and Secondary Illness in Families, , 2002",cited-by,"13610716Illness Among Schoolchildren During Influenza Season Effect on School Absenteeism, Parental Absenteeism From Work, and Secondary Illness in Families","Illness Among Schoolchildren During Influenza Season Effect on School Absenteeism, Parental Absenteeism From Work, and Secondary Illness in Families","[['Kathleen', 'M.', 'Neuzil'], ['Cynthia', '', 'Hohlbein'], ['Yuwei', '', 'Zhu']]",,2002,"[u'http://archpedi.ama-assn.org/cgi/reprint/156/10/986.pdf', u'http://archpedi.highwire.org/cgi/reprint/156/10/986.pdf']"
10.2105/AJPH.83.12.1712,"Keech, M., Scott, A., Ryan, P., , The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population, Occupational Medicine-oxford, 1998",cited-by,10.1093/occmed/48.2.85,The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population,"[['M.', '', 'Keech'], ['A.', 'J.', 'Scott'], ['P.', 'J. J.', 'Ryan']]",Occupational Medicine-oxford,1998,"[u'http://occmed.oxfordjournals.org/cgi/reprint/48/2/85.pdf', u'http://occmed.oxfordjournals.org/cgi/doi/10.1093/occmed/48.2.85']"
10.2105/AJPH.83.12.1712,"Nichol, K., Mallon, K., Mendelman, P., , Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00029-X,"Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine","[['Kristin', 'L', 'Nichol'], ['Kenneth', 'P', 'Mallon'], ['Paul', 'M', 'Mendelman']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0300029X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0300029X']"
10.2105/AJPH.83.12.1712,"Doebbeling, B., Edmond, M., Davis, C., et. al, Influenza Vaccination of Health Care Workers: Evaluation of Factors That Are Important in Acceptance, Preventive Medicine, 1997",cited-by,10.1006/pmed.1996.9991,Influenza Vaccination of Health Care Workers: Evaluation of Factors That Are Important in Acceptance,"[['Bradley', 'N.', 'Doebbeling'], ['Michael', 'B.', 'Edmond'], ['Charles', 'S.', 'Davis'], ['James', 'R.', 'Woodin'], ['Rodney', 'R.', 'Zeitler']]",Preventive Medicine,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0091743596999910', u'http://linkinghub.elsevier.com/retrieve/pii/S0091743596999910']"
10.2105/AJPH.83.12.1712,"Ferguson, N., Mallett, S., Jackson, H., et. al, A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals, , 2003",cited-by,6946003A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals,A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals,"[['Neil', 'M.', 'Ferguson'], ['Susan', '', 'Mallett'], ['Helen', '', 'Jackson'], ['Noel', '', 'Roberts'], ['Penelope', '', 'Ward']]",,2003,"[u'http://jac.oxfordjournals.org/cgi/reprint/51/4/977.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkg136v1.pdf']"
10.2105/AJPH.83.12.1712,"Gravenstein, S., , Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America, Clinical Infectious Diseases, 2009",cited-by,10.1086/598513,"Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America","[['Stefan', '', 'Gravenstein']]",Clinical Infectious Diseases,2009,"[u'http://www.uphs.upenn.edu/bugdrug/antibiotic_manual/idsainfluenza2009.pdf', u'http://linmed.files.wordpress.com/2009/05/flu_guideline_2009.pdf', u'http://maladiesinfectieuses.hug-ge.ch/_library/pdf/influenza.pdf', u'http://www.srlf.org/Data/upload/file/Grippe%20A/(26)%20-%20Recos%20Flu%20IDSA%202009.pdf', u'http://www.maine.gov/dhhs/boh/ddc/epi/influenzatoolkit/Supporting%20documents/IDSA%20Seasonal%20Guidelines.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/598513']"
10.2105/AJPH.83.12.1712,"Lee, P., Matchar, D., Clements, D., et. al, Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults, , 2002",cited-by,5954845Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,"[['Patrick', 'Y.', 'Lee'], ['David', 'B.', 'Matchar'], ['Dennis', 'A.', 'Clements'], ['Joel', '', 'Huber'], ['John', 'D.', 'Hamilton'], ['Eric', 'D.', 'Peterson']]",,2002,[u'http://www.pforster.ch/yvaccin/DocumVaccinInfluenzaBAG/Lee_2002.pdf']
10.2105/AJPH.83.12.1712,"Meier, C., Napalkov, P., Wegmüller, Y., et. al, Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom, European Journal of Clinical Microbiology & Infectious Diseases, 2000",cited-by,10.1007/s100960000376,"Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom","[['C.', 'R.', 'Meier'], ['P.', 'N.', 'Napalkov'], ['Y.', '', 'Wegm\xc3\xbcller'], ['T.', '', 'Jefferson'], ['H.', '', 'Jick']]",European Journal of Clinical Microbiology & Infectious Diseases,2000,"[u'http://www.springerlink.com/index/twlnr6d64q7pk6n1.pdf', u'http://www.springerlink.com/content/twlnr6d64q7pk6n1', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s100960000376', u'http://www.springerlink.com/index/pdf/10.1007/s100960000376']"
10.2105/AJPH.83.12.1712,"Treanor, J., Falsey, A., , Respiratory viral infections in the elderly, Antiviral Research, 1999",cited-by,10.1016/S0166-3542(99)00062-5,Respiratory viral infections in the elderly,"[['John', '', 'Treanor'], ['Ann', '', 'Falsey']]",Antiviral Research,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166354299000625', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354299000625']"
10.2105/AJPH.83.12.1712,"Jackson, L., Yu, O., Heckbert, S., et. al, Influenza Vaccination Is Not Associated with a Reduction in the Risk of Recurrent Coronary Events, , 2002",cited-by,3242287Influenza Vaccination Is Not Associated with a Reduction in the Risk of Recurrent Coronary Events,Influenza Vaccination Is Not Associated with a Reduction in the Risk of Recurrent Coronary Events,"[['Lisa', 'A.', 'Jackson'], ['Onchee', '', 'Yu'], ['Susan', 'R.', 'Heckbert'], ['Bruce', 'M.', 'Psaty'], ['Darren', '', 'Malais'], ['William', 'E.', 'Barlow'], ['William', 'W.', 'Thompson']]",,2002,[u'http://aje.oxfordjournals.org/cgi/reprint/156/7/634.pdf']
10.2105/AJPH.83.12.1712,"Krieger, J., Castorina, J., Walls, M., et. al, Increasing influenza and pneumococcal immunization rates: a randomized controlled study of a senior center–based intervention, American Journal of Preventive Medicine, 2000",cited-by,10.1016/S0749-3797(99)00134-8,Increasing influenza and pneumococcal immunization rates: a randomized controlled study of a senior center–based intervention,"[['James', 'W', 'Krieger'], ['Joseph', 'S', 'Castorina'], ['Mary', 'L', 'Walls'], ['Marcia', 'R', 'Weaver'], ['Sandra', '', 'Ciske']]",American Journal of Preventive Medicine,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0749379799001348', u'http://linkinghub.elsevier.com/retrieve/pii/S0749379799001348']"
10.2105/AJPH.83.12.1712,"Monto, A., , Viral respiratory infections in the community: Epidemiology, agents, and interventions, American Journal of Medicine, 1995",cited-by,10.1016/S0002-9343(99)80307-6,"Viral respiratory infections in the community: Epidemiology, agents, and interventions","[['Arnold', 'S.', 'Monto']]",American Journal of Medicine,1995,"[u'http://www.sciencedirect.com/science/article/pii/S0002934399803076', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934399803076']"
10.2105/AJPH.83.12.1712,"Thompson, W., Meltzer, M., Reeve, G., et. al, Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults, , 2007",cited-by,5478601Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults,Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults,"[['William', 'W.', 'Thompson'], ['Martin', 'I.', 'Meltzer'], ['Gordon', 'R.', 'Reeve'], ['Walter', 'J.', 'Talamonti'], ['Nancy', 'J.', 'Cox'], ['Heather', 'A.', 'Lilac'], ['Keiji', '', 'Fukuda']]",,2007,[u'http://www.beforeyoutakethatpill.com/2008/12/bridges_flu_shots.pdf']
10.2105/AJPH.83.12.1712,"Rangel, M., Shoenbach, V., Weigle, K., et. al, Racial and ethnic disparities in influenza vaccination among elderly adults, Journal of General Internal Medicine, 2005",cited-by,10.1111/j.1525-1497.2005.0097.x,Racial and ethnic disparities in influenza vaccination among elderly adults,"[['Mar\xc3\xada', 'C.', 'Rangel'], ['Victor', 'J.', 'Shoenbach'], ['Kristen', 'A.', 'Weigle'], ['Vijaya', 'K.', 'Hogan'], ['Ronald', 'P.', 'Strauss'], ['Shrikant', 'I.', 'Bangdiwala']]",Journal of General Internal Medicine,2005,"[u'http://www.springerlink.com/index/j03215642087221g.pdf', u'http://www.springerlink.com/content/j03215642087221g', u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.0097.x']"
10.2105/AJPH.83.12.1712,"MONTO, A., , Occurrence of respiratory virus: time, place and person, Pediatric Infectious Disease Journal, 2004",cited-by,10.1097/01.inf.0000108193.91607.34,"Occurrence of respiratory virus: time, place and person","[['ARNOLD', 'S.', 'MONTO']]",Pediatric Infectious Disease Journal,2004,"[u'http://www.hvidovre-hospital.dk/HHmikrobiologisk.nsf/pics/Parainfluenza1.pdf/$FILE/Parainfluenza1.pdf', u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200401001-00009']"
10.2105/AJPH.83.12.1712,"Elting, L., Whimbey, E., Lo, W., et. al, Epidemiology of Influenza A virus infection in patients with acute or chronic leukemia, Supportive Care in Cancer, 1995",cited-by,10.1007/BF00368891,Epidemiology of Influenza A virus infection in patients with acute or chronic leukemia,"[['Linda', 'S.', 'Elting'], ['Estella', '', 'Whimbey'], ['William', '', 'Lo'], ['Robert', '', 'Couch'], ['Michael', '', 'Andreeff'], ['Gerald', 'P.', 'Bodey']]",Supportive Care in Cancer,1995,"[u'http://www.springerlink.com/index/k0j5655327364587.pdf', u'http://www.springerlink.com/content/k0j5655327364587', u'http://www.springerlink.com/index/10.1007/BF00368891', u'http://www.springerlink.com/index/pdf/10.1007/BF00368891']"
10.2105/AJPH.83.12.1712,"Treanor, J., Nolan, C., O’Brien, D., et. al, Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects, Vaccine, 2006",cited-by,10.1016/j.vaccine.2005.07.088,Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects,"[['John', '', 'Treanor'], ['Carrie', '', 'Nolan'], ['Diane', '', 'O\xe2\x80\x99Brien'], ['David', '', 'Burt'], ['George', '', 'Lowell'], ['Janine', '', 'Linden'], ['Louis', '', 'Fries']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X05007723', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X05007723']"
10.2105/AJPH.83.12.1712,"Hanania, N., Sockrider, M., Castro, M., et. al, Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy, Journal of Allergy and Clinical Immunology, 2004",cited-by,10.1016/j.jaci.2003.12.584,Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy,"[['Nicola', 'A', 'Hanania'], ['Marianna', '', 'Sockrider'], ['Mario', '', 'Castro'], ['Janet', 'T', 'Holbrook'], ['James', '', 'Tonascia'], ['Robert', '', 'Wise'], ['Robert', 'L', 'Atmar']]",Journal of Allergy and Clinical Immunology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0091674904002702', u'http://linkinghub.elsevier.com/retrieve/pii/S0091674904002702']"
10.2105/AJPH.83.12.1712,"Prosser, L., Bridges, C., Uyeki, T., et. al, Values for preventing influenza-related morbidity and vaccine adverse events in children, Health and Quality of Life Outcomes, 2005",cited-by,10.1186/1477-7525-3-18,Values for preventing influenza-related morbidity and vaccine adverse events in children,"[['Lisa', 'A', 'Prosser'], ['Carolyn', 'Buxton', 'Bridges'], ['Timothy', 'M', 'Uyeki'], ['Virginia', 'H', 'R\xc3\xaago'], ['G', 'Thomas', 'Ray'], ['Martin', 'I', 'Meltzer'], ['Benjamin', '', 'Schwartz'], ['William', 'W', 'Thompson'], ['Keiji', '', 'Fukuda'], ['Tracy', 'A', 'Lieu']]",Health and Quality of Life Outcomes,2005,"[u'http://www.hqlo.com/content/3/1/18', u'http://www.biomedcentral.com/content/pdf/1477-7525-3-18.pdf', u'http://www.springerlink.com/content/8nr11852q7788822', u'http://www.springerlink.com/index/8nr11852q7788822.pdf']"
10.2105/AJPH.83.12.1712,"Nichol, K., , Live attenuated influenza virus vaccines: new options for the prevention of influenza, Vaccine, 2001",cited-by,10.1016/S0264-410X(01)00143-8,Live attenuated influenza virus vaccines: new options for the prevention of influenza,"[['Kristin', 'L.', 'Nichol']]",Vaccine,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X01001438', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X01001438']"
10.2105/AJPH.83.12.1712,"Dayan, G., Nguyen, V., Debbag, R., et. al, Cost-effectiveness of influenza vaccination in high-risk children in Argentina, Vaccine, 2001",cited-by,10.1016/S0264-410X(01)00160-8,Cost-effectiveness of influenza vaccination in high-risk children in Argentina,"[['Gustavo', 'H', 'Dayan'], ['Van', 'Hung', 'Nguyen'], ['Roberto', '', 'Debbag'], ['Roberto', '', 'G\xc3\xb3mez'], ['Susan', 'C', 'Wood']]",Vaccine,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X01001608', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X01001608']"
10.2105/AJPH.83.12.1712,"Monto, A., , Epidemiology of influenza, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.07.066,Epidemiology of influenza,"[['Arnold', 'S.', 'Monto']]",Vaccine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X08010219', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08010219']"
10.2105/AJPH.83.12.1712,"Nichol, K., , Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00110-3,Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults,"[['Kristin', 'L', 'Nichol']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99001103', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99001103']"
10.2105/AJPH.83.12.1712,"Postma, M., Baltussen, R., Heijnen, M., et. al, Pharmacoeconomics of Influenza Vaccination in the Elderly: Reviewing the Available Evidence, Drugs & Aging, 2000",cited-by,10.2165/00002512-200017030-00005,Pharmacoeconomics of Influenza Vaccination in the Elderly: Reviewing the Available Evidence,"[['Maarten', 'J.', 'Postma'], ['Rob', 'M. P. M.', 'Baltussen'], ['Marie-Louise', 'A.', 'Heijnen'], ['Lolkje', 'T. W. de Jong-van den', 'Berg'], ['Johannes', 'C.', 'Jager']]",Drugs & Aging,2000,"[u'http://www.sff.fmns.rug.nl/downloads/2000/16_postma_2000.pdf', u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002512-200017030-00005']"
10.2105/AJPH.83.12.1712,"Ehlinger, E., , Burden of Influenza‐Like Illness and Effectiveness of Influenza Vaccination among Working Adults Aged 50–64 Years, Clinical Infectious Diseases, 2009",cited-by,10.1086/595842,Burden of Influenza‐Like Illness and Effectiveness of Influenza Vaccination among Working Adults Aged 50–64 Years,"[['Edward', '', 'Ehlinger']]",Clinical Infectious Diseases,2009,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/595842']
10.2105/AJPH.83.12.1712,"Wang, Q., Cheng, F., Lu, M., et. al, Crystal Structure of Unliganded Influenza B Virus Hemagglutinin, Journal of Virology, 2008",cited-by,10.1128/JVI.02477-07,Crystal Structure of Unliganded Influenza B Virus Hemagglutinin,"[['Qinghua', '', 'Wang'], ['Feng', '', 'Cheng'], ['Mingyang', '', 'Lu'], ['Xia', '', 'Tian'], ['Jianpeng', '', 'Ma']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/JVI.02477-07v1.pdf', u'http://jvi.asm.org/cgi/reprint/82/6/3011.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02477-07']"
10.2105/AJPH.83.12.1712,"Hite, L., Glezen, W., Demmler, G., et. al, Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus, International Journal of Infectious Diseases, 2007",cited-by,10.1016/j.ijid.2005.10.008,Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus,"[['Ladonna', 'K.', 'Hite'], ['W.', 'Paul', 'Glezen'], ['Gail', 'J.', 'Demmler'], ['Flor', 'M.', 'Munoz']]",International Journal of Infectious Diseases,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1201971206000178', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971206000178']"
10.2105/AJPH.83.12.1712,"Avritscher, E., Cooksley, C., Geraci, J., et. al, Cost-effectiveness of influenza vaccination in working-age cancer patients, Cancer, 2007",cited-by,10.1002/cncr.22670,Cost-effectiveness of influenza vaccination in working-age cancer patients,"[['Elenir', 'B. C.', 'Avritscher'], ['Catherine', 'D.', 'Cooksley'], ['Jane', 'M.', 'Geraci'], ['Benjamin', 'N.', 'Bekele'], ['Scott', 'B.', 'Cantor'], ['Kenneth', 'V.', 'Rolston'], ['Linda', 'S.', 'Elting']]",Cancer,2007,[u'http://doi.wiley.com/10.1002/cncr.22670']
10.2105/AJPH.83.12.1712,"Olshaker, J., , Influenza, Emergency Medicine Clinics of North America, 2003",cited-by,10.1016/S0733-8627(03)00018-X,Influenza,"[['Jonathan', 'S', 'Olshaker']]",Emergency Medicine Clinics of North America,2003,"[u'http://www.sciencedirect.com/science/article/pii/S073386270300018X', u'http://linkinghub.elsevier.com/retrieve/pii/S073386270300018X']"
10.2105/AJPH.83.12.1712,"Gordon, A., Saborío, S., Videa, E., et. al, Clinical Attack Rate and Presentation of Pandemic H1N1 Influenza versus Seasonal Influenza A and B in a Pediatric Cohort in Nicaragua, Clinical Infectious Diseases, 2010",cited-by,10.1086/652647,Clinical Attack Rate and Presentation of Pandemic H1N1 Influenza versus Seasonal Influenza A and B in a Pediatric Cohort in Nicaragua,"[['Aubree', '', 'Gordon'], ['Saira', '', 'Sabor\xc3\xado'], ['Elsa', '', 'Videa'], ['Roger', '', 'L\xc3\xb3pez'], ['Guillermina', '', 'Kuan'], ['Angel', '', 'Balmaseda'], ['Eva', '', 'Harris']]",Clinical Infectious Diseases,2010,"[u'http://origem.info/FIC/pdf/Gordon_etal_Clinical_attack_rate_H1N1_vs_seasonal_Nicaragua_CID_Jun10.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/652647']"
10.2105/AJPH.83.12.1712,"Rose, G., Cooper, C., , Fluarix™, inactivated split-virus influenza vaccine, Expert Opinion on Biological Therapy, 2006",cited-by,10.1517/14712598.6.3.301,"Fluarix™, inactivated split-virus influenza vaccine","[['G', 'W', 'Rose'], ['C', 'L', 'Cooper']]",Expert Opinion on Biological Therapy,2006,[u'http://informahealthcare.com/doi/abs/10.1517/14712598.6.3.301']
10.2105/AJPH.83.12.1712,"Weaver, M., Krieger, J., Castorina, J., et. al, Cost-effectiveness of Combined Outreach for the Pneumococcal and Influenza Vaccines, , 2001",cited-by,13092508Cost-effectiveness of Combined Outreach for the Pneumococcal and Influenza Vaccines,Cost-effectiveness of Combined Outreach for the Pneumococcal and Influenza Vaccines,"[['Marcia', '', 'Weaver'], ['James', '', 'Krieger'], ['Joseph', '', 'Castorina'], ['Mary', '', 'Walls'], ['Sandy', '', 'Ciske']]",,2001,[u'http://archinte.ama-assn.org/cgi/reprint/161/1/111.pdf']
10.2105/AJPH.83.12.1712,"Monto, A., , Global burden of influenza: what we know and what we need to know, International Congress Series, 2004",cited-by,10.1016/j.ics.2004.02.049,Global burden of influenza: what we know and what we need to know,"[['Arnold', 'S.', 'Monto']]",International Congress Series,2004,"[u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/103.pdf', u'http://www.sciencedirect.com/science/article/pii/S0531513104001803', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513104001803']"
10.2105/AJPH.83.12.1712,"Wilde, J., , Rapid diagnostic testing for the identification of respiratory agents in the emergency department, Clinical Pediatric Emergency Medicine, 2002",cited-by,10.1053/epem.2002.128769,Rapid diagnostic testing for the identification of respiratory agents in the emergency department,"[['James', 'A.', 'Wilde']]",Clinical Pediatric Emergency Medicine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1522840102800052', u'http://linkinghub.elsevier.com/retrieve/pii/S1522840102800052']"
10.2105/AJPH.83.12.1712,"Nowalk, M., Lin, C., Zimmerman, R., et. al, Tailored Interventions to Introduce Influenza Vaccination Among 6- to 23-month-old Children at Inner-city Health Centers, , 0",cited-by,14091535Tailored Interventions to Introduce Influenza Vaccination Among 6- to 23-month-old Children at Inner-city Health Centers,Tailored Interventions to Introduce Influenza Vaccination Among 6- to 23-month-old Children at Inner-city Health Centers,"[['Mary', 'Patricia', 'Nowalk'], ['Chyongchiou', 'J.', 'Lin'], ['Richard', 'Kent', 'Zimmerman'], ['Judith', 'A.', 'Troy'], ['Alejandro', '', 'Hoberman'], ['Diana', 'H.', 'Kearney'], ['Stephanie', 'M.', 'Cleary']]",,0,[u'http://www.ajmc.com/media/pdf/AJMC05Nov_Nowalk717to724.pdf']
10.2105/AJPH.83.12.1712,"Pebody, R., Mangtani, P., , School absence data for influenza surveillance: a pilot study in the United Kingdom, , 2010",cited-by,13523861School absence data for influenza surveillance: a pilot study in the United Kingdom,School absence data for influenza surveillance: a pilot study in the United Kingdom,"[['R', '', 'Pebody'], ['P', '', 'Mangtani']]",,2010,[u'http://www.eurosurveillance.org/images/dynamic/ee/v15n03/art19467.pdf']
10.2105/AJPH.83.12.1712,"Vaux, S., Noël, D., Fonteneau, L., et. al, Influenza vaccination coverage of healthcare workers and residents and their determinants in nursing homes for elderly people in France: a cross-sectional survey, BMC Public Health, 2010",cited-by,10.1186/1471-2458-10-159,Influenza vaccination coverage of healthcare workers and residents and their determinants in nursing homes for elderly people in France: a cross-sectional survey,"[['Sophie', '', 'Vaux'], ['Delphine', '', 'No\xc3\xabl'], ['Laure', '', 'Fonteneau'], ['Jean-Paul', '', 'Guthmann'], ['Daniel', '', 'L\xc3\xa9vy-Bruhl']]",BMC Public Health,2010,"[u'http://www.biomedcentral.com/content/pdf/1471-2458-10-159.pdf', u'http://www.biomedcentral.com/1471-2458/10/159', u'http://www.springerlink.com/content/0710729l46335824', u'http://www.springerlink.com/index/0710729l46335824.pdf']"
10.2105/AJPH.83.12.1712,"Zimmerman, R., Nowalk, M., Lin, C., et. al, Interventions over 2 years to increase influenza vaccination of children aged 6–23 months in inner-city family health centers, Vaccine, 2006",cited-by,10.1016/j.vaccine.2005.10.016,Interventions over 2 years to increase influenza vaccination of children aged 6–23 months in inner-city family health centers,"[['Richard', 'K.', 'Zimmerman'], ['Mary', 'Patricia', 'Nowalk'], ['Chyongchiou', 'J.', 'Lin'], ['Feng', 'Shou', 'Ko'], ['Bruce', '', 'Block'], ['Gregory', '', 'Anderson'], ['J.', 'Todd', 'Wahrenberger'], ['Dwight', 'E.', 'Fox']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X05010510', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X05010510']"
10.2105/AJPH.83.12.1712,"Hanania, N., Atmar, R., Castro, M., , Influenza vaccine in patients with asthma, Expert Review of Vaccines, 2006",cited-by,10.1586/14760584.5.1.111,Influenza vaccine in patients with asthma,"[['Nicola', 'A', 'Hanania'], ['Robert', 'L', 'Atmar'], ['Mario', '', 'Castro']]",Expert Review of Vaccines,2006,[u'http://www.future-drugs.com/doi/abs/10.1586/14760584.5.1.111']
10.2105/AJPH.83.12.1712,"Monto, A., , Preventing Influenza in Healthy Adults: The Evolving Story, , 2010",cited-by,13512707Preventing Influenza in Healthy Adults: The Evolving Story,Preventing Influenza in Healthy Adults: The Evolving Story,"[['Arnold', 'S.', 'Monto']]",,2010,"[u'http://jama.ama-assn.org/cgi/reprint/284/13/1655.pdf', u'http://jama.highwire.org/cgi/reprint/284/13/1655.pdf']"
10.2105/AJPH.83.12.1712,"Bender, J., Ampofo, K., Gesteland, P., et. al, Development and Validation of a Risk Score for Predicting Hospitalization in Children With Influenza Virus Infection, Pediatric Emergency Care, 2009",cited-by,10.1097/PEC.0b013e3181a792a9,Development and Validation of a Risk Score for Predicting Hospitalization in Children With Influenza Virus Infection,"[['Jeffrey', 'M.', 'Bender'], ['Krow', '', 'Ampofo'], ['Per', '', 'Gesteland'], ['Gregory', 'J.', 'Stoddard'], ['Douglas', '', 'Nelson'], ['Carrie', 'L.', 'Byington'], ['Andrew', 'T.', 'Pavia'], ['Rajendu', '', 'Srivastava']]",Pediatric Emergency Care,2009,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006565-200906000-00001']
10.2105/AJPH.83.12.1712,"Shorr, A., , Preventing Pneumonia: The Role for Pneumococcal and Influenza Vaccines, Clinics in Chest Medicine, 2005",cited-by,10.1016/j.ccm.2004.10.003,Preventing Pneumonia: The Role for Pneumococcal and Influenza Vaccines,"[['Andrew', 'F.', 'Shorr']]",Clinics in Chest Medicine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0272523104000917', u'http://linkinghub.elsevier.com/retrieve/pii/S0272523104000917']"
10.2105/AJPH.83.12.1712,"Monto, A., , Epidemiology and Virology of Influenza Illness, , 0",cited-by,11380765Epidemiology and Virology of Influenza Illness,Epidemiology and Virology of Influenza Illness,"[['Arnold', 'S.', 'Monto']]",,0,"[u'http://www.ajmc.com/media/pdf/AMSub5_2000MontoS255_64.pdf', u'http://www.hcplive.com/_micro/ajmc/_picture/folder_12/AMSub5_2000MontoS255_64.pdf']"
10.2105/AJPH.83.12.1712,"Rennels, M., Meissner, H., , Reduction of the Influenza Burden in Children, , 0",cited-by,12425433Reduction of the Influenza Burden in Children,Reduction of the Influenza Burden in Children,"[['Margaret', 'B.', 'Rennels'], ['H.', 'Cody', 'Meissner']]",,0,[]
10.2105/AJPH.83.12.1712,"Palmer, L., Rousculp, M., Johnston, S., et. al, Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.05.011,Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study,"[['Liisa', 'A.', 'Palmer'], ['Matthew', 'D.', 'Rousculp'], ['Stephen', 'S.', 'Johnston'], ['Parthiv', 'J.', 'Mahadevia'], ['Kristin', 'L.', 'Nichol']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10006766', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10006766']"
10.2105/AJPH.83.12.1712,"Zimmerman, R., Hoberman, A., Nowalk, M., et. al, Feasibility of Influenza Immunization for Inner-City Children Aged 6 to 23 Months, , 2004",cited-by,6121405Feasibility of Influenza Immunization for Inner-City Children Aged 6 to 23 Months,Feasibility of Influenza Immunization for Inner-City Children Aged 6 to 23 Months,"[['Richard', 'K.', 'Zimmerman'], ['Alejandro', '', 'Hoberman'], ['Mary', 'Patricia', 'Nowalk'], ['Chyongchiou', 'J.', 'Lin'], ['David', 'P.', 'Greenberg'], ['Stuart', 'T.', 'Weinberg'], ['Charles', 'W.', 'Bemm'], ['Bruce', '', 'Block']]",,2004,[u'http://minority-health.pitt.edu/archive/00000471/01/Feasibility_of_Flu_Immunization_for_Inner-City_Children_Aged_6_to_23_Months.pdf']
10.2105/AJPH.83.12.1712,"Blitz, S., Cram, P., Chernew, M., et. al, Diagnostic Testing or Empirical Neuraminidase Inhibitor Therapy for Patients With Influenza-Like Illness: What a Difference a Day Makes, , 2002",cited-by,5529074Diagnostic Testing or Empirical Neuraminidase Inhibitor Therapy for Patients With Influenza-Like Illness: What a Difference a Day Makes,Diagnostic Testing or Empirical Neuraminidase Inhibitor Therapy for Patients With Influenza-Like Illness: What a Difference a Day Makes,"[['Susan', 'G.', 'Blitz'], ['Peter', '', 'Cram'], ['Michael', 'E.', 'Chernew'], ['Arnold', 'S.', 'Monto'], ['A.', 'Mark', 'Fendrick']]",,2002,[u'http://www.ajmc.com/media/pdf/AJMC2002marBlitz221_227.pdf']
10.2105/AJPH.83.12.1712,"Fleming, D., , The management of influenza in people of working age, Occupational Medicine-oxford, 2002",cited-by,10.1093/occmed/52.5.259,The management of influenza in people of working age,"[['D.', 'M.', 'Fleming']]",Occupational Medicine-oxford,2002,"[u'http://occmed.oxfordjournals.org/cgi/reprint/52/5/259.pdf', u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.259']"
10.2105/AJPH.83.12.1712,"Bellefon, G., Wirth, B., , Kinetic Monte Carlo (KMC) simulation of fission product silver transport through TRISO fuel particle, Journal of Nuclear Materials, 2011",cited-by,10.1016/j.jnucmat.2011.04.010,Kinetic Monte Carlo (KMC) simulation of fission product silver transport through TRISO fuel particle,"[['G.', 'M. de', 'Bellefon'], ['B.', 'D.', 'Wirth']]",Journal of Nuclear Materials,2011,[u'http://www.sciencedirect.com/science/article/pii/S0022311511003497']
10.2105/AJPH.83.12.1712,"Lembo, F., Parisi, D., Portincasa, A., , P215. Orbital floor reconstruction: PDS or titanium mesh?, Oral Oncology, 2011",cited-by,10.1016/j.oraloncology.2011.06.458,P215. Orbital floor reconstruction: PDS or titanium mesh?,"[['F.', '', 'Lembo'], ['D.', '', 'Parisi'], ['A.', '', 'Portincasa']]",Oral Oncology,2011,[u'http://www.sciencedirect.com/science/article/pii/S1368837511006646']
10.2105/AJPH.83.12.1712,"Patwardhan, A., Kelleher, K., Cunningham, D., et. al, The use of a mandatory best practice reminder in the electronic record improves influenza vaccination rate in a pediatric rheumatology clinic, Clinical Governance: An International Journal, 2011",cited-by,10.1108/14777271111175350,The use of a mandatory best practice reminder in the electronic record improves influenza vaccination rate in a pediatric rheumatology clinic,"[['Anjali', '', 'Patwardhan'], ['Kelly', '', 'Kelleher'], ['Dennis', '', 'Cunningham'], ['James', '', 'Menke'], ['Charles', '', 'Spencer']]",Clinical Governance: An International Journal,2011,[u'http://dx.doi.org/10.1108/14777271111175350']
10.2105/AJPH.83.12.1712,"Glezen, W., , Professionals: A Randomized Trial Effectiveness of Influenza Vaccine in Health Care, , 2010",cited-by,14334160Professionals: A Randomized Trial Effectiveness of Influenza Vaccine in Health Care,Professionals: A Randomized Trial Effectiveness of Influenza Vaccine in Health Care,"[['W.', 'Paul', 'Glezen']]",,2010,[u'http://jama.ama-assn.org/cgi/reprint/281/10/908.pdf']
10.2105/AJPH.83.12.1712,"Taylor, C., Marathe, A., Beckman, R., , Same influenza vaccination strategies but different outcomes across US cities?, International Journal of Infectious Diseases, 2010",cited-by,10.1016/j.ijid.2010.02.2267,Same influenza vaccination strategies but different outcomes across US cities?,"[['Claudia', '', 'Taylor'], ['Achla', '', 'Marathe'], ['Richard', '', 'Beckman']]",International Journal of Infectious Diseases,2010,"[u'http://www.sciencedirect.com/science/article/pii/S1201971210024057', u'http://linkinghub.elsevier.com/retrieve/pii/S1201971210024057']"
10.2105/AJPH.83.12.1712,"Schmidt, W., Wloch, C., Biran, A., et. al, Formative research on the feasibility of hygiene interventions for influenza control in UK primary schools, BMC Public Health, 2009",cited-by,10.1186/1471-2458-9-390,Formative research on the feasibility of hygiene interventions for influenza control in UK primary schools,"[['Wolf-Peter', '', 'Schmidt'], ['Catherine', '', 'Wloch'], ['Adam', '', 'Biran'], ['Val', '', 'Curtis'], ['Punam', '', 'Mangtani']]",BMC Public Health,2009,"[u'http://www.springerlink.com/content/aj52g61425828687', u'http://www.biomedcentral.com/content/pdf/1471-2458-9-390.pdf', u'http://www.biomedcentral.com/1471-2458/9/390', u'http://www.springerlink.com/index/aj52g61425828687.pdf']"
10.2105/AJPH.83.12.1712,"Llach, X., Gamisans, M., Tudel, J., et. al, Estudio de costes de la gripe, Atencion Primaria, 2006",cited-by,10.1157/13092984,Estudio de costes de la gripe,"[['Xavier', 'Badia', 'Llach'], ['Montserrat', 'Roset', 'Gamisans'], ['Jos\xc3\xa9', 'M. Franc\xc3\xa9s', 'Tudel'], ['Concha', '\xc3\x81lvarez', 'Sanz'], ['Carlos', 'Rubio', 'Terr\xc3\xa9s']]",Atencion Primaria,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0212656706704954', u'http://linkinghub.elsevier.com/retrieve/pii/S0212656706704954']"
10.2105/AJPH.83.12.1712,"Zimmerman, R., Hoberman, A., Nowalk, M., et. al, Feasibility of influenza immunization for inner-city children aged 6 to 23 months, American Journal of Preventive Medicine, 2004",cited-by,10.1016/j.amepre.2004.07.016,Feasibility of influenza immunization for inner-city children aged 6 to 23 months,"[['Richard', 'K.', 'Zimmerman'], ['Alejandro', '', 'Hoberman'], ['Mary', 'Patricia', 'Nowalk'], ['Chyongchiou', 'J.', 'Lin'], ['David', 'P.', 'Greenberg'], ['Stuart', 'T.', 'Weinberg'], ['Charles', 'W.', 'Bemm'], ['Bruce', '', 'Block']]",American Journal of Preventive Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S074937970400193X', u'http://linkinghub.elsevier.com/retrieve/pii/S074937970400193X']"
10.2105/AJPH.83.12.1712,"Dougherty, F., Woolweaver, G., , Flight Testing of a Sliding Mode Control Autopilot for an Unmanned Underwater Vehicle, , 1989",cited-by,10.1109/UUST.1989.754739,Flight Testing of a Sliding Mode Control Autopilot for an Unmanned Underwater Vehicle,"[['Frank', '', 'Dougherty'], ['Gary', '', 'Woolweaver']]",,1989,"[u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=00754739', u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=754739']"
10.2105/AJPH.83.12.1712,"Pavia, T., Byington, C., Ampofo, K., et. al, Respiratory Viral Infection Seasonal Invasive Pneumococcal Disease in Children: Role of Preceding, , 0",cited-by,12058481Respiratory Viral Infection Seasonal Invasive Pneumococcal Disease in Children: Role of Preceding,Respiratory Viral Infection Seasonal Invasive Pneumococcal Disease in Children: Role of Preceding,"[['T.', '', 'Pavia'], ['Carrie', 'L.', 'Byington'], ['Krow', '', 'Ampofo'], ['Jeffrey', '', 'Bender'], ['Xiaoming', '', 'Sheng'], ['Kent', '', 'Korgenski'], ['Judy', '', 'Daly']]",,0,"[u'http://pediatrics.aappublications.org/cgi/reprint/122/2/229.pdf', u'http://intl-pediatrics.aappublications.org/cgi/reprint/122/2/229.pdf']"
10.2105/AJPH.83.12.1712,"Wenzel, R., , Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor, , 0",cited-by,12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,"[['Richard', 'P.', 'Wenzel']]",,0,[u'http://jama.ama-assn.org/cgi/reprint/283/8/1016.pdf']
10.1001~jama.283.8.1016,"Brown LE, Hampson AW, Webster RG, eds. Options for the Control of Influenza III. New York, NY: Elsevier Science BV; 1996:17-25.",references,NOT found in MAS
10.1001~jama.283.8.1016,Kavet J. A perspective on the significance of pandemic influenza. Am J Public Health. 1977;67:1063-1070.,references,10.2105/AJPH.67.11.1063,A perspective on the significance of pandemic influenza,"[[u'J', u'', u'Kavet']]",American Journal of Public Health,1977,[u'http://www.ajph.org/cgi/doi/10.2105/AJPH.67.11.1063'],./output/10.1001~jama.283.8.1016/10.2105~AJPH.67.11.1063
10.2105/AJPH.67.11.1063,"Nichol, K., , Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza, , 2001",cited-by,2905336Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,"[['Kristin', 'L.', 'Nichol']]",,2001,"[u'http://archinte.ama-assn.org/cgi/reprint/161/5/749.pdf', u'http://tudor.szote.u-szeged.hu/webtext/letolt/anyag/CASPi_200212/day4/4.2.3.%20nichol%20paper.pdf']"
10.2105/AJPH.67.11.1063,"Hilleman, M., , Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00254-2,"Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control","[['Maurice', 'R.', 'Hilleman']]",Vaccine,2002,"[u'http://biomicro.sdstate.edu/WangX/Micr425/Pathogenesis/Influenza_A.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X02002542', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/78.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/pathogenesis/pathogenesis-1.pdf', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/epidemiology/epidemiology-6.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02002542']"
10.2105/AJPH.67.11.1063,"Nichol, K., Mallon, K., Mendelman, P., , Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00029-X,"Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine","[['Kristin', 'L', 'Nichol'], ['Kenneth', 'P', 'Mallon'], ['Paul', 'M', 'Mendelman']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0300029X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0300029X']"
10.2105/AJPH.67.11.1063,"Lin, J., Nichol, K., , Excess Mortality Due to Pneumonia or Influenza During Influenza Seasons Among Persons With Acquired Immunodeficiency Syndrome, Archives of Internal Medicine, 2001",cited-by,10.1001/archinte.161.3.441,Excess Mortality Due to Pneumonia or Influenza During Influenza Seasons Among Persons With Acquired Immunodeficiency Syndrome,"[['Joseph', 'C.', 'Lin'], ['Kristin', 'L.', 'Nichol']]",Archives of Internal Medicine,2001,"[u'http://archinte.ama-assn.org/cgi/doi/10.1001/archinte.161.3.441', u'http://archinte.ama-assn.org/cgi/reprint/161/3/441.pdf']"
10.2105/AJPH.67.11.1063,"Meier, C., Napalkov, P., Wegmüller, Y., et. al, Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom, European Journal of Clinical Microbiology & Infectious Diseases, 2000",cited-by,10.1007/s100960000376,"Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom","[['C.', 'R.', 'Meier'], ['P.', 'N.', 'Napalkov'], ['Y.', '', 'Wegm\xc3\xbcller'], ['T.', '', 'Jefferson'], ['H.', '', 'Jick']]",European Journal of Clinical Microbiology & Infectious Diseases,2000,"[u'http://www.springerlink.com/index/twlnr6d64q7pk6n1.pdf', u'http://www.springerlink.com/content/twlnr6d64q7pk6n1', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s100960000376', u'http://www.springerlink.com/index/pdf/10.1007/s100960000376']"
10.2105/AJPH.67.11.1063,"Akazawa, M., Sindelar, J., Paltiel, A., , Economic Costs of Influenza-Related Work Absenteeism, Value in Health, 2003",cited-by,10.1046/j.1524-4733.2003.00209.x,Economic Costs of Influenza-Related Work Absenteeism,"[['Manabu', '', 'Akazawa'], ['Jody', 'L.', 'Sindelar'], ['A.', 'David', 'Paltiel']]",Value in Health,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1098301510601404', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1524-4733.2003.00209.x']"
10.2105/AJPH.67.11.1063,"Rothberg, M., He, S., Rose, D., , Management of influenza symptoms in healthy adults, Journal of General Internal Medicine, 2003",cited-by,10.1046/j.1525-1497.2003.20822.x,Management of influenza symptoms in healthy adults,"[['Michael', 'B.', 'Rothberg'], ['Shunian', '', 'He'], ['David', 'N.', 'Rose']]",Journal of General Internal Medicine,2003,"[u'http://www.springerlink.com/index/c2hlvw3483877856.pdf', u'http://www.springerlink.com/content/c2hlvw3483877856', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1525-1497.2003.20822.x']"
10.2105/AJPH.67.11.1063,"Nichol, K., , Live attenuated influenza virus vaccines: new options for the prevention of influenza, Vaccine, 2001",cited-by,10.1016/S0264-410X(01)00143-8,Live attenuated influenza virus vaccines: new options for the prevention of influenza,"[['Kristin', 'L.', 'Nichol']]",Vaccine,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X01001438', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X01001438']"
10.2105/AJPH.67.11.1063,"O'Reilly, F., Stevens, A., , Sickness absence due to influenza, Occupational Medicine-oxford, 2002",cited-by,10.1093/occmed/52.5.265,Sickness absence due to influenza,"[['F.', 'W.', ""O'Reilly""], ['A.', 'B.', 'Stevens']]",Occupational Medicine-oxford,2002,"[u'http://www.cepis.ops-oms.org/bvsacd/cd49/265.pdf', u'http://www.cepis.ops-oms.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://www.bvsde.ops-oms.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://bvsde.per.paho.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://bvsde.per.paho.org/bvsacd/cd49/265.pdf', u'http://www.bvsde.paho.org/bvsacd/cd49/265.pdf', u'http://www.opas.org.br/gentequefazsaude/bvsde/bvsacd/cd49/265.pdf', u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.265']"
10.2105/AJPH.67.11.1063,"Fleming, D., Elliot, A., , The impact of influenza on the health and health care utilisation of elderly people, Vaccine, 2005",cited-by,10.1016/j.vaccine.2005.04.018,The impact of influenza on the health and health care utilisation of elderly people,"[['Douglas', 'M.', 'Fleming'], ['Alex', 'J.', 'Elliot']]",Vaccine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X05004585', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/124.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X05004585']"
10.2105/AJPH.67.11.1063,"Dayan, G., Nguyen, V., Debbag, R., et. al, Cost-effectiveness of influenza vaccination in high-risk children in Argentina, Vaccine, 2001",cited-by,10.1016/S0264-410X(01)00160-8,Cost-effectiveness of influenza vaccination in high-risk children in Argentina,"[['Gustavo', 'H', 'Dayan'], ['Van', 'Hung', 'Nguyen'], ['Roberto', '', 'Debbag'], ['Roberto', '', 'G\xc3\xb3mez'], ['Susan', 'C', 'Wood']]",Vaccine,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X01001608', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X01001608']"
10.2105/AJPH.67.11.1063,"Nichol, K., , Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00110-3,Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults,"[['Kristin', 'L', 'Nichol']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99001103', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99001103']"
10.2105/AJPH.67.11.1063,"Postma, M., Baltussen, R., Heijnen, M., et. al, Pharmacoeconomics of Influenza Vaccination in the Elderly: Reviewing the Available Evidence, Drugs & Aging, 2000",cited-by,10.2165/00002512-200017030-00005,Pharmacoeconomics of Influenza Vaccination in the Elderly: Reviewing the Available Evidence,"[['Maarten', 'J.', 'Postma'], ['Rob', 'M. P. M.', 'Baltussen'], ['Marie-Louise', 'A.', 'Heijnen'], ['Lolkje', 'T. W. de Jong-van den', 'Berg'], ['Johannes', 'C.', 'Jager']]",Drugs & Aging,2000,"[u'http://www.sff.fmns.rug.nl/downloads/2000/16_postma_2000.pdf', u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002512-200017030-00005']"
10.2105/AJPH.67.11.1063,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004']
10.2105/AJPH.67.11.1063,"Stiver, H., , The threat and prospects for control of an influenza pandemic, Expert Review of Vaccines, 2004",cited-by,10.1586/14760584.3.1.35,The threat and prospects for control of an influenza pandemic,"[['H', 'Grant', 'Stiver']]",Expert Review of Vaccines,2004,[u'http://www.future-drugs.com/doi/abs/10.1586/14760584.3.1.35']
10.2105/AJPH.67.11.1063,"Poland, G., Johnson, D., , Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season, American Journal of Medicine, 2008",cited-by,10.1016/j.amjmed.2008.05.002,Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season,"[['Gregory', 'A.', 'Poland'], ['David', 'R.', 'Johnson']]",American Journal of Medicine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0002934308004658', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934308004658']"
10.2105/AJPH.67.11.1063,"D’Heilly, S., Nichol, K., , Work‐Site–Based Influenza Vaccination in Healthcare and Non‐Healthcare Settings, Infection Control and Hospital Epidemiology, 2004",cited-by,10.1086/502324,Work‐Site–Based Influenza Vaccination in Healthcare and Non‐Healthcare Settings,"[['Sarah', 'J.', 'D\xe2\x80\x99Heilly'], ['Kristin', 'L.', 'Nichol']]",Infection Control and Hospital Epidemiology,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/502324']
10.2105/AJPH.67.11.1063,"Jefferson, T., , Do vaccines make best use of available resources? (in other words are they cost-effective?), Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00297-2,Do vaccines make best use of available resources? (in other words are they cost-effective?),"[['Tom', '', 'Jefferson']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99002972', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99002972']"
10.2105/AJPH.67.11.1063,"Lovell, V., , Valuing Good Health: An Estimate of Costs and Savings for the Healthy Families Act, , 0",cited-by,10821395Valuing Good Health: An Estimate of Costs and Savings for the Healthy Families Act,Valuing Good Health: An Estimate of Costs and Savings for the Healthy Families Act,"[['Vicky', '', 'Lovell']]",,0,"[u'http://www.iwpr.org/pdf/PrePub_B248.pdf', u'http://paidsickdaysca.org/learn/IWPR_ValuingGoodHealth.pdf', u'http://www.iwpr.org/pdf/B248.pdf']"
10.2105/AJPH.67.11.1063,"Lovell, V., , Valuing Good Health in California: The Costs and Benefits of the Healthy Families, Healthy Workplaces Act of 2008, , 2008",cited-by,"5137586Valuing Good Health in California: The Costs and Benefits of the Healthy Families, Healthy Workplaces Act of 2008","Valuing Good Health in California: The Costs and Benefits of the Healthy Families, Healthy Workplaces Act of 2008","[['Vicky', '', 'Lovell']]",,2008,"[u'http://paidsickdaysca.org/learn/IWPR_CA_report.pdf', u'http://www.iwpr.org/pdf/B259capsd.pdf']"
10.2105/AJPH.67.11.1063,"Miller, M., , Considerations for adding pneumonia and influenza vaccines to public health programmes, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00115-2,Considerations for adding pneumonia and influenza vaccines to public health programmes,"[['Mark', 'A', 'Miller']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99001152', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99001152']"
10.2105/AJPH.67.11.1063,"Tuells, J., , La gripe del cerdo (1976): cuando el pánico y la política toman las decisiones, Vacunas, 2007",cited-by,10.1016/S1576-9887(07)73982-1,La gripe del cerdo (1976): cuando el pánico y la política toman las decisiones,"[['J.', '', 'Tuells']]",Vacunas,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1576988707739821', u'http://linkinghub.elsevier.com/retrieve/pii/S1576988707739821']"
10.2105/AJPH.67.11.1063,"Lovell, V., , Valuing Good Health in San Francisco: The Costs and Benefits of a Proposed Paid Sick Days Policy, , 0",cited-by,5311694Valuing Good Health in San Francisco: The Costs and Benefits of a Proposed Paid Sick Days Policy,Valuing Good Health in San Francisco: The Costs and Benefits of a Proposed Paid Sick Days Policy,"[['Vicky', '', 'Lovell']]",,0,[u'http://www.iwpr.org/pdf/B252.pdf']
10.2105/AJPH.67.11.1063,"Lovell, V., , Valuing Good Health in Massachusetts: An Estimate of Costs and Savings for the Paid Sick Days Act 1, , 0",cited-by,10818092Valuing Good Health in Massachusetts: An Estimate of Costs and Savings for the Paid Sick Days Act 1,Valuing Good Health in Massachusetts: An Estimate of Costs and Savings for the Paid Sick Days Act 1,"[['Vicky', '', 'Lovell']]",,0,"[u'http://www.iwpr.org/pdf/B249.pdf', u'http://www.gbls.org/employment/PDS_Acostest_3_may_05.pdf']"
10.2105/AJPH.67.11.1063,"Tuellsa, J., , La gripe del cerdo (1976): cuando el pánico y la política toman las decisiones, , 2011",cited-by,10184101La gripe del cerdo (1976): cuando el pánico y la política toman las decisiones,La gripe del cerdo (1976): cuando el pánico y la política toman las decisiones,"[['J.', '', 'Tuellsa']]",,2011,"[u'http://www.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13109043&pident_usuario=0&pcontactid=&pident_revista=72&ty=12&accion=s&origen=elsevier&web=www.elsevier.es&lan=es&fichero=72v08n02a13109043pdf001.pdf', u'http://www.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13109043&pident_usuario=0&pcontactid=&pident_revista=72&ty=12&accion=l&origen=elsevier&web=www.elsevier.es&lan=es&fichero=72v08n02a13109043pdf001.pdf', u'http://www.vacunas.org/images/stories/recursos/varios/2009/TUELLS_Vacunas_2007_gripe_cerdo1976.pdf']"
10.2105/AJPH.67.11.1063,"Shim, E., Meyers, L., Galvani, A., , Optimal H1N1 vaccination strategies based on self-interest versus group interest, BMC Public Health, 2011",cited-by,10.1186/1471-2458-11-S1-S4,Optimal H1N1 vaccination strategies based on self-interest versus group interest,"[['Eunha', '', 'Shim'], ['Lauren', 'Ancel', 'Meyers'], ['Alison', 'P', 'Galvani']]",BMC Public Health,2011,"[u'http://www.biomedcentral.com/1471-2458-11-S1-S4', u'http://www.biomedcentral.com/content/pdf/1471-2458-11-S1-S4.pdf', u'http://www.biomedcentral.com/content/pdf/1471-2458-11-S1-info.pdf', u'http://www.springerlink.com/content/n085hk1h27l8014w', u'http://www.springerlink.com/index/n085hk1h27l8014w.pdf']"
10.2105/AJPH.67.11.1063,"Talbird, S., Brogan, A., Winiarski, A., , Oseltamivir for Influenza Postexposure Prophylaxis, American Journal of Preventive Medicine, 2009",cited-by,10.1016/j.amepre.2009.08.012,Oseltamivir for Influenza Postexposure Prophylaxis,"[['Sandra', 'E.', 'Talbird'], ['Anita', 'J.', 'Brogan'], ['Aleksander', 'P.', 'Winiarski']]",American Journal of Preventive Medicine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0749379709005273', u'http://linkinghub.elsevier.com/retrieve/pii/S0749379709005273']"
10.2105/AJPH.67.11.1063,"Fernández, J., , Análisis de un modelo económico de una estrategia poblacional de vacunación gripal en trabajadores sanos, Revista Espanola De Salud Publica, 2006",cited-by,10.1590/S1135-57272006000300002,Análisis de un modelo económico de una estrategia poblacional de vacunación gripal en trabajadores sanos,"[['Jesus', 'Mart\xc3\xadn', 'Fern\xc3\xa1ndez']]",Revista Espanola De Salud Publica,2006,"[u'http://redalyc.uaemex.mx/redalyc/pdf/170/17080302.pdf', u'http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272006000300002&lng=es&nrm=iso&tlng=es']"
10.2105/AJPH.67.11.1063,"Sheikha, N., Younis, A., , Administrative factors affecting employees absenteeism in academic and public libraries in Jordan, International Information & Library Review, 2006",cited-by,10.1016/j.iilr.2006.02.002,Administrative factors affecting employees absenteeism in academic and public libraries in Jordan,"[['Nader', 'Ahmad Abu', 'Sheikha'], ['Abdul', 'Razeq M.', 'Younis']]",International Information & Library Review,2006,"[u'http://www.sciencedirect.com/science/article/pii/S1057231706000142', u'http://linkinghub.elsevier.com/retrieve/pii/S1057231706000142']"
10.2105/AJPH.67.11.1063,"Tasset-Tisseau, A., Plun-Favreau, J., Turan, E., et. al, Influenza corporate vaccination programs: an international modelling approach, International Congress Series, 2004",cited-by,10.1016/j.ics.2004.02.093,Influenza corporate vaccination programs: an international modelling approach,"[['A', '', 'Tasset-Tisseau'], ['J', '', 'Plun-Favreau'], ['E', '', 'Turan'], ['J', '', 'Sta-Ana'], ['N', '', 'Braham-Sygitowicz']]",International Congress Series,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0531513104002250', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513104002250']"
10.2105/AJPH.67.11.1063,"Ruoff, G., , Zanamivir for the management of influenza, Current Therapeutic Research-clinical and Experimental, 2000",cited-by,10.1016/S0011-393X(00)90002-X,Zanamivir for the management of influenza,"[['Gary', 'E.', 'Ruoff']]",Current Therapeutic Research-clinical and Experimental,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0011393X0090002X', u'http://linkinghub.elsevier.com/retrieve/pii/S0011393X0090002X']"
10.2105/AJPH.67.11.1063,"Schell, K., , La vaccination contre les maladies virales, Sozial-und Praventivmedizin, 1979",cited-by,10.1007/BF02083602,La vaccination contre les maladies virales,"[['K.', 'R.', 'Schell']]",Sozial-und Praventivmedizin,1979,"[u'http://www.springerlink.com/index/10.1007/BF02083602', u'http://www.springerlink.com/index/pdf/10.1007/BF02083602']"
10.2105/AJPH.67.11.1063,"Schell, K., , Vaccination against virus diseases, Sozial-und Praventivmedizin, 1979",cited-by,10.1007/BF02083602,Vaccination against virus diseases,"[['K.', 'R.', 'Schell']]",Sozial-und Praventivmedizin,1979,"[u'http://www.springerlink.com/index/tx8h5r7287622070.pdf', u'http://www.springerlink.com/content/tx8h5r7287622070']"
10.2105/AJPH.67.11.1063,"Miller, K., Williams, C., , Women's Policy Research Valuing Good Health in New Hampshire: The Costs and Benefits of Paid Sick Days, , 0",cited-by,10127171Women's Policy Research Valuing Good Health in New Hampshire: The Costs and Benefits of Paid Sick Days,Women's Policy Research Valuing Good Health in New Hampshire: The Costs and Benefits of Paid Sick Days,"[['Kevin', '', 'Miller'], ['Claudia', '', 'Williams']]",,0,"[u'http://www.nhwomen.org/pdf/B276NH.pdf', u'http://www.iwpr.org/pdf/B276NH.pdf', u'http://www.iwpr.org/pdf/B281Maine.pdf', u'http://www.iwpr.org/pdf/B268Mass.pdf']"
10.2105/AJPH.67.11.1063,"Mahayiddin, A., , EFFECTIVENESS OF INFLUENZA VACCINATION IN PREVENTION OF INFLUENZA-LIKE ILLNESS AMONG INHABITANTS OF OLD FOLK HOMES, , 0",cited-by,11132942EFFECTIVENESS OF INFLUENZA VACCINATION IN PREVENTION OF INFLUENZA-LIKE ILLNESS AMONG INHABITANTS OF OLD FOLK HOMES,EFFECTIVENESS OF INFLUENZA VACCINATION IN PREVENTION OF INFLUENZA-LIKE ILLNESS AMONG INHABITANTS OF OLD FOLK HOMES,"[['Aziah', 'Ahmad', 'Mahayiddin']]",,0,[u'http://www.tm.mahidol.ac.th/seameo/2007_38_5/08-4094.pdf']
10.2105/AJPH.67.11.1063,"Miller, K., Williams, C., , Women's Policy Research Valuing Good Health in North Carolina: The Costs and Benefits of Paid Sick Days, , 0",cited-by,11590495Women's Policy Research Valuing Good Health in North Carolina: The Costs and Benefits of Paid Sick Days,Women's Policy Research Valuing Good Health in North Carolina: The Costs and Benefits of Paid Sick Days,"[['Kevin', '', 'Miller'], ['Claudia', '', 'Williams']]",,0,[u'http://www.iwpr.org/pdf/B273NCCBA.pdf']
10.2105/AJPH.67.11.1063,"Wenzel, R., , Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor, , 0",cited-by,12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,"[['Richard', 'P.', 'Wenzel']]",,0,[u'http://jama.ama-assn.org/cgi/reprint/283/8/1016.pdf']
10.1001~jama.283.8.1016,Schoenbaum SC. Economic impact of influenza. Am J Med. 1987;82(suppl 6A):26-30.,references,NOT found in MAS
10.1001~jama.283.8.1016,"Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med. 1989;321:1696-1702.",references,10.1056/NEJM198912213212502,Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in Families,"[[u'Frederick', u'G.', u'Hayden'], [u'Robert', u'B.', u'Belshe'], [u'Richard', u'D.', u'Clover'], [u'Alan', u'J.', u'Hay'], [u'Marion', u'G.', u'Oakes'], [u'Whaijen', u'', u'Soo']]",New England Journal of Medicine,1989,[u'http://www.nejm.org/doi/abs/10.1056/NEJM198912213212502'],./output/10.1001~jama.283.8.1016/10.1056~NEJM198912213212502
10.1056/NEJM198912213212502,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']"
10.1056/NEJM198912213212502,"Bright, R., Shay, D., Shu, B., et. al, Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States, Jama-journal of The American Medical Association, 2006",cited-by,10.1001/jama.295.8.joc60020,Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States,"[['Rick', 'A.', 'Bright'], ['David', 'K.', 'Shay'], ['Bo', '', 'Shu'], ['Nancy', 'J.', 'Cox'], ['Alexander', 'I.', 'Klimov']]",Jama-journal of The American Medical Association,2006,"[u'http://jama.ama-assn.org/cgi/reprint/295/8/891.pdf', u'http://jama.ama-assn.org/cgi/doi/10.1001/jama.295.8.joc60020']"
10.1056/NEJM198912213212502,"Bright, R., Medina, M., Xu, X., et. al, Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern, Lancet, 2005",cited-by,10.1016/S0140-6736(05)67338-2,Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern,"[['Rick', 'A', 'Bright'], ['Marie-jo', '', 'Medina'], ['Xiyan', '', 'Xu'], ['Gilda', '', 'Perez-Oronoz'], ['Teresa', 'R', 'Wallis'], ['Xiaohong', 'M', 'Davis'], ['Laura', '', 'Povinelli'], ['Nancy', 'J', 'Cox'], ['Alexander', 'I', 'Klimov']]",Lancet,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0140673605673382', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673605673382']"
10.1056/NEJM198912213212502,"Tablan, O., Anderson, L., Besser, R., et. al, GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By, , 0",cited-by,"13520052GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By","GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By","[['Ofelia', 'C.', 'Tablan'], ['Larry', 'J.', 'Anderson'], ['Richard', '', 'Besser'], ['Carolyn', '', 'Bridges'], ['Rana', '', 'Hajjeh']]",,0,"[u'http://origin.cdc.gov/hicpac/pdf/guidelines/hapneu2003guidelines.pdf', u'http://www.cdc.gov/hicpac/pdf/guidelines/hapneu2003guidelines.pdf']"
10.1056/NEJM198912213212502,"Heikkinen, T., Järvinen, A., , The common cold, Lancet, 2003",cited-by,10.1016/S0140-6736(03)12162-9,The common cold,"[['Terho', '', 'Heikkinen'], ['Asko', '', 'J\xc3\xa4rvinen']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603121629', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603121629']"
10.1056/NEJM198912213212502,"Salgado, C., Farr, B., Hall, K., et. al, Influenza in the acute hospital setting, Lancet Infectious Diseases, 2002",cited-by,10.1016/S1473-3099(02)00221-9,Influenza in the acute hospital setting,"[['Cassandra', 'D', 'Salgado'], ['Barry', 'M', 'Farr'], ['Keri', 'K', 'Hall'], ['Frederick', 'G', 'Hayden']]",Lancet Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1473309902002219', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309902002219', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/preparedness/preparedness-13.pdf']"
10.1056/NEJM198912213212502,"Monto, A., McKimm-Breschkin, J., Macken, C., et. al, Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.01339-05,Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use,"[['Arnold', 'S.', 'Monto'], ['J.', 'L.', 'McKimm-Breschkin'], ['Catherine', '', 'Macken'], ['Alan', 'W.', 'Hampson'], ['Alan', '', 'Hay'], ['Alexander', '', 'Klimov'], ['Masato', '', 'Tashiro'], ['Robert', 'G.', 'Webster'], ['Michelle', '', 'Aymard'], ['Frederick', 'G.', 'Hayden'], ['Maria', '', 'Zambon']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/doi/10.1128/AAC.01339-05', u'http://aac.asm.org/cgi/reprint/50/7/2395.pdf']"
10.1056/NEJM198912213212502,"Wang, P., Zhang, J., Guan, Y., et. al, Distribution of Amantadine‐Resistant H5N1 Avian Influenza Variants in Asia, Journal of Infectious Diseases, 2006",cited-by,10.1086/504723,Distribution of Amantadine‐Resistant H5N1 Avian Influenza Variants in Asia,"[['Pui', '', 'Wang'], ['Jinxia', '', 'Zhang'], ['Yi', '', 'Guan'], ['Honglin', '', 'Chen']]",Journal of Infectious Diseases,2006,"[u'http://hub.hku.hk/bitstream/123456789/45168/1/121229.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/504723']"
10.1056/NEJM198912213212502,"McKimm-Breschkin, J., Trivedi, T., Hampson, A., et. al, Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir, Antimicrobial Agents and Chemotherapy, 2003",cited-by,10.1128/AAC.47.7.2264-2272.2003,Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir,"[['J.', '', 'McKimm-Breschkin'], ['T.', '', 'Trivedi'], ['A.', '', 'Hampson'], ['A.', '', 'Hay'], ['A.', '', 'Klimov'], ['M.', '', 'Tashiro'], ['F.', '', 'Hayden'], ['M.', '', 'Zambon']]",Antimicrobial Agents and Chemotherapy,2003,"[u'http://aac.highwire.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.47.7.2264-2272.2003']"
10.1056/NEJM198912213212502,"Yen, H., Herlocher, L., Hoffmann, E., et. al, Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.10.4075-4084.2005,Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility,"[['Hui-Ling', '', 'Yen'], ['Louise', 'M.', 'Herlocher'], ['Erich', '', 'Hoffmann'], ['Mikhail', 'N.', 'Matrosovich'], ['Arnold', 'S.', 'Monto'], ['Robert', 'G.', 'Webster'], ['Elena', 'A.', 'Govorkova']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/10/4075.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.10.4075-4084.2005']"
10.1056/NEJM198912213212502,"Suzuki, H., Saito, R., Masuda, H., et. al, Emergence of amantadine-resistant influenza A viruses: epidemiological study, Journal of Infection and Chemotherapy, 2003",cited-by,10.1007/s10156-003-0262-6,Emergence of amantadine-resistant influenza A viruses: epidemiological study,"[['Hiroshi', '', 'Suzuki'], ['Reiko', '', 'Saito'], ['Hiroki', '', 'Masuda'], ['Hitoshi', '', 'Oshitani'], ['Mizuho', '', 'Sato'], ['Isamu', '', 'Sato']]",Journal of Infection and Chemotherapy,2003,"[u'http://www.springerlink.com/content/8k93grcjhcjm93dr', u'http://www.springerlink.com/index/8k93grcjhcjm93dr.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s10156-003-0262-6', u'http://www.springerlink.com/index/pdf/10.1007/s10156-003-0262-6']"
10.1056/NEJM198912213212502,"GUBAREVA, L., BETHELL, R., HART, G., et. al, Characterization of Mutants of Influenza A Virus Selected with the Neuraminidase Inhibitor 4-Guanidino-Neu5Ac2en, , 1996",cited-by,6119882Characterization of Mutants of Influenza A Virus Selected with the Neuraminidase Inhibitor 4-Guanidino-Neu5Ac2en,Characterization of Mutants of Influenza A Virus Selected with the Neuraminidase Inhibitor 4-Guanidino-Neu5Ac2en,"[['L.', 'V.', 'GUBAREVA'], ['R.', '', 'BETHELL'], ['G.', 'J.', 'HART'], ['K.', 'G.', 'MURTI'], ['C.', 'R.', 'PENN'], ['ANDR.', 'G.', 'WEBSTER']]",,1996,[u'http://jvi.asm.org/cgi/reprint/70/3/1818.pdf']
10.1056/NEJM198912213212502,"Tisdale, M., , Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors, Reviews in Medical Virology, 2000",cited-by,10.1002/(SICI)1099-1654(200001/02)10:1<45::AID-RMV265>3.0.CO;2-R,Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors,"[['Margaret', '', 'Tisdale']]",Reviews in Medical Virology,2000,[u'http://doi.wiley.com/10.1002/%28SICI%291099-1654%28200001/02%2910%3A1%3C45%3A%3AAID-RMV265%3E3.0.CO%3B2-R']
10.1056/NEJM198912213212502,"Peters, P., Gravenstein, S., Norwood, P., et. al, Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population, Journal of The American Geriatrics Society, 2001",cited-by,10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[['Patrick', 'H.', 'Peters'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Norwood'], ['Veerle', 'De', 'Bock'], ['Anthony', 'Van', 'Couter'], ['Michael', '', 'Gibbens'], ['Tony-Andrea', 'Von', 'Planta'], ['Penelope', '', 'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x']
10.1056/NEJM198912213212502,"Barnett, J., Lewis, A., Cadman, A., et. al, Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies, Antimicrobial Agents and Chemotherapy, 2000",cited-by,10.1128/AAC.44.1.78-87.2000,Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies,"[['J.', 'M.', 'Barnett'], ['A.', 'P.', 'Lewis'], ['A.', '', 'Cadman'], ['D.', '', 'Gor'], ['M.', '', 'Dempsey'], ['M.', '', 'Walters'], ['A.', '', 'Candlin'], ['M.', '', 'Tisdale'], ['Groot', 'de', 'R'], ['P.', 'J.', 'Morley'], ['I.', 'J.', 'Owens'], ['G.', 'F.', 'Rimmelzwaan'], ['R.', 'J.', 'Fenton'], ['E.', 'C. J.', 'Claas'], ['A.', 'D. M. E.', 'Osterhaus']]",Antimicrobial Agents and Chemotherapy,2000,"[u'http://aac.asm.org/cgi/reprint/44/1/78.pdf', u'http://publishing.eur.nl/ir/repub/asset/9217/10602727.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.44.1.78-87.2000']"
10.1056/NEJM198912213212502,"Herlocher, M., Carr, J., Ives, J., et. al, Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00214-5,Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets,"[['M.', 'L', 'Herlocher'], ['J', '', 'Carr'], ['J', '', 'Ives'], ['S', '', 'Elias'], ['R', '', 'Truscon'], ['N', '', 'Roberts'], ['A.', 'S', 'Monto']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201002145', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201002145']"
10.1056/NEJM198912213212502,"Zambon, M., Hayden, F., , Position statement: global neuraminidase inhibitor susceptibility network, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00124-3,Position statement: global neuraminidase inhibitor susceptibility network,"[['Maria', '', 'Zambon'], ['Frederick', 'G.', 'Hayden']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001243', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001243']"
10.1056/NEJM198912213212502,"Mast, E., Harmon, M., Gravenstein, S., et. al, Emergence and Possible Transmission of Amantadine resistant Viruses during Nursing Home Outbreaks of Influenza A (H3N2), , 0",cited-by,5784778Emergence and Possible Transmission of Amantadine resistant Viruses during Nursing Home Outbreaks of Influenza A (H3N2),Emergence and Possible Transmission of Amantadine resistant Viruses during Nursing Home Outbreaks of Influenza A (H3N2),"[['Eric', 'E.', 'Mast'], ['Maurice', 'W.', 'Harmon'], ['Stefan', '', 'Gravenstein'], ['Si', 'Ping', 'Wu'], ['Nancy', 'H.', 'Arden'], ['Richard', '', 'Circo'], ['Gail', '', 'Tyszka'], ['Alan', 'P.', 'Kendal'], ['Jeffrey', 'P.', 'Davis']]",,0,[u'http://aje.oxfordjournals.org/cgi/reprint/134/9/988.pdf']
10.1056/NEJM198912213212502,"Ferguson, N., Mallett, S., Jackson, H., et. al, A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals, , 2003",cited-by,6946003A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals,A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals,"[['Neil', 'M.', 'Ferguson'], ['Susan', '', 'Mallett'], ['Helen', '', 'Jackson'], ['Noel', '', 'Roberts'], ['Penelope', '', 'Ward']]",,2003,"[u'http://jac.oxfordjournals.org/cgi/reprint/51/4/977.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkg136v1.pdf']"
10.1056/NEJM198912213212502,"Monto, A., , The role of antivirals in the control of influenza, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00075-6,The role of antivirals in the control of influenza,"[['Arnold', 'S.', 'Monto']]",Vaccine,2003,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-18.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X03000756', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/prevention/prevention-8.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03000756']"
10.1056/NEJM198912213212502,"Gravenstein, S., , Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America, Clinical Infectious Diseases, 2009",cited-by,10.1086/598513,"Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America","[['Stefan', '', 'Gravenstein']]",Clinical Infectious Diseases,2009,"[u'http://www.uphs.upenn.edu/bugdrug/antibiotic_manual/idsainfluenza2009.pdf', u'http://linmed.files.wordpress.com/2009/05/flu_guideline_2009.pdf', u'http://maladiesinfectieuses.hug-ge.ch/_library/pdf/influenza.pdf', u'http://www.srlf.org/Data/upload/file/Grippe%20A/(26)%20-%20Recos%20Flu%20IDSA%202009.pdf', u'http://www.maine.gov/dhhs/boh/ddc/epi/influenzatoolkit/Supporting%20documents/IDSA%20Seasonal%20Guidelines.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/598513']"
10.1056/NEJM198912213212502,"Furuta, Y., Takahashi, K., Fukuda, Y., et. al, In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.977-981.2002,In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705,"[['Y.', '', 'Furuta'], ['K.', '', 'Takahashi'], ['Y.', '', 'Fukuda'], ['M.', '', 'Kuno'], ['T.', '', 'Kamiyama'], ['K.', '', 'Kozaki'], ['N.', '', 'Nomura'], ['H.', '', 'Egawa'], ['S.', '', 'Minami'], ['Y.', '', 'Watanabe'], ['H.', '', 'Narita'], ['K.', '', 'Shiraki']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://journals.pasteur.ac.ir/aac02/46(4)/977.pdf', u'http://aac.asm.org/cgi/reprint/46/4/977.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.977-981.2002']"
10.1056/NEJM198912213212502,", Community Respiratory Virus Infections in Immunocompromised Patients with Cancer, American Journal of Medicine, 1997",cited-by,10.1016/S0002-9343(97)80004-6,Community Respiratory Virus Infections in Immunocompromised Patients with Cancer,[],American Journal of Medicine,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0002934397800046', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934397800046']"
10.1056/NEJM198912213212502,"Stiver, G., , The treatment of influenza with antiviral drugs, , 0",cited-by,10332941The treatment of influenza with antiviral drugs,The treatment of influenza with antiviral drugs,"[['Grant', '', 'Stiver']]",,0,"[u'http://www.ualberta.ca/~mlalu/ref03.pdf', u'http://www.ualberta.ca/~mlalu/CMAJantiviral.pdf', u'http://www.cmaj.ca/cgi/reprint/168/1/49.pdf']"
10.1056/NEJM198912213212502,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']"
10.1056/NEJM198912213212502,"Treanor, J., Falsey, A., , Respiratory viral infections in the elderly, Antiviral Research, 1999",cited-by,10.1016/S0166-3542(99)00062-5,Respiratory viral infections in the elderly,"[['John', '', 'Treanor'], ['Ann', '', 'Falsey']]",Antiviral Research,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166354299000625', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354299000625']"
10.1056/NEJM198912213212502,"Hayden, F., , Antivirals for influenza: Historical perspectives and lessons learned, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.05.016,Antivirals for influenza: Historical perspectives and lessons learned,"[['Frederick', 'G.', 'Hayden']]",Antiviral Research,2006,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-10.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354206001653', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206001653']"
10.1056/NEJM198912213212502,"Monto, A., , Viral respiratory infections in the community: Epidemiology, agents, and interventions, American Journal of Medicine, 1995",cited-by,10.1016/S0002-9343(99)80307-6,"Viral respiratory infections in the community: Epidemiology, agents, and interventions","[['Arnold', 'S.', 'Monto']]",American Journal of Medicine,1995,"[u'http://www.sciencedirect.com/science/article/pii/S0002934399803076', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934399803076']"
10.1056/NEJM198912213212502,"MONTO, A., , Occurrence of respiratory virus: time, place and person, Pediatric Infectious Disease Journal, 2004",cited-by,10.1097/01.inf.0000108193.91607.34,"Occurrence of respiratory virus: time, place and person","[['ARNOLD', 'S.', 'MONTO']]",Pediatric Infectious Disease Journal,2004,"[u'http://www.hvidovre-hospital.dk/HHmikrobiologisk.nsf/pics/Parainfluenza1.pdf/$FILE/Parainfluenza1.pdf', u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200401001-00009']"
10.1056/NEJM198912213212502,"Kimberlin, D., Whitley, R., , Antiviral resistance: mechanisms, clinical significance, and future implications, Journal of Antimicrobial Chemotherapy, 1996",cited-by,10.1093/jac/37.3.403,"Antiviral resistance: mechanisms, clinical significance, and future implications","[['David', 'W.', 'Kimberlin'], ['Richard', 'J.', 'Whitley']]",Journal of Antimicrobial Chemotherapy,1996,"[u'http://jac.oxfordjournals.org/cgi/reprint/37/3/403.pdf', u'http://jac.oxfordjournals.org/cgi/doi/10.1093/jac/37.3.403']"
10.1056/NEJM198912213212502,"Trial, A., Welliver, R., Monto, A., et. al, Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts, , 2001",cited-by,6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[['A', 'Randomized Controlled', 'Trial'], ['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz'], ['Edwig', '', 'Schatteman'], ['Michael', '', 'Hassman'], ['James', '', 'Hedrick'], ['Helen', 'C.', 'Jackson'], ['Penelope', '', 'Ward'], ['John', 'S.', 'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf']
10.1056/NEJM198912213212502,", Respiratory Viral Infections in Immunocompetent and Immunocompromised Persons, American Journal of Medicine, 1997",cited-by,10.1016/S0002-9343(97)00003-X,Respiratory Viral Infections in Immunocompetent and Immunocompromised Persons,[],American Journal of Medicine,1997,"[u'http://www.sciencedirect.com/science/article/pii/S000293439700003X', u'http://linkinghub.elsevier.com/retrieve/pii/S000293439700003X']"
10.1056/NEJM198912213212502,"Tsolia, M., Logotheti, I., Papadopoulos, N., et. al, Impact of influenza infection in healthy children examined as outpatients and their families, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.05.006,Impact of influenza infection in healthy children examined as outpatients and their families,"[['M.', 'N.', 'Tsolia'], ['I.', '', 'Logotheti'], ['N.', 'G.', 'Papadopoulos'], ['M.', '', 'Mavrikou'], ['N.', 'P.', 'Spyridis'], ['P.', '', 'Drossatou'], ['D.', '', 'Kafetzis'], ['A.', '', 'Konstantopoulos']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06005445', u'http://www.vaccini.com.br/_arquivos/reciv_influenza.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06005445']"
10.1056/NEJM198912213212502,"Schmidtke, M., Zell, R., Bauer, K., et. al, Amantadine Resistance among Porcine H1N1, H1N2, and H3N2 Influenza A Viruses Isolated in Germany between 1981 and 2001, Intervirology, 2006",cited-by,10.1159/000094244,"Amantadine Resistance among Porcine H1N1, H1N2, and H3N2 Influenza A Viruses Isolated in Germany between 1981 and 2001","[['Michaela', '', 'Schmidtke'], ['Roland', '', 'Zell'], ['Katja', '', 'Bauer'], ['Andi', '', 'Krumbholz'], ['Christina', '', 'Schrader'], ['Jochen', '', 'Suess'], ['Peter', '', 'Wutzler']]",Intervirology,2006,"[u'http://www.karger.com/doi/10.1159/000094244', u'http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000094244']"
10.1056/NEJM198912213212502,"Saito, R., Sakai, T., Sato, I., et. al, Frequency of Amantadine-Resistant Influenza A Viruses during Two Seasons Featuring Cocirculation of H1N1 and H3N2, , 2003",cited-by,12055750Frequency of Amantadine-Resistant Influenza A Viruses during Two Seasons Featuring Cocirculation of H1N1 and H3N2,Frequency of Amantadine-Resistant Influenza A Viruses during Two Seasons Featuring Cocirculation of H1N1 and H3N2,"[['Reiko', '', 'Saito'], ['Takatsugu', '', 'Sakai'], ['Isamu', '', 'Sato'], ['Yasuko', '', 'Sano'], ['Hitoshi', '', 'Oshitani'], ['Mizuho', '', 'Sato'], ['Hiroshi', '', 'Suzuki']]",,2003,[u'http://jcm.asm.org/cgi/reprint/41/5/2164.pdf']
10.1056/NEJM198912213212502,"Gravenstein, S., Drinka, P., Osterweil, D., et. al, Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.006,Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population,"[['Stefan', '', 'Gravenstein'], ['Paul', '', 'Drinka'], ['Dan', '', 'Osterweil'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult'], ['Arvydas', '', 'Ambrozaitis'], ['Ruth', '', 'Kandel'], ['Ellen', '', 'Binder'], ['Janet', '', 'Hammond'], ['Janet', '', 'McElhaney'], ['Nancy', '', 'Flack'], ['Janet', '', 'Daly'], ['Oliver', '', 'Keene']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005323', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005323']"
10.1056/NEJM198912213212502,"Padgett, K., Selmi, C., Kenny, T., et. al, Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis, Journal of Autoimmunity, 2005",cited-by,10.1016/j.jaut.2005.01.012,"Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis","[['Kerstien', 'A.', 'Padgett'], ['Carlo', '', 'Selmi'], ['Thomas', 'P.', 'Kenny'], ['Patrick', 'S. C.', 'Leung'], ['David', 'L.', 'Balkwill'], ['Aftab', 'A.', 'Ansari'], ['Ross', 'L.', 'Coppel'], ['M.', 'Eric', 'Gershwin']]",Journal of Autoimmunity,2005,[u'http://www.sciencedirect.com/science/article/pii/S0896841105000156']
10.1056/NEJM198912213212502,"Dayan, G., Nguyen, V., Debbag, R., et. al, Cost-effectiveness of influenza vaccination in high-risk children in Argentina, Vaccine, 2001",cited-by,10.1016/S0264-410X(01)00160-8,Cost-effectiveness of influenza vaccination in high-risk children in Argentina,"[['Gustavo', 'H', 'Dayan'], ['Van', 'Hung', 'Nguyen'], ['Roberto', '', 'Debbag'], ['Roberto', '', 'G\xc3\xb3mez'], ['Susan', 'C', 'Wood']]",Vaccine,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X01001608', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X01001608']"
10.1056/NEJM198912213212502,"McKeegan, K., Borges-Walmsley, M., Walmsley, A., , Microbial and viral drug resistance mechanisms, Trends in Microbiology, 2002",cited-by,10.1016/S0966-842X(02)02429-0,Microbial and viral drug resistance mechanisms,"[['Kenneth', 'S.', 'McKeegan'], ['M.', 'Ines', 'Borges-Walmsley'], ['Adrian', 'R.', 'Walmsley']]",Trends in Microbiology,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0966842X02024290', u'http://linkinghub.elsevier.com/retrieve/pii/S0966842X02024290']"
10.1056/NEJM198912213212502,"Guo, C., Sun, X., Kanie, O., et. al, An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses, Glycobiology, 2002",cited-by,10.1093/glycob/12.3.183,An O-glycoside of sialic acid derivative that inhibits both hemagglutinin and sialidase activities of influenza viruses,"[['Chao-Tan', '', 'Guo'], ['Xue-Long', '', 'Sun'], ['Osamu', '', 'Kanie'], ['Kennedy', 'Francis', 'Shortridge'], ['Takashi', '', 'Suzuki'], ['Daisei', '', 'Miyamoto'], ['Kazuya', 'I.-P. Jwa', 'Hidari'], ['Chi-Huey', '', 'Wong'], ['Yasuo', '', 'Suzuki']]",Glycobiology,2002,[u'http://www.glycob.oupjournals.org/cgi/doi/10.1093/glycob/12.3.183']
10.1056/NEJM198912213212502,"Kimberlin, D., Crumpacker, C., Straus, S., et. al, Antiviral resistance in clinical practice, Antiviral Research, 1995",cited-by,10.1016/0166-3542(95)00031-G,Antiviral resistance in clinical practice,"[['David', 'W.', 'Kimberlin'], ['Clayde', 'S.', 'Crumpacker'], ['Stephen', 'E.', 'Straus'], ['Karen', 'K.', 'Biron'], ['W.', 'Lawrence', 'Drew'], ['Frederick', 'G.', 'Hayden'], ['Mark', '', 'McKinlay'], ['Douglas', 'D.', 'Richman'], ['Richard', 'J.', 'Whitley']]",Antiviral Research,1995,"[u'http://www.sciencedirect.com/science/article/pii/016635429500031G', u'http://linkinghub.elsevier.com/retrieve/pii/016635429500031G']"
10.1056/NEJM198912213212502,"Saito, R., Oshitani, H., Masuda, H., et. al, Detection of Amantadine-Resistant Influenza A Virus Strains in Nursing Homes by PCR-Restriction Fragment Length Polymorphism Analysis with Nasopharyngeal Swabs, , 0",cited-by,12069034Detection of Amantadine-Resistant Influenza A Virus Strains in Nursing Homes by PCR-Restriction Fragment Length Polymorphism Analysis with Nasopharyngeal Swabs,Detection of Amantadine-Resistant Influenza A Virus Strains in Nursing Homes by PCR-Restriction Fragment Length Polymorphism Analysis with Nasopharyngeal Swabs,"[['Reiko', '', 'Saito'], ['Hitoshi', '', 'Oshitani'], ['Hiroki', '', 'Masuda'], ['Hiroshi', '', 'Suzuki']]",,0,[u'http://jcm.asm.org/cgi/reprint/40/1/84.pdf']
10.1056/NEJM198912213212502,"Nijhuis, M., Maarseveen, N., Boucher, C., , Antiviral Resistance and Impact on Viral Replication Capacity: Evolution of Viruses Under Antiviral Pressure Occurs in Three Phases, , 0",cited-by,10.1007/978-3-540-79086-0_11,Antiviral Resistance and Impact on Viral Replication Capacity: Evolution of Viruses Under Antiviral Pressure Occurs in Three Phases,"[['M.', '', 'Nijhuis'], ['N.', 'M. van', 'Maarseveen'], ['C.', 'A. B.', 'Boucher']]",,0,"[u'http://www.springerlink.com/content/t578u6g08v204m71', u'http://www.springerlink.com/index/t578u6g08v204m71.pdf']"
10.1056/NEJM198912213212502,"Ray, K., Potdar, V., Cherian, S., et. al, Characterization of the complete genome of influenza A (H5N1) virus isolated during the 2006 outbreak in poultry in India, Virus Genes, 2008",cited-by,10.1007/s11262-007-0195-8,Characterization of the complete genome of influenza A (H5N1) virus isolated during the 2006 outbreak in poultry in India,"[['Koninika', '', 'Ray'], ['Varsha', 'A.', 'Potdar'], ['Sarah', 'S.', 'Cherian'], ['Shailesh', 'D.', 'Pawar'], ['Santosh', 'M.', 'Jadhav'], ['Shamal', 'R.', 'Waregaonkar'], ['Anshu', 'A.', 'Joshi'], ['Akhilesh', 'C.', 'Mishra']]",Virus Genes,2008,"[u'http://www.springerlink.com/content/b2m26633325u02h8', u'http://www.springerlink.com/index/b2m26633325u02h8.pdf', u'http://www.springerlink.com/index/10.1007/s11262-007-0195-8', u'http://www.springerlink.com/index/pdf/10.1007/s11262-007-0195-8']"
10.1056/NEJM198912213212502,"Jr, J., Michaelis, M., Doerr, H., , The threat of avian influenza A (H5N1). Part III: antiviral therapy, Medical Microbiology and Immunology, 2007",cited-by,10.1007/s00430-007-0048-z,The threat of avian influenza A (H5N1). Part III: antiviral therapy,"[['Jindrich', 'Cinatl', 'Jr'], ['Martin', '', 'Michaelis'], ['Hans', 'W.', 'Doerr']]",Medical Microbiology and Immunology,2007,"[u'http://www.springerlink.com/index/41xpm470518281m7.pdf', u'http://www.springerlink.com/content/41xpm470518281m7', u'http://www.springerlink.com/index/10.1007/s00430-007-0048-z', u'http://www.springerlink.com/index/pdf/10.1007/s00430-007-0048-z']"
10.1056/NEJM198912213212502,"Monto, A., Moult, A., Sharp, S., , Effect of zanamivir on duration and resolution of influenza symptoms, Clinical Therapeutics, 2000",cited-by,10.1016/S0149-2918(00)83026-X,Effect of zanamivir on duration and resolution of influenza symptoms,"[['Arnold', 'S.', 'Monto'], ['Andrew', 'B.', 'Moult'], ['Stephen', 'J.', 'Sharp']]",Clinical Therapeutics,2000,"[u'http://www.sciencedirect.com/science/article/pii/S014929180083026X', u'http://linkinghub.elsevier.com/retrieve/pii/S014929180083026X']"
10.1056/NEJM198912213212502,"Nguyen-Van-Tam, J., Nicholson, K., , Influenza deaths in Leicestershire during the 1989–90 epidemic: implications for prevention, Epidemiology and Infection, 1992",cited-by,10.1017/S0950268800050032,Influenza deaths in Leicestershire during the 1989–90 epidemic: implications for prevention,"[['J.', 'S.', 'Nguyen-Van-Tam'], ['K.', 'G.', 'Nicholson']]",Epidemiology and Infection,1992,[u'http://www.journals.cambridge.org/abstract_S0950268800050032']
10.1056/NEJM198912213212502,"Yen, H., Webster, R., , Pandemic Influenza as a Current Threat, , 0",cited-by,10.1007/978-3-540-92165-3_1,Pandemic Influenza as a Current Threat,"[['Hui-Ling', '', 'Yen'], ['Robert', 'G.', 'Webster']]",,0,"[u'http://www.springerlink.com/index/v165143460m7u34q.pdf', u'http://www.springerlink.com/content/v165143460m7u34q']"
10.1056/NEJM198912213212502,"D’Heilly, S., Janoff, E., Nichol, P., et. al, Rapid diagnosis of influenza infection in older adults: Influence on clinical care in a routine clinical setting, Journal of Clinical Virology, 2008",cited-by,10.1016/j.jcv.2007.12.014,Rapid diagnosis of influenza infection in older adults: Influence on clinical care in a routine clinical setting,"[['Sarah', 'J.', 'D\xe2\x80\x99Heilly'], ['Edward', 'N.', 'Janoff'], ['Paul', '', 'Nichol'], ['Kristin', 'L.', 'Nichol']]",Journal of Clinical Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1386653208000176', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653208000176']"
10.1056/NEJM198912213212502,"Luce, B., Nichol, K., Belshe, R., et. al, Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.03.046,Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States,"[['Bryan', 'R.', 'Luce'], ['Kristin', 'L.', 'Nichol'], ['Robert', 'B.', 'Belshe'], ['Kevin', 'D.', 'Frick'], ['Su', 'Xia', 'Li'], ['Audra', '', 'Boscoe'], ['Matthew', 'D.', 'Rousculp'], ['Parthiv', 'J.', 'Mahadevia']]",Vaccine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X08003800', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08003800']"
10.1056/NEJM198912213212502,"HAY, A., PYKE, S., , Recovery ofDrug-Resistant Influenza A Virusduring Therapeutic UseofRimantadine, , 0",cited-by,10272174Recovery ofDrug-Resistant Influenza A Virusduring Therapeutic UseofRimantadine,Recovery ofDrug-Resistant Influenza A Virusduring Therapeutic UseofRimantadine,"[['ALAN', 'J.', 'HAY'], ['STEPHEN', '', 'PYKE']]",,0,[]
10.1056/NEJM198912213212502,"Ruigrok, R., Hirst, E., Hay, A., , The Specific Inhibition of Influenza A Virus Maturation by Amantadine: An Electron Microscopic Examination, Journal of General Virology, 1991",cited-by,10.1099/0022-1317-72-1-191,The Specific Inhibition of Influenza A Virus Maturation by Amantadine: An Electron Microscopic Examination,"[['R.', 'W. H.', 'Ruigrok'], ['E.', 'M. A.', 'Hirst'], ['A.', 'J.', 'Hay']]",Journal of General Virology,1991,"[u'http://vir.sgmjournals.org/cgi/reprint/72/1/191.pdf', u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-72-1-191']"
10.1056/NEJM198912213212502,"McCauley, J., Pullen, L., Forsyth, M., et. al, 4-Guanidino-Neu5Ac2en fails to protect chickens from infection with highly pathogenic avian influenza virus, Antiviral Research, 1995",cited-by,10.1016/0166-3542(95)00005-7,4-Guanidino-Neu5Ac2en fails to protect chickens from infection with highly pathogenic avian influenza virus,"[['J.', 'W.', 'McCauley'], ['L.', 'A.', 'Pullen'], ['M.', '', 'Forsyth'], ['C.', 'R.', 'Penn'], ['G.', 'P.', 'Thomas']]",Antiviral Research,1995,"[u'http://www.sciencedirect.com/science/article/pii/0166354295000057', u'http://linkinghub.elsevier.com/retrieve/pii/0166354295000057']"
10.1056/NEJM198912213212502,"Kendal, A., Klenk, H., , Amantadine inhibits an early, M 2 protein-dependent event in the replication cycle of avian influenza (H 7) viruses, Archives of Virology, 1991",cited-by,10.1007/BF01310675,"Amantadine inhibits an early, M 2 protein-dependent event in the replication cycle of avian influenza (H 7) viruses","[['A.', 'P.', 'Kendal'], ['H.', 'D.', 'Klenk']]",Archives of Virology,1991,"[u'http://www.springerlink.com/index/w3015677t5k81200.pdf', u'http://www.springerlink.com/content/w3015677t5k81200', u'http://www.springerlink.com/index/10.1007/BF01310675', u'http://www.springerlink.com/index/pdf/10.1007/BF01310675']"
10.1056/NEJM198912213212502,"Hibbert, C., Piedra, P., McLaurin, K., et. al, Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres, Vaccine, 2007",cited-by,10.1016/j.vaccine.2007.09.018,"Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres","[['Clare', 'L.', 'Hibbert'], ['Pedro', 'A.', 'Piedra'], ['Kimmie', 'K.', 'McLaurin'], ['Timo', '', 'Vesikari'], ['Josephine', '', 'Mauskopf'], ['Parthiv', 'J.', 'Mahadevia']]",Vaccine,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X07010407', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X07010407']"
10.1056/NEJM198912213212502,"Abed, Y., Boivin, G., , Treatment of respiratory virus infections, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.01.006,Treatment of respiratory virus infections,"[['Yacine', '', 'Abed'], ['Guy', '', 'Boivin']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016635420600026X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420600026X']"
10.1056/NEJM198912213212502,"Ambrozaitis, A., Gravenstein, S., Essen, G., et. al, Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.007,Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population,"[['Arvydas', '', 'Ambrozaitis'], ['Stefan', '', 'Gravenstein'], ['Gerrit', 'A. van', 'Essen'], ['Ethan', '', 'Rubinstein'], ['Ligita', '', 'Balciuniene'], ['Ausra', '', 'Stikleryte'], ['Catriona', '', 'Crawford'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005335', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005335']"
10.1056/NEJM198912213212502,"Olshaker, J., , Influenza, Emergency Medicine Clinics of North America, 2003",cited-by,10.1016/S0733-8627(03)00018-X,Influenza,"[['Jonathan', 'S', 'Olshaker']]",Emergency Medicine Clinics of North America,2003,"[u'http://www.sciencedirect.com/science/article/pii/S073386270300018X', u'http://linkinghub.elsevier.com/retrieve/pii/S073386270300018X']"
10.1056/NEJM198912213212502,"IWAHASHI, J., TSUJI, K., ISHIBASHI, T., et. al, Isolation of Amantadine-Resistant Influenza A Viruses (H3N2) from Patients following Administration of Amantadine in Japan, , 2001",cited-by,10241861Isolation of Amantadine-Resistant Influenza A Viruses (H3N2) from Patients following Administration of Amantadine in Japan,Isolation of Amantadine-Resistant Influenza A Viruses (H3N2) from Patients following Administration of Amantadine in Japan,"[['JUN', '', 'IWAHASHI'], ['KATSURO', '', 'TSUJI'], ['TETSUYA', '', 'ISHIBASHI'], ['JUNBOKU', '', 'KAJIWARA'], ['YOSHIHIRO', '', 'IMAMURA'], ['RYOICHI', '', 'MORI'], ['KOYU', '', 'HARA'], ['TAKAHITO', '', 'KASHIWAGI'], ['YASUSHI', '', 'OHTSU'], ['NOBUYUKI', '', 'HAMADA'], ['HISAO', '', 'MAEDA'], ['MICHIKO', '', 'TOYODA'], ['TETSUYA', '', 'TOYODA']]",,2001,[u'http://jcm.asm.org/cgi/reprint/39/4/1652.pdf']
10.1056/NEJM198912213212502,"Read, C., Mohsen, A., Nguyen-Van-Tam, J., et. al, Outbreaks of influenza A in nursing homes in Sheffield during the 1997-1998 season: implications for diagnosis and control, Journal of Public Health, 2000",cited-by,10.1093/pubmed/22.1.116,Outbreaks of influenza A in nursing homes in Sheffield during the 1997-1998 season: implications for diagnosis and control,"[['C.', '', 'Read'], ['A', '', 'Mohsen'], ['J.', '', 'Nguyen-Van-Tam'], ['M', '', 'McKendrick'], ['G', '', 'Kudesia']]",Journal of Public Health,2000,"[u'http://jpubhealth.oxfordjournals.org/cgi/reprint/22/1/116.pdf', u'http://jpubhealth.oxfordjournals.org/cgi/doi/10.1093/pubmed/22.1.116']"
10.1056/NEJM198912213212502,"Hodinka, R., , WHAT CLINICIANS NEED TO KNOW ABOUT ANTIVIRAL DRUGS AND VIRAL RESISTANCE, Infectious Disease Clinics of North America, 1997",cited-by,10.1016/S0891-5520(05)70399-8,WHAT CLINICIANS NEED TO KNOW ABOUT ANTIVIRAL DRUGS AND VIRAL RESISTANCE,"[['Richard', 'L.', 'Hodinka']]",Infectious Disease Clinics of North America,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0891552005703998', u'http://linkinghub.elsevier.com/retrieve/pii/S0891552005703998']"
10.1056/NEJM198912213212502,"Prud'homme, I., Zoueva, O., Weber, J., , Amantadine susceptibility in influenza A virus isolates: determination methods and lack of resistance in a Canadian sample, 1991–1994, Clinical and Diagnostic Virology, 1997",cited-by,10.1016/S0928-0197(97)00011-1,"Amantadine susceptibility in influenza A virus isolates: determination methods and lack of resistance in a Canadian sample, 1991–1994","[['I.', 'T.', ""Prud'homme""], ['O.', '', 'Zoueva'], ['J.', 'M.', 'Weber']]",Clinical and Diagnostic Virology,1997,"[u'http://www.sciencedirect.com/science/article/pii/S0928019797000111', u'http://linkinghub.elsevier.com/retrieve/pii/S0928019797000111']"
10.1056/NEJM198912213212502,"SHAW, M., ARDEN, N., MAASSAB, H., , NewAspects ofInfluenza Viruses, , 1992",cited-by,14091884NewAspects ofInfluenza Viruses,NewAspects ofInfluenza Viruses,"[['MICHAELW.', '', 'SHAW'], ['NANCY', 'H.', 'ARDEN'], ['HUNEINF.', '', 'MAASSAB']]",,1992,[u'http://cmr.asm.org/cgi/reprint/5/1/74.pdf']
10.1056/NEJM198912213212502,"Cohen, N., Morita, J., Plate, D., et. al, Control of an Outbreak due to an Adamantane-Resistant Strain of Influenza A (H3N2) in a Chronic Care Facility, Infection, 2008",cited-by,10.1007/s15010-008-7295-9,Control of an Outbreak due to an Adamantane-Resistant Strain of Influenza A (H3N2) in a Chronic Care Facility,"[['N.', 'J.', 'Cohen'], ['J.', 'Y.', 'Morita'], ['D.', 'K.', 'Plate'], ['R.', 'C.', 'Jones'], ['M.', 'T.', 'Simon'], ['J.', '', 'Nawrocki'], ['A.', 'M.', 'Siston'], ['S.', 'I.', 'Gerber']]",Infection,2008,"[u'http://www.springerlink.com/index/g27w5w771525g937.pdf', u'http://www.springerlink.com/content/g27w5w771525g937', u'http://www.springerlink.com/index/10.1007/s15010-008-7295-9', u'http://www.springerlink.com/index/pdf/10.1007/s15010-008-7295-9']"
10.1056/NEJM198912213212502,"Wilde, J., , Rapid diagnostic testing for the identification of respiratory agents in the emergency department, Clinical Pediatric Emergency Medicine, 2002",cited-by,10.1053/epem.2002.128769,Rapid diagnostic testing for the identification of respiratory agents in the emergency department,"[['James', 'A.', 'Wilde']]",Clinical Pediatric Emergency Medicine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1522840102800052', u'http://linkinghub.elsevier.com/retrieve/pii/S1522840102800052']"
10.1056/NEJM198912213212502,"Drinka, P., Gravenstein, S., Schilling, M., et. al, Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols, , 0",cited-by,12341046Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols,Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols,"[['Paul', 'J.', 'Drinka'], ['Stefan', '', 'Gravenstein'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Barbara', 'A.', 'Miller'], ['Peter', '', 'Shult']]",,0,"[u'http://archinte.ama-assn.org/cgi/reprint/158/19/2155.pdf', u'http://archinte.highwire.org/cgi/reprint/158/19/2155.pdf']"
10.1056/NEJM198912213212502,"Aoki, F., Boivin, G., , Influenza virus shedding—Excretion patterns and effects of antiviral treatment, Journal of Clinical Virology, 2009",cited-by,10.1016/j.jcv.2009.01.010,Influenza virus shedding—Excretion patterns and effects of antiviral treatment,"[['Fred', 'Y.', 'Aoki'], ['Guy', '', 'Boivin']]",Journal of Clinical Virology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1386653209000444', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653209000444']"
10.1056/NEJM198912213212502,"Ruf, B., Szucs, T., , Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy, Infection, 2009",cited-by,10.1007/s15010-009-8241-1,Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy,"[['B.', 'R.', 'Ruf'], ['T.', '', 'Szucs']]",Infection,2009,"[u'http://www.springerlink.com/index/880245655hpk7483.pdf', u'http://www.springerlink.com/content/880245655hpk7483', u'http://www.springerlink.com/index/10.1007/s15010-009-8241-1', u'http://www.springerlink.com/index/pdf/10.1007/s15010-009-8241-1']"
10.1056/NEJM198912213212502,"Harper, S., Klimov, A., Uyeki, T., et. al, Influenza, Clinics in Laboratory Medicine, 2002",cited-by,10.1016/S0272-2712(02)00022-7,Influenza,"[['Scott', '', 'Harper'], ['Alexander', '', 'Klimov'], ['Timothy', '', 'Uyeki'], ['Keiji', '', 'Fukuda']]",Clinics in Laboratory Medicine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0272271202000227', u'http://linkinghub.elsevier.com/retrieve/pii/S0272271202000227']"
10.1056/NEJM198912213212502,"Nelson, C., Englund, J., , New approaches to the use of ribavirin, Seminars in Pediatric Infectious Diseases, 1996",cited-by,10.1016/S1045-1870(96)81007-7,New approaches to the use of ribavirin,"[['Christopher', 'T.', 'Nelson'], ['Janet', 'A.', 'Englund']]",Seminars in Pediatric Infectious Diseases,1996,"[u'http://www.sciencedirect.com/science/article/pii/S1045187096810077', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187096810077']"
10.1056/NEJM198912213212502,"Kimberlin, D., Spector, S., Hill, E., et. al, Assays for antiviral drug resistance, Antiviral Research, 1995",cited-by,10.1016/0166-3542(95)00028-K,Assays for antiviral drug resistance,"[['David', 'W.', 'Kimberlin'], ['Stephen', 'A.', 'Spector'], ['Edgar', 'L.', 'Hill'], ['Karen', 'K.', 'Biron'], ['Alan', 'J.', 'Hay'], ['Douglas', 'L.', 'Mayers'], ['Richard', 'J.', 'Whitley']]",Antiviral Research,1995,"[u'http://www.sciencedirect.com/science/article/pii/016635429500028K', u'http://linkinghub.elsevier.com/retrieve/pii/016635429500028K']"
10.1056/NEJM198912213212502,"Carlescu, I., Scutaru, D., Popa, M., et. al, Synthetic sialic-acid-containing polyvalent antiviral inhibitors, Medicinal Chemistry Research, 2009",cited-by,10.1007/s00044-008-9139-7,Synthetic sialic-acid-containing polyvalent antiviral inhibitors,"[['Irina', '', 'Carlescu'], ['Dan', '', 'Scutaru'], ['Marcel', '', 'Popa'], ['Constantin', 'V.', 'Uglea']]",Medicinal Chemistry Research,2009,"[u'http://www.springerlink.com/index/6127r24821227845.pdf', u'http://www.springerlink.com/content/6127r24821227845', u'http://www.springerlink.com/index/pdf/10.1007/s00044-008-9139-7', u'http://www.springerlink.com/index/10.1007/s00044-008-9139-7']"
10.1056/NEJM198912213212502,"Wheeler, J., , New modalities for preventing and treating influenza, Seminars in Pediatric Infectious Diseases, 2001",cited-by,10.1053/spid.2001.24104,New modalities for preventing and treating influenza,"[['J.', 'Gary', 'Wheeler']]",Seminars in Pediatric Infectious Diseases,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1045187001700106', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187001700106']"
10.1056/NEJM198912213212502,"Johnston, S., , Anti-influenza therapies, Virus Research, 2001",cited-by,10.1016/S0168-1702(01)00397-5,Anti-influenza therapies,"[['Sebastian', 'L.', 'Johnston']]",Virus Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0168170201003975', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170201003975']"
10.1056/NEJM198912213212502,"Hisaki, M., Imabori, H., Azuma, M., et. al, Synthesis and anti-influenza virus activity of novel pyrimidine derivatives, Antiviral Research, 1999",cited-by,10.1016/S0166-3542(99)00019-4,Synthesis and anti-influenza virus activity of novel pyrimidine derivatives,"[['M.', '', 'Hisaki'], ['H.', '', 'Imabori'], ['M.', '', 'Azuma'], ['T.', '', 'Suzutani'], ['F.', '', 'Iwakura'], ['Y.', '', 'Ohta'], ['K.', '', 'Kawanishi'], ['Y.', '', 'Ichigobara'], ['M.', '', 'Node'], ['K.', '', 'Nishide'], ['I.', '', 'Yoshida'], ['M.', '', 'Ogasawara']]",Antiviral Research,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166354299000194', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354299000194']"
10.1056/NEJM198912213212502,"REES, W., HARKINS, J., WOODS, W., et. al, Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse, Equine Veterinary Journal, 1997",cited-by,10.1111/j.2042-3306.1997.tb01650.x,"Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse","[['W.', 'A.', 'REES'], ['J.', 'D.', 'HARKINS'], ['W.', 'E.', 'WOODS'], ['R.', 'A.', 'BLOWN'], ['M.', '', 'LU'], ['CLARA', '', 'FENGER'], ['R.', 'E.', 'HOLLAND'], ['T.', 'M.', 'CHAMBERS'], ['T.', '', 'TOBIN']]",Equine Veterinary Journal,1997,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.2042-3306.1997.tb01650.x']
10.1056/NEJM198912213212502,"Deyde, V., Garten, R., Sheu, T., et. al, Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008, Influenza and Other Respiratory Viruses, 2009",cited-by,10.1111/j.1750-2659.2009.00103.x,Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008,"[['Varough', '', 'Deyde'], ['Rebecca', '', 'Garten'], ['Tiffany', '', 'Sheu'], ['Catherine', '', 'Smith'], ['Allison', '', 'Myrick'], ['John', '', 'Barnes'], ['Xiyan', '', 'Xu'], ['Michael', '', 'Shaw'], ['Alexander', '', 'Klimov'], ['Larisa', '', 'Gubareva']]",Influenza and Other Respiratory Viruses,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1750-2659.2009.00103.x']
10.1056/NEJM198912213212502,"Bragstad, K., Jørgensen, P., Handberg, K., et. al, Genome characterisation of the newly discovered avian influenza A H5N7 virus subtype combination, Archives of Virology, 2007",cited-by,10.1007/s00705-006-0860-6,Genome characterisation of the newly discovered avian influenza A H5N7 virus subtype combination,"[['K.', '', 'Bragstad'], ['P.', 'H.', 'J\xc3\xb8rgensen'], ['K.', 'J.', 'Handberg'], ['A.', '', 'Fomsgaard']]",Archives of Virology,2007,"[u'http://www.springerlink.com/index/r34734118086226x.pdf', u'http://www.springerlink.com/content/r34734118086226x', u'http://www.springerlink.com/index/10.1007/s00705-006-0860-6', u'http://www.springerlink.com/index/pdf/10.1007/s00705-006-0860-6']"
10.1056/NEJM198912213212502,"Kafetzis, D., , Prophylaxis, therapy and prevention of viral respiratory infections, Paediatric Respiratory Reviews, 2004",cited-by,10.1016/S1526-0542(04)90035-8,"Prophylaxis, therapy and prevention of viral respiratory infections","[['Dimitris', 'A.', 'Kafetzis']]",Paediatric Respiratory Reviews,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1526054204900358', u'http://linkinghub.elsevier.com/retrieve/pii/S1526054204900358']"
10.1056/NEJM198912213212502,"Fleming, D., , The management of influenza in people of working age, Occupational Medicine-oxford, 2002",cited-by,10.1093/occmed/52.5.259,The management of influenza in people of working age,"[['D.', 'M.', 'Fleming']]",Occupational Medicine-oxford,2002,"[u'http://occmed.oxfordjournals.org/cgi/reprint/52/5/259.pdf', u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.259']"
10.1056/NEJM198912213212502,"Prober, C., , Antiviral therapy for influenza virus infections, Seminars in Pediatric Infectious Diseases, 2002",cited-by,10.1053/spid.2002.29755,Antiviral therapy for influenza virus infections,"[['Charles', 'G', 'Prober']]",Seminars in Pediatric Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1045187002500376', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187002500376']"
10.1056/NEJM198912213212502,"Wiltink, E., Janknegt, R., , Antiviral drugs, Pharmacy World & Science, 1991",cited-by,10.1007/BF01974982,Antiviral drugs,"[['E.', 'H. H.', 'Wiltink'], ['R.', '', 'Janknegt']]",Pharmacy World & Science,1991,"[u'http://www.springerlink.com/index/q7l50657l2559044.pdf', u'http://www.springerlink.com/content/q7l50657l2559044', u'http://www.springerlink.com/index/10.1007/BF01974982', u'http://www.springerlink.com/index/pdf/10.1007/BF01974982']"
10.1056/NEJM198912213212502,"Rahman, M., Bright, R., Kieke, B., et. al, Adamantane Resistant Infl uenza Infection During the 2004-05 Season, , 0",cited-by,10657781Adamantane Resistant Infl uenza Infection During the 2004-05 Season,Adamantane Resistant Infl uenza Infection During the 2004-05 Season,"[['Mahbubur', '', 'Rahman'], ['Rick', 'A.', 'Bright'], ['Burney', 'A.', 'Kieke'], ['James', 'G.', 'Donahue'], ['Robert', 'T.', 'Greenlee'], ['Mary', '', 'Vandermause'], ['Amanda', '', 'Balish'], ['Angela', '', 'Foust'], ['Nancy', 'J.', 'Cox'], ['Alexander', 'I.', 'Klimov'], ['David', 'K.', 'Shay'], ['Edward', 'A.', 'Belongia']]",,0,"[u'http://origin.cdc.gov/eid/content/14/1/pdfs/173.pdf', u'http://www.cdc.gov/eid/content/14/1/pdfs/173.pdf']"
10.1056/NEJM198912213212502,"Griffiths, P., , A perspective on antiviral resistance, Journal of Clinical Virology, 2009",cited-by,10.1016/j.jcv.2009.06.017,A perspective on antiviral resistance,"[['Paul', 'D.', 'Griffiths']]",Journal of Clinical Virology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1386653209002856', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653209002856']"
10.1056/NEJM198912213212502,"Suguitan, A., Subbarao, K., , The Pandemic Threat of Avian Influenza Viruses, Perspectives in Medical Virology, 2006",cited-by,10.1016/S0168-7069(06)16005-X,The Pandemic Threat of Avian Influenza Viruses,"[['Amorsolo', 'L.', 'Suguitan'], ['Kanta', '', 'Subbarao']]",Perspectives in Medical Virology,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016870690616005X', u'http://linkinghub.elsevier.com/retrieve/pii/S016870690616005X']"
10.1056/NEJM198912213212502,"Schilling, M., Gravenstein, S., Drinka, P., et. al, Emergence and Transmission of Amantadine-Resistant Influenza A in a Nursing Home: RESISTANCE IN A NURSING HOME INFLUENZA A OUTBREAK, Journal of The American Geriatrics Society, 2004",cited-by,10.1111/j.1532-5415.2004.52567.x,Emergence and Transmission of Amantadine-Resistant Influenza A in a Nursing Home: RESISTANCE IN A NURSING HOME INFLUENZA A OUTBREAK,"[['Margo', '', 'Schilling'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Drinka'], ['Nancy', '', 'Cox'], ['Peggy', '', 'Krause'], ['Laura', '', 'Povinelli'], ['Peter', '', 'Shult']]",Journal of The American Geriatrics Society,2004,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1532-5415.2004.52567.x']
10.1056/NEJM198912213212502,"Griffiths, P., , Will systemic antivirals be sold over the counter?, Reviews in Medical Virology, 2001",cited-by,10.1002/rmv.312,Will systemic antivirals be sold over the counter?,"[['P.', 'D.', 'Griffiths']]",Reviews in Medical Virology,2001,[u'http://doi.wiley.com/10.1002/rmv.312']
10.1056/NEJM198912213212502,"Tisdale, M., Daly, J., Gor, D., , Methods for determining resistance to neuraminidase inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00656-2,Methods for determining resistance to neuraminidase inhibitors,"[['Margaret', '', 'Tisdale'], ['Janet', '', 'Daly'], ['Dee', '', 'Gor']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101006562', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101006562']"
10.1056/NEJM198912213212502,"Colacino, J., Staschke, K., Laver, W., , Approaches and strategies for the treatment of influenza virus infections, , 0",cited-by,11571009Approaches and strategies for the treatment of influenza virus infections,Approaches and strategies for the treatment of influenza virus infections,"[['Joseph', 'M', 'Colacino'], ['Kirk', 'A', 'Staschke'], ['W', 'Graeme', 'Laver']]",,0,[u'http://arbidol.org/Approaches-and-strategies-for-the-treatment-of-influenza.pdf']
10.1056/NEJM198912213212502,"Smith, A., Raison, P., Konings, R., , Synthesis and crystal structure characterisation of sodium neptunate compounds, Journal of Nuclear Materials, 2011",cited-by,10.1016/j.jnucmat.2011.04.009,Synthesis and crystal structure characterisation of sodium neptunate compounds,"[['A.', 'L.', 'Smith'], ['P.', 'E.', 'Raison'], ['R.', 'J. M.', 'Konings']]",Journal of Nuclear Materials,2011,[u'http://www.sciencedirect.com/science/article/pii/S0022311511003485']
10.1056/NEJM198912213212502,"Welliver, R., Monto, A., Carewicz, O., , Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in, , 2010",cited-by,13851601Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,"[['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz']]",,2010,[u'http://jama.ama-assn.org/cgi/reprint/285/6/748.pdf']
10.1056/NEJM198912213212502,"Seo, E., Park, G., Kim, S., et. al, Oseltamivir efficacy, side effects, and safety in children with influenza, Korean Journal of Pediatrics, 2010",cited-by,10.3345/kjp.2010.53.1.56,"Oseltamivir efficacy, side effects, and safety in children with influenza","[['Eun', 'Sun', 'Seo'], ['Geun', 'Hwa', 'Park'], ['Sung', 'Mi', 'Kim'], ['Sung', 'Won', 'Kim'], ['Woo', 'Sik', 'Jung'], ['Kyung', 'Soon', 'Cho'], ['Yeon', 'Gyeong', 'Park'], ['Chang', 'Kyu', 'Lee'], ['Chun', '', 'Kang'], ['Joo', 'Yeon', 'Lee'], ['Woo', 'Young', 'Choi']]",Korean Journal of Pediatrics,2010,[u'http://synapse.koreamed.org/DOIx.php?id=10.3345/kjp.2010.53.1.56']
10.1056/NEJM198912213212502,"Capasso, A., Petrella, C., Milano, W., , P.3.c.006 Olanzapine in the treatment of anorexia nervosa: a case report, European Neuropsychopharmacology, 2010",cited-by,10.1016/S0924-977X(10)70676-3,P.3.c.006 Olanzapine in the treatment of anorexia nervosa: a case report,"[['A.', '', 'Capasso'], ['C.', '', 'Petrella'], ['W.', '', 'Milano']]",European Neuropsychopharmacology,2010,[u'http://www.sciencedirect.com/science/article/pii/S0924977X10706763']
10.1056/NEJM198912213212502,"Nagachinta, T., Sawanpanyalert, N., Chanprasert, P., , A Review of Influenza, , 2009",cited-by,13575225A Review of Influenza,A Review of Influenza,"[['Tippavan', '', 'Nagachinta'], ['Narumol', '', 'Sawanpanyalert'], ['Puangpen', '', 'Chanprasert']]",,2009,[u'http://www.idthai.org/Publication/pdf/Vol26-3/p.115-132.pdf']
10.1056/NEJM198912213212502,"McDevitt, J., MacIntosh, D., Myatt, T., , Removal of influenza viral aerosols by high efficiency electrostatic air cleaner and implications for household infection transmission, , 2008",cited-by,6012049Removal of influenza viral aerosols by high efficiency electrostatic air cleaner and implications for household infection transmission,Removal of influenza viral aerosols by high efficiency electrostatic air cleaner and implications for household infection transmission,"[['James', 'J.', 'McDevitt'], ['David', 'L.', 'MacIntosh'], ['Theodore', 'A.', 'Myatt']]",,2008,"[u'https://www.trane.com/residential/downloads/Indoor%20Air%202008%20final%20paper.pdf', u'http://www.tranecds.com/residential/downloads/indoor%20air%202008%20final%20paper.pdf', u'http://trane.com/residential/downloads/indoor%20air%202008%20final%20paper.pdf', u'http://www.trane.com/residential/downloads/Indoor%20Air%202008%20final%20paper.pdf', u'https://www.tranecds.com/residential/downloads/indoor%20air%202008%20final%20paper.pdf']"
10.1056/NEJM198912213212502,"Drinka, P., Haupt, T., , Emergence of Rimantadine-Resistant Virus Within 6 Days of Starting Rimantadine Prophylaxis with Oseltamivir Treatment of Symptomatic Cases: RIMANTADINE RESISTANCE IN THE NURSING HOME, Journal of The American Geriatrics Society, 2007",cited-by,10.1111/j.1532-5415.2007.01172.x,Emergence of Rimantadine-Resistant Virus Within 6 Days of Starting Rimantadine Prophylaxis with Oseltamivir Treatment of Symptomatic Cases: RIMANTADINE RESISTANCE IN THE NURSING HOME,"[['Paul', 'J.', 'Drinka'], ['Tom', '', 'Haupt']]",Journal of The American Geriatrics Society,2007,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1532-5415.2007.01172.x']
10.1056/NEJM198912213212502,"Gassenmeier, K., Daniher, A., Furrer, S., , 1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor, , 2006",cited-by,10.1016/S0167-4501(06)80073-7,1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor,"[['Klaus', '', 'Gassenmeier'], ['Andrew', '', 'Daniher'], ['Stefan', '', 'Furrer']]",,2006,[u'http://www.sciencedirect.com/science/article/pii/S0167450106800737']
10.1056/NEJM198912213212502,"Hayden, F., , Neuraminidase inhibitors: assessment of limitations to greater therapeutic use, International Congress Series, 2004",cited-by,10.1016/j.ics.2004.02.060,Neuraminidase inhibitors: assessment of limitations to greater therapeutic use,"[['Frederick', 'G', 'Hayden']]",International Congress Series,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0531513104001918', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513104001918']"
10.1056/NEJM198912213212502,"Couloigner, V., Abbeele, T., , Rhinopharyngites de l’enfant, Emc - Oto-rhino-laryngologie, 2004",cited-by,10.1016/j.emcorl.2004.01.001,Rhinopharyngites de l’enfant,"[['V', '', 'Couloigner'], ['T', 'Van Den', 'Abbeele']]",Emc - Oto-rhino-laryngologie,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1762568804000235', u'http://linkinghub.elsevier.com/retrieve/pii/S1762568804000235']"
10.1056/NEJM198912213212502,"Tremblay, C., , Antiviral agents against respiratory viruses, Clinical Microbiology Newsletter, 2001",cited-by,10.1016/S0196-4399(01)89050-4,Antiviral agents against respiratory viruses,"[['Cecile', 'L.', 'Tremblay']]",Clinical Microbiology Newsletter,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0196439901890504', u'http://linkinghub.elsevier.com/retrieve/pii/S0196439901890504']"
10.1001~jama.283.8.1016,"Hayden FG, Gwaltney JM Jr, van de Castle RL, et al. Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults. Antimicrob Agents Chemother. 1981;19:226-233.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Hayden FG, Osterhaus AD, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med. 1997;337:874-880.",references,10.1056/NEJM199709253371302,Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections,"[[u'Frederick', u'G.', u'Hayden'], [u'Albert', u'D. M. E.', u'Osterhaus'], [u'John', u'J.', u'Treanor'], [u'Douglas', u'M.', u'Fleming'], [u'Fred', u'Y.', u'Aoki'], [u'Karl', u'G.', u'Nicholson'], [u'Arthur', u'M.', u'Bohnen'], [u'Hilary', u'M.', u'Hirst'], [u'Oliver', u'', u'Keene'], [u'Kevin', u'', u'Wightman']]",New England Journal of Medicine,1997,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199709253371302'],./output/10.1001~jama.283.8.1016/10.1056~NEJM199709253371302
10.1056/NEJM199709253371302,"Bartlett, J., Dowell, S., Mandell, L., et. al, Practice Guidelines for the Management of Community‐Acquired Pneumonia in Adults, Clinical Infectious Diseases, 2000",cited-by,10.1086/313954,Practice Guidelines for the Management of Community‐Acquired Pneumonia in Adults,"[['John', 'G.', 'Bartlett'], ['Scott', 'F.', 'Dowell'], ['Lionel', 'A.', 'Mandell'], ['Daniel', 'M.', 'Musher'], ['Michael', 'J.', 'Fine']]",Clinical Infectious Diseases,2000,"[u'http://www.gata.edu.tr/dahilibilimler/ailehekimligi/dosyalar/111.pdf', u'http://www2.medicine.wisc.edu/home/files/domfiles/infectiousdisease/CommunityAcquiredAdultPneumonia.pdf', u'http://www.gata.edu.tr/dahilibilimler/nefroloji/dosyalar/111.pdf', u'http://www.antiinfectieux.org/antiinfectieux/Assets/PTS/infections-respiratoires/pneumonie/CAP-IDSA-guideline.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/313954']"
10.1056/NEJM199709253371302,"Nicholson, K., Wood, J., Zambon, M., , Influenza, Lancet, 2003",cited-by,10.1016/S0140-6736(03)14854-4,Influenza,"[['Karl', 'G', 'Nicholson'], ['John', 'M', 'Wood'], ['Maria', '', 'Zambon']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603148544', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603148544']"
10.1056/NEJM199709253371302,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, Lancet, 2000",cited-by,10.1016/S0140-6736(99)11433-8,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699114338', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699114338']"
10.1056/NEJM199709253371302,"Cox, N., Subbarao, K., , Influenza, Lancet, 1999",cited-by,10.1016/S0140-6736(99)01241-6,Influenza,"[['Nancy', 'J', 'Cox'], ['Kanta', '', 'Subbarao']]",Lancet,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699012416', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699012416']"
10.1056/NEJM199709253371302,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1056/NEJM199709253371302,"Elden, L., Nijhuis, M., Schipper, P., et. al, Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR, Journal of Clinical Microbiology, 2001",cited-by,10.1128/JCM.39.1.196-200.2001,Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR,"[['L.', 'J. R. van', 'Elden'], ['M.', '', 'Nijhuis'], ['P.', '', 'Schipper'], ['R.', '', 'Schuurman'], ['A.', 'M. van', 'Loon']]",Journal of Clinical Microbiology,2001,[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.39.1.196-200.2001']
10.1056/NEJM199709253371302,"Moscona, A., , Neuraminidase Inhibitors for Influenza, , 2009",cited-by,5346198Neuraminidase Inhibitors for Influenza,Neuraminidase Inhibitors for Influenza,"[['Anne', '', 'Moscona']]",,2009,"[u'http://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'https://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://intl-content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://www.columbia.edu/itc/hs/medical/pathophys/immunology/readings/Influenza_neuraminidase_inhib_rev.pdf', u'http://www.svinfectologia.org/influenza1%201363.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/111.pdf', u'http://www.cornellpediatrics.org/bm~doc/neuraminidase-inhibitors-moscona.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Nueramidase%20Tx%20for%20Influenza%20Sep%202005.pdf', u'http://nejm.highwire.org/cgi/reprint/353/13/1363.pdf']"
10.1056/NEJM199709253371302,"Boivin, G., Hardy, I., Tellier, G., et. al, Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition, Clinical Infectious Diseases, 2000",cited-by,10.1086/317425,Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition,"[['Guy', '', 'Boivin'], ['Isabelle', '', 'Hardy'], ['Guy', '', 'Tellier'], ['Jean', '', 'Maziade']]",Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/317425']
10.1056/NEJM199709253371302,"UYEKI, T., , Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza, Pediatric Infectious Disease Journal, 2003",cited-by,10.1097/01.inf.0000050458.35010.b6,Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza,"[['TIMOTHY', 'M.', 'UYEKI']]",Pediatric Infectious Disease Journal,2003,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200302000-00015']
10.1056/NEJM199709253371302,"HEDRICK, J., BARZILAI, A., BEHRE, U., et. al, Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial, Pediatric Infectious Disease Journal, 2000",cited-by,10.1097/00006454-200005000-00005,Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial,"[['JAMES', 'A.', 'HEDRICK'], ['ASHER', '', 'BARZILAI'], ['ULRICH', '', 'BEHRE'], ['FREDERICK', 'W.', 'HENDERSON'], ['JANET', '', 'HAMMOND'], ['LUCY', '', 'REILLY'], ['OLIVER', '', 'KEENE']]",Pediatric Infectious Disease Journal,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200005000-00005']
10.1056/NEJM199709253371302,"Ward, C., Dempseyb, M., Ring, C., et. al, Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement, Journal of Clinical Virology, 2004",cited-by,10.1016/S1386-6532(03)00122-7,Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement,"[['C.', 'L.', 'Ward'], ['M.', 'H.', 'Dempseyb'], ['C.', 'J. A', 'Ring'], ['R.', 'E', 'Kempson'], ['L', '', 'Zhang'], ['D', '', 'Gor'], ['B.', 'W', 'Snowden'], ['M', '', 'Tisdale']]",Journal of Clinical Virology,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1386653203001227', u'http://www.hvidovre-hospital.dk/HHmikrobiologisk.nsf/pics/Influenza1.pdf/$FILE/Influenza1.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653203001227']"
10.1056/NEJM199709253371302,"Rimmelzwaan, G., Baars, M., Claas, E., et. al, Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro, Journal of Virological Methods, 1998",cited-by,10.1016/S0166-0934(98)00071-8,"Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro","[['G.', 'F', 'Rimmelzwaan'], ['M', '', 'Baars'], ['E.', 'C. J', 'Claas'], ['A.', 'D. M. E', 'Osterhaus']]",Journal of Virological Methods,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0166093498000718', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093498000718']"
10.1056/NEJM199709253371302,"Cunney, R., Bialachowski, A., Thornley, D., et. al, An Outbreak of Influenza A in a Neonatal Intensive Care Unit, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501786,An Outbreak of Influenza A in a Neonatal Intensive Care Unit,"[['Robert', 'J.', 'Cunney'], ['Anne', '', 'Bialachowski'], ['Diane', '', 'Thornley'], ['Fiona', 'M.', 'Smaill'], ['Ross', 'A.', 'Pennie']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501786']
10.1056/NEJM199709253371302,"Varghese, J., Smith, P., Sollis, S., et. al, Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase, Structure, 1998",cited-by,10.1016/S0969-2126(98)00075-6,Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase,"[['Joseph', 'N', 'Varghese'], ['Paul', 'W', 'Smith'], ['Steven', 'L', 'Sollis'], ['Tony', 'J', 'Blick'], ['Anjali', '', 'Sahasrabudhe'], ['Jennifer', 'L', 'McKimm-Breschkin'], ['Peter', 'M', 'Colman']]",Structure,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0969212698000756', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212698000756']"
10.1056/NEJM199709253371302,"PELTOLA, V., MCCULLERS, J., , Respiratory viruses predisposing to bacterial infections: role of neuraminidase, Pediatric Infectious Disease Journal, 2004",cited-by,10.1097/01.inf.0000108197.81270.35,Respiratory viruses predisposing to bacterial infections: role of neuraminidase,"[['VILLE', 'T.', 'PELTOLA'], ['JONATHAN', 'A.', 'MCCULLERS']]",Pediatric Infectious Disease Journal,2004,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200401001-00013']
10.1056/NEJM199709253371302,"Heikkinen, T., Marttila, J., Salmi, A., et. al, Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses, Journal of Clinical Microbiology, 2002",cited-by,10.1128/JCM.40.11.4337-4339.2002,Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses,"[['Terho', '', 'Heikkinen'], ['Jane', '', 'Marttila'], ['Aimo', 'A.', 'Salmi'], ['Olli', '', 'Ruuskanen']]",Journal of Clinical Microbiology,2002,"[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.40.11.4337-4339.2002', u'http://jcm.asm.org/cgi/reprint/40/11/4337.pdf']"
10.1056/NEJM199709253371302,"Heikkinen, T., Chonmaitree, T., , Importance of Respiratory Viruses in Acute Otitis Media, Clinical Microbiology Reviews, 2003",cited-by,10.1128/CMR.16.2.230-241.2003,Importance of Respiratory Viruses in Acute Otitis Media,"[['Terho', '', 'Heikkinen'], ['Tasnee', '', 'Chonmaitree']]",Clinical Microbiology Reviews,2003,[u'http://cmr.asm.org/cgi/doi/10.1128/CMR.16.2.230-241.2003']
10.1056/NEJM199709253371302,"Jefferson, T., Jones, M., Doshi, P., et. al, Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis, British Medical Journal, 2009",cited-by,10.1136/bmj.b5106,Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis,"[['Tom', '', 'Jefferson'], ['Mark', '', 'Jones'], ['Peter', '', 'Doshi'], ['Chris', 'Del', 'Mar']]",British Medical Journal,2009,"[u'http://www.bmj.com/cgi/reprint/339/dec07_2/b5106.pdf', u'http://dx.doi.org/10.1136/bmj.b5106', u'http://www.bmj.com/cgi/doi/10.1136/bmj.b5106']"
10.1056/NEJM199709253371302,"Furuta, Y., Takahashi, K., Fukuda, Y., et. al, In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.977-981.2002,In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705,"[['Y.', '', 'Furuta'], ['K.', '', 'Takahashi'], ['Y.', '', 'Fukuda'], ['M.', '', 'Kuno'], ['T.', '', 'Kamiyama'], ['K.', '', 'Kozaki'], ['N.', '', 'Nomura'], ['H.', '', 'Egawa'], ['S.', '', 'Minami'], ['Y.', '', 'Watanabe'], ['H.', '', 'Narita'], ['K.', '', 'Shiraki']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://journals.pasteur.ac.ir/aac02/46(4)/977.pdf', u'http://aac.asm.org/cgi/reprint/46/4/977.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.977-981.2002']"
10.1056/NEJM199709253371302,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf']
10.1056/NEJM199709253371302,"BOIVIN, G., HARDY, I., KRESS, A., , Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR, Journal of Clinical Microbiology, 2001",cited-by,10.1128/JCM.39.2.730-732.2001,Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,"[['GUY', '', 'BOIVIN'], ['ISABELLE', '', 'HARDY'], ['ANDREW', '', 'KRESS']]",Journal of Clinical Microbiology,2001,"[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.39.2.730-732.2001', u'http://jcm.asm.org/cgi/reprint/39/2/730.pdf']"
10.1056/NEJM199709253371302,"Stiver, G., , The treatment of influenza with antiviral drugs, , 0",cited-by,10332941The treatment of influenza with antiviral drugs,The treatment of influenza with antiviral drugs,"[['Grant', '', 'Stiver']]",,0,"[u'http://www.ualberta.ca/~mlalu/ref03.pdf', u'http://www.ualberta.ca/~mlalu/CMAJantiviral.pdf', u'http://www.cmaj.ca/cgi/reprint/168/1/49.pdf']"
10.1056/NEJM199709253371302,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']"
10.1056/NEJM199709253371302,"Khan, K., , Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults, Clinical Infectious Diseases, 2001",cited-by,10.1086/324491,Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults,"[['Kamran', '', 'Khan']]",Clinical Infectious Diseases,2001,"[u'http://www.pceo.org/pubs/CID%20Article.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/324491']"
10.1056/NEJM199709253371302,"Treanor, J., Falsey, A., , Respiratory viral infections in the elderly, Antiviral Research, 1999",cited-by,10.1016/S0166-3542(99)00062-5,Respiratory viral infections in the elderly,"[['John', '', 'Treanor'], ['Ann', '', 'Falsey']]",Antiviral Research,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166354299000625', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354299000625']"
10.1056/NEJM199709253371302,"Hayden, F., , Antivirals for influenza: Historical perspectives and lessons learned, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.05.016,Antivirals for influenza: Historical perspectives and lessons learned,"[['Frederick', 'G.', 'Hayden']]",Antiviral Research,2006,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-10.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354206001653', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206001653']"
10.1056/NEJM199709253371302,"Heikkinen, T., Marttila, J., Salmi, A., et. al, Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses, , 0",cited-by,10724682Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses,Nasal Swab versus Nasopharyngeal Aspirate for Isolation of Respiratory Viruses,"[['Terho', '', 'Heikkinen'], ['Jane', '', 'Marttila'], ['Aimo', 'A.', 'Salmi'], ['Olli', '', 'Ruuskanen']]",,0,[u'http://jcm.asm.org/cgi/reprint/40/11/4337.pdf']
10.1056/NEJM199709253371302,"Smith, K., Roberts, M., , Cost-effectiveness of newer treatment strategies for influenza, American Journal of Medicine, 2002",cited-by,10.1016/S0002-9343(02)01222-6,Cost-effectiveness of newer treatment strategies for influenza,"[['Kenneth', 'J', 'Smith'], ['Mark', 'S', 'Roberts']]",American Journal of Medicine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0002934302012226', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934302012226']"
10.1056/NEJM199709253371302,"Walsh, E., Cox, C., Falsey, A., , Clinical Features of Influenza A Virus Infection in Older Hospitalized Persons, Journal of The American Geriatrics Society, 2002",cited-by,10.1046/j.1532-5415.2002.50404.x,Clinical Features of Influenza A Virus Infection in Older Hospitalized Persons,"[['Edward', 'E.', 'Walsh'], ['Christopher', '', 'Cox'], ['Ann', 'R.', 'Falsey']]",Journal of The American Geriatrics Society,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2002.50404.x']
10.1056/NEJM199709253371302,"Lee, C., Loeb, M., Phillips, A., et. al, Zanamivir Use During Transmission of Amantadine‐Resistant Influenza A in a Nursing Home, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501727,Zanamivir Use During Transmission of Amantadine‐Resistant Influenza A in a Nursing Home,"[['Christine', '', 'Lee'], ['Mark', '', 'Loeb'], ['Anne', '', 'Phillips'], ['Judy', '', 'Nesbitt'], ['Karen', '', 'Smith'], ['Margaret', '', 'Fearon'], ['Margaret', 'A.', 'McArthur'], ['Tony', '', 'Mazzulli'], ['Yan', '', 'Li'], ['Allison', '', 'McGeer']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501727']
10.1056/NEJM199709253371302,"Barnett, J., Cadman, A., Burrell, F., et. al, In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir, Virology, 1999",cited-by,10.1006/viro.1999.0058,In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir,"[['J.', 'M.', 'Barnett'], ['A.', '', 'Cadman'], ['F.', 'M.', 'Burrell'], ['S.', 'H.', 'Madar'], ['A.', 'P.', 'Lewis'], ['M.', '', 'Tisdale'], ['R.', '', 'Bethell']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299900582', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299900582']"
10.1056/NEJM199709253371302,"BOIVIN, G., HARDY, I., KRESS, A., , Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR, , 0",cited-by,11106017Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCR,"[['GUY', '', 'BOIVIN'], ['ISABELLE', '', 'HARDY'], ['ANDREW', '', 'KRESS']]",,0,[u'http://jcm.asm.org/cgi/reprint/39/2/730.pdf']
10.1056/NEJM199709253371302,"Boeckh, M., , The challenge of respiratory virus infections in hematopoietic cell transplant recipients, British Journal of Haematology, 2008",cited-by,10.1111/j.1365-2141.2008.07295.x,The challenge of respiratory virus infections in hematopoietic cell transplant recipients,"[['Michael', '', 'Boeckh']]",British Journal of Haematology,2008,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1365-2141.2008.07295.x']
10.1056/NEJM199709253371302,"Sato, M., Hosoya, M., Kato, K., et. al, VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS, Pediatric Infectious Disease Journal, 2005",cited-by,10.1097/01.inf.0000180976.81055.ce,VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS,"[['Masatoki', '', 'Sato'], ['Mitsuaki', '', 'Hosoya'], ['Kazuo', '', 'Kato'], ['Hitoshi', '', 'Suzuki']]",Pediatric Infectious Disease Journal,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200510000-00019']
10.1056/NEJM199709253371302,"Stamboulian, D., Bonvehí, P., Nacinovich, F., et. al, INFLUENZA, Infectious Disease Clinics of North America, 2000",cited-by,10.1016/S0891-5520(05)70222-1,INFLUENZA,"[['Daniel', '', 'Stamboulian'], ['Pablo', 'E.', 'Bonveh\xc3\xad'], ['Francisco', 'M.', 'Nacinovich'], ['Nancy', '', 'Cox']]",Infectious Disease Clinics of North America,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0891552005702221', u'http://linkinghub.elsevier.com/retrieve/pii/S0891552005702221']"
10.1056/NEJM199709253371302,"Murphy, K., Eivindson, A., Pauksens, K., et. al, Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study, Clinical Drug Investigation, 2000",cited-by,10.2165/00044011-200020050-00005,"Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study","[['Kevin', 'R.', 'Murphy'], ['Arne', '', 'Eivindson'], ['Karlis', '', 'Pauksens'], ['William', 'J.', 'Stein'], ['Guy', '', 'Tellier'], ['Richard', '', 'Watts'], ['Stephen', 'J.', 'Sharp'], ['Elke', '', 'Loeschel']]",Clinical Drug Investigation,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200020050-00005']
10.1056/NEJM199709253371302,"Kaiser, L., Henry, D., Flack, N., et. al, Short‐Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo‐Controlled Study, Clinical Infectious Diseases, 2000",cited-by,10.1086/313696,Short‐Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo‐Controlled Study,"[['Laurent', '', 'Kaiser'], ['Dan', '', 'Henry'], ['Nancy', 'P.', 'Flack'], ['Oliver', '', 'Keene'], ['Frederick', 'G.', 'Hayden']]",Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/313696']
10.1056/NEJM199709253371302,"Arden, N., , Control of Influenza in the Long‐Term–Care Facility: A Review of Established Approaches and Newer Options, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501702,Control of Influenza in the Long‐Term–Care Facility: A Review of Established Approaches and Newer Options,"[['Nancy', 'H.', 'Arden']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501702']
10.1056/NEJM199709253371302,"Johny, A., Clark, A., Price, N., et. al, The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation, Bone Marrow Transplantation, 2002",cited-by,10.1038/sj.bmt.1703343,The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation,"[['AA', '', 'Johny'], ['A', '', 'Clark'], ['N', '', 'Price'], ['D', '', 'Carrington'], ['A', '', 'Oakhill'], ['DI', '', 'Marks']]",Bone Marrow Transplantation,2002,"[u'http://dx.doi.org/10.1038/sj.bmt.1703343', u'http://www.nature.com/doifinder/10.1038/sj.bmt.1703343']"
10.1056/NEJM199709253371302,"Boivin, G., Goyette, N., , Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00219-4,Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors,"[['Guy', '', 'Boivin'], ['Nathalie', '', 'Goyette']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201002194', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201002194']"
10.1056/NEJM199709253371302,"Zalman, L., Brothers, M., Dragovich, P., et. al, Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor, Antimicrobial Agents and Chemotherapy, 2000",cited-by,10.1128/AAC.44.5.1236-1241.2000,"Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor","[['L.', 'S.', 'Zalman'], ['M.', 'A.', 'Brothers'], ['P.', 'S.', 'Dragovich'], ['R.', '', 'Zhou'], ['T.', 'J.', 'Prins'], ['S.', 'T.', 'Worland'], ['A.', 'K.', 'Patick']]",Antimicrobial Agents and Chemotherapy,2000,"[u'http://aac.asm.org/cgi/doi/10.1128/AAC.44.5.1236-1241.2000', u'http://aac.asm.org/cgi/reprint/44/5/1236.pdf']"
10.1056/NEJM199709253371302,"Church, D., Davies, H., Mitton, C., et. al, Clinical and Economic Evaluation of Rapid Influenza A Virus Testing in Nursing Homes in Calgary, Canada, Clinical Infectious Diseases, 2002",cited-by,10.1086/338960,"Clinical and Economic Evaluation of Rapid Influenza A Virus Testing in Nursing Homes in Calgary, Canada","[['Deirdre', 'L.', 'Church'], ['H.', 'Dele', 'Davies'], ['Craig', '', 'Mitton'], ['Heather', '', 'Semeniuk'], ['Melissa', '', 'Logue'], ['Colleen', '', 'Maxwell'], ['Cam', '', 'Donaldson']]",Clinical Infectious Diseases,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/338960']
10.1056/NEJM199709253371302,"Billings, J., Hertz, M., Wendt, C., , Community respiratory virus infections following lung transplantation, Transplant Infectious Disease, 2001",cited-by,10.1034/j.1399-3062.2001.003003138.x,Community respiratory virus infections following lung transplantation,"[['J.', 'L.', 'Billings'], ['M.', 'I.', 'Hertz'], ['C.', 'H.', 'Wendt']]",Transplant Infectious Disease,2001,[u'http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-3062.2001.003003138.x']
10.1056/NEJM199709253371302,"Villar, E., Barroso, I., , Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview, Glycoconjugate Journal, 2006",cited-by,10.1007/s10719-006-5433-0,Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview,"[['Enrique', '', 'Villar'], ['Isabel', 'Mu\xc3\xb1oz', 'Barroso']]",Glycoconjugate Journal,2006,"[u'http://www.springerlink.com/index/n549v716hp2mr30p.pdf', u'http://www.springerlink.com/content/n549v716hp2mr30p', u'http://www.springerlink.com/index/10.1007/s10719-006-5433-0', u'http://www.springerlink.com/index/pdf/10.1007/s10719-006-5433-0']"
10.1056/NEJM199709253371302,"Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']"
10.1056/NEJM199709253371302,"Gravenstein, S., Drinka, P., Osterweil, D., et. al, Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.006,Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population,"[['Stefan', '', 'Gravenstein'], ['Paul', '', 'Drinka'], ['Dan', '', 'Osterweil'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult'], ['Arvydas', '', 'Ambrozaitis'], ['Ruth', '', 'Kandel'], ['Ellen', '', 'Binder'], ['Janet', '', 'Hammond'], ['Janet', '', 'McElhaney'], ['Nancy', '', 'Flack'], ['Janet', '', 'Daly'], ['Oliver', '', 'Keene']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005323', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005323']"
10.1056/NEJM199709253371302,"Rothberg, M., He, S., Rose, D., , Management of influenza symptoms in healthy adults, Journal of General Internal Medicine, 2003",cited-by,10.1046/j.1525-1497.2003.20822.x,Management of influenza symptoms in healthy adults,"[['Michael', 'B.', 'Rothberg'], ['Shunian', '', 'He'], ['David', 'N.', 'Rose']]",Journal of General Internal Medicine,2003,"[u'http://www.springerlink.com/index/c2hlvw3483877856.pdf', u'http://www.springerlink.com/content/c2hlvw3483877856', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1525-1497.2003.20822.x']"
10.1056/NEJM199709253371302,"McKimm-Breschkin, J., , Neuraminidase inhibitors for the treatment and prevention of influenza, Expert Opinion on Pharmacotherapy, 2002",cited-by,10.1517/14656566.3.2.103,Neuraminidase inhibitors for the treatment and prevention of influenza,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Expert Opinion on Pharmacotherapy,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.3.2.103']
10.1056/NEJM199709253371302,"CASS, L., GUNAWARDENA, K., MACMAHON, M., et. al, Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir, Respiratory Medicine, 2000",cited-by,10.1053/rmed.1999.0718,Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir,"[['L.', 'M. R.', 'CASS'], ['K.', 'A.', 'GUNAWARDENA'], ['M.', 'M.', 'MACMAHON'], ['A.', '', 'BYE']]",Respiratory Medicine,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0954611199907187', u'http://linkinghub.elsevier.com/retrieve/pii/S0954611199907187']"
10.1056/NEJM199709253371302,"Oxford, J., Bossuyt, S., Balasingam, S., et. al, Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors, Clinical Microbiology and Infection, 2003",cited-by,10.1046/j.1469-0691.2003.00564.x,Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors,"[['J.', 'S.', 'Oxford'], ['S.', '', 'Bossuyt'], ['S.', '', 'Balasingam'], ['A.', '', 'Mann'], ['P.', '', 'Novelli'], ['R.', '', 'Lambkin']]",Clinical Microbiology and Infection,2003,"[u'http://birdflubook.com/resources/Oxford1.pdf', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1469-0691.2003.00564.x']"
10.1056/NEJM199709253371302,"Varghese, J., , Development of neuraminidase inhibitors as anti-influenza virus drugs, Drug Development Research, 1999",cited-by,10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6,Development of neuraminidase inhibitors as anti-influenza virus drugs,"[['Joseph', 'N.', 'Varghese']]",Drug Development Research,1999,[u'http://doi.wiley.com/10.1002/%28SICI%291098-2299%28199903/04%2946%3A3/4%3C176%3A%3AAID-DDR4%3E3.0.CO%3B2-6']
10.1056/NEJM199709253371302,"Gavin, P., Thomson, R., , Review of Rapid Diagnostic Tests for Influenza, , 2003",cited-by,5357707Review of Rapid Diagnostic Tests for Influenza,Review of Rapid Diagnostic Tests for Influenza,"[['Patrick', 'J', 'Gavin'], ['Richard', 'B', 'Thomson']]",,2003,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/diagnosis/diagnosis-4.pdf']
10.1056/NEJM199709253371302,"Beigel, J., , Influenza, Critical Care Medicine, 2008",cited-by,10.1097/CCM.0b013e318180b039,Influenza,"[['John', 'H.', 'Beigel']]",Critical Care Medicine,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003246-200809000-00025']
10.1056/NEJM199709253371302,"Englund, J., , Antiviral therapy of influenza, Seminars in Pediatric Infectious Diseases, 2002",cited-by,10.1053/spid.2002.122999,Antiviral therapy of influenza,"[['Janet', 'A.', 'Englund']]",Seminars in Pediatric Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1045187002500571', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187002500571']"
10.1056/NEJM199709253371302,"SAGRERA, X., GINOVART, G., RASPALL, F., et. al, Outbreaks of influenza A virus infection in neonatal intensive care units, Pediatric Infectious Disease Journal, 2002",cited-by,10.1097/00006454-200203000-00007,Outbreaks of influenza A virus infection in neonatal intensive care units,"[['XAVIER', '', 'SAGRERA'], ['GEMMA', '', 'GINOVART'], ['FREDERIC', '', 'RASPALL'], ['NURIA', '', 'RABELLA'], ['PERE', '', 'SALA'], ['MONTSERRAT', '', 'SIERRA'], ['XAVIER', '', 'DEMESTRE'], ['CLARA', '', 'VILA']]",Pediatric Infectious Disease Journal,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200203000-00007']
10.1056/NEJM199709253371302,"BRADLEY, J., , Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines, Pediatric Infectious Disease Journal, 2002",cited-by,10.1097/00006454-200206000-00035,Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines,"[['JOHN', 'S.', 'BRADLEY']]",Pediatric Infectious Disease Journal,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200206000-00035']
10.1056/NEJM199709253371302,"Kawai, N., Ikematsu, H., Iwaki, N., et. al, A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B, Journal of Infection, 2008",cited-by,10.1016/j.jinf.2007.09.002,A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B,"[['Naoki', '', 'Kawai'], ['Hideyuki', '', 'Ikematsu'], ['Norio', '', 'Iwaki'], ['Tetsunari', '', 'Maeda'], ['Hideo', '', 'Kanazawa'], ['Takashi', '', 'Kawashima'], ['Osame', '', 'Tanaka'], ['Satoshi', '', 'Yamauchi'], ['Kenichi', '', 'Kawamura'], ['Toru', '', 'Nagai'], ['Satsuki', '', 'Horii'], ['Nobuo', '', 'Hirotsu'], ['Seizaburo', '', 'Kashiwagi']]",Journal of Infection,2008,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-25.pdf', u'http://www.sciencedirect.com/science/article/pii/S0163445307007578', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445307007578']"
10.1056/NEJM199709253371302,"Carr, M., Sayre, N., Duffy, M., et. al, Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses, Journal of Virological Methods, 2008",cited-by,10.1016/j.jviromet.2008.07.011,Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses,"[['Michael', 'J.', 'Carr'], ['Naomi', '', 'Sayre'], ['Margaret', '', 'Duffy'], ['Jeff', '', 'Connell'], ['William', 'W.', 'Hall']]",Journal of Virological Methods,2008,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-4.pdf', u'http://www.sciencedirect.com/science/article/pii/S016609340800253X', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-3.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S016609340800253X']"
10.1056/NEJM199709253371302,"Neuzil, K., O’Connor, T., Gorse, G., et. al, Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine, Clinical Infectious Diseases, 2003",cited-by,10.1086/345668,Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine,"[['Kathleen', 'M.', 'Neuzil'], ['Theresa', 'Z.', 'O\xe2\x80\x99Connor'], ['Geoffrey', 'J.', 'Gorse'], ['Kristin', 'L.', 'Nichol']]",Clinical Infectious Diseases,2003,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/345668']
10.1056/NEJM199709253371302,"Smith, K., Roberts, M., , Cost-effectiveness of Newer Treatment Strategies for Influenza, , 0",cited-by,5139943Cost-effectiveness of Newer Treatment Strategies for Influenza,Cost-effectiveness of Newer Treatment Strategies for Influenza,"[['Kenneth', 'J.', 'Smith'], ['Mark', 'S.', 'Roberts']]",,0,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-13.pdf']
10.1056/NEJM199709253371302,"Jr, J., Michaelis, M., Doerr, H., , The threat of avian influenza A (H5N1). Part III: antiviral therapy, Medical Microbiology and Immunology, 2007",cited-by,10.1007/s00430-007-0048-z,The threat of avian influenza A (H5N1). Part III: antiviral therapy,"[['Jindrich', 'Cinatl', 'Jr'], ['Martin', '', 'Michaelis'], ['Hans', 'W.', 'Doerr']]",Medical Microbiology and Immunology,2007,"[u'http://www.springerlink.com/index/41xpm470518281m7.pdf', u'http://www.springerlink.com/content/41xpm470518281m7', u'http://www.springerlink.com/index/10.1007/s00430-007-0048-z', u'http://www.springerlink.com/index/pdf/10.1007/s00430-007-0048-z']"
10.1056/NEJM199709253371302,"Rawlinson, W., Waliuzzaman, Z., Fennell, M., et. al, New point of care test is highly specific but less sensitive for influenza virus A and B in children and adults, Journal of Medical Virology, 2004",cited-by,10.1002/jmv.20155,New point of care test is highly specific but less sensitive for influenza virus A and B in children and adults,"[['William', 'D.', 'Rawlinson'], ['Zubair', 'M.', 'Waliuzzaman'], ['Michael', '', 'Fennell'], ['James', 'R.', 'Appleman'], ['Craig', 'D.', 'Shimasaki'], ['Ian', 'W.', 'Carter']]",Journal of Medical Virology,2004,[u'http://doi.wiley.com/10.1002/jmv.20155']
10.1056/NEJM199709253371302,"Dharnidharka, V., Harmon, W., , Management of pediatric postrenal transplantation infections, Seminars in Nephrology, 2001",cited-by,10.1053/snep.2001.24947,Management of pediatric postrenal transplantation infections,"[['Vikas', 'R.', 'Dharnidharka'], ['William', 'E.', 'Harmon']]",Seminars in Nephrology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0270929501700514', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=asnep0210521']"
10.1056/NEJM199709253371302,"Monto, A., Moult, A., Sharp, S., , Effect of zanamivir on duration and resolution of influenza symptoms, Clinical Therapeutics, 2000",cited-by,10.1016/S0149-2918(00)83026-X,Effect of zanamivir on duration and resolution of influenza symptoms,"[['Arnold', 'S.', 'Monto'], ['Andrew', 'B.', 'Moult'], ['Stephen', 'J.', 'Sharp']]",Clinical Therapeutics,2000,"[u'http://www.sciencedirect.com/science/article/pii/S014929180083026X', u'http://linkinghub.elsevier.com/retrieve/pii/S014929180083026X']"
10.1056/NEJM199709253371302,"Dreitlein, W., Maratos, J., Brocavich, J., , Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza, Clinical Therapeutics, 2001",cited-by,10.1016/S0149-2918(01)80042-4,Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza,"[['William', 'B.', 'Dreitlein'], ['Julia', '', 'Maratos'], ['Joseph', '', 'Brocavich']]",Clinical Therapeutics,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0149291801800424', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291801800424']"
10.1056/NEJM199709253371302,"Low, D., , Reducing antibiotic use in influenza: challenges and rewards, Clinical Microbiology and Infection, 2008",cited-by,10.1111/j.1469-0691.2007.01910.x,Reducing antibiotic use in influenza: challenges and rewards,"[['D.', '', 'Low']]",Clinical Microbiology and Infection,2008,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1469-0691.2007.01910.x']
10.1056/NEJM199709253371302,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004']
10.1056/NEJM199709253371302,"Unoshima, M., Iwasaka, H., Eto, J., et. al, Antiviral Effects of Geranylgeranylacetone: Enhancement of MxA Expression and Phosphorylation of PKR during Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2003",cited-by,10.1128/AAC.47.9.2914-2921.2003,Antiviral Effects of Geranylgeranylacetone: Enhancement of MxA Expression and Phosphorylation of PKR during Influenza Virus Infection,"[['Masako', '', 'Unoshima'], ['Hideo', '', 'Iwasaka'], ['Junko', '', 'Eto'], ['Yoshiko', '', 'Takita-Sonoda'], ['Takayuki', '', 'Noguchi'], ['Akira', '', 'Nishizono']]",Antimicrobial Agents and Chemotherapy,2003,[u'http://aac.asm.org/cgi/doi/10.1128/AAC.47.9.2914-2921.2003']
10.1056/NEJM199709253371302,"Suess, T., Buchholz, U., Dupke, S., et. al, Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009, American Journal of Epidemiology, 2010",cited-by,10.1093/aje/kwq071,"Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009","[['T.', '', 'Suess'], ['U.', '', 'Buchholz'], ['S.', '', 'Dupke'], ['R.', '', 'Grunow'], ['Matthias', 'an der', 'Heiden'], ['A.', '', 'Heider'], ['B.', '', 'Biere'], ['B.', '', 'Schweiger'], ['W.', '', 'Haas'], ['G.', '', 'Krause']]",American Journal of Epidemiology,2010,[u'http://aje.oxfordjournals.org/cgi/doi/10.1093/aje/kwq071']
10.1056/NEJM199709253371302,"McCullers, J., , Antiviral therapy of influenza, Expert Opinion on Investigational Drugs, 2005",cited-by,10.1517/13543784.14.3.305,Antiviral therapy of influenza,"[['Jonathan', 'A', 'McCullers']]",Expert Opinion on Investigational Drugs,2005,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.14.3.305']
10.1056/NEJM199709253371302,"Rothbarth, P., Groen, J., Bohnen, A., et. al, Influenza virus serology—a comparative study, Journal of Virological Methods, 1999",cited-by,10.1016/S0166-0934(98)00174-8,Influenza virus serology—a comparative study,"[['Philip', 'H', 'Rothbarth'], ['Jan', '', 'Groen'], ['Arthur', 'M', 'Bohnen'], ['Ronald', 'de', 'Groot'], ['Albert', 'D. M. E', 'Osterhaus']]",Journal of Virological Methods,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166093498001748', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093498001748']"
10.1056/NEJM199709253371302,"Abed, Y., Boivin, G., , Treatment of respiratory virus infections, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.01.006,Treatment of respiratory virus infections,"[['Yacine', '', 'Abed'], ['Guy', '', 'Boivin']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016635420600026X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420600026X']"
10.1056/NEJM199709253371302,"Ambrozaitis, A., Gravenstein, S., Essen, G., et. al, Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.007,Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population,"[['Arvydas', '', 'Ambrozaitis'], ['Stefan', '', 'Gravenstein'], ['Gerrit', 'A. van', 'Essen'], ['Ethan', '', 'Rubinstein'], ['Ligita', '', 'Balciuniene'], ['Ausra', '', 'Stikleryte'], ['Catriona', '', 'Crawford'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005335', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005335']"
10.1056/NEJM199709253371302,"Olshaker, J., , Influenza, Emergency Medicine Clinics of North America, 2003",cited-by,10.1016/S0733-8627(03)00018-X,Influenza,"[['Jonathan', 'S', 'Olshaker']]",Emergency Medicine Clinics of North America,2003,"[u'http://www.sciencedirect.com/science/article/pii/S073386270300018X', u'http://linkinghub.elsevier.com/retrieve/pii/S073386270300018X']"
10.1056/NEJM199709253371302,"Horváth, A., Andersen, I., Junker, K., et. al, Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00158-9,Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies,"[['A', '', 'Horv\xc3\xa1th'], ['I', '', 'Andersen'], ['K', '', 'Junker'], ['B', 'Lyck', 'Fogh-Schultz'], ['E', 'Holm', 'Nielsen'], ['S', '', 'Gizurarson'], ['O', '', 'Andersen'], ['J', '', 'K\xc3\xa1rm\xc3\xa1n'], ['E', '', 'Rajnav\xc3\xb6lgyi'], ['A', '', 'Erdei'], ['S.-E', '', 'Svehag']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001589', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001589']"
10.1056/NEJM199709253371302,"Awofeso, N., Fennell, M., Waliuzzaman, Z., et. al, Influenza outbreak in a correctional facility, Australian and New Zealand Journal of Public Health, 2001",cited-by,10.1111/j.1467-842X.2001.tb00655.x,Influenza outbreak in a correctional facility,"[['Niyi', '', 'Awofeso'], ['Michael', '', 'Fennell'], ['Zubair', '', 'Waliuzzaman'], ['Caroline', '', ""O'Connor""], ['Debbie', '', 'Pittam'], ['Leng', '', 'Boonwaat'], ['Sophie', '', 'Kantzow'], ['William', 'D.', 'Rawlinson']]",Australian and New Zealand Journal of Public Health,2001,[u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1467-842X.2001.tb00655.x']
10.1056/NEJM199709253371302,"Colman, P., , Zanamivir: an influenza virus neuraminidase inhibitor, Expert Review of Anti-infective Therapy, 2005",cited-by,10.1586/14787210.3.2.191,Zanamivir: an influenza virus neuraminidase inhibitor,"[['PM', '', 'Colman']]",Expert Review of Anti-infective Therapy,2005,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.3.2.191']
10.1056/NEJM199709253371302,"Snelgrove, R., Williams, A., Thorpe, C., et. al, Manipulation of immunity to and pathology of respiratory infections, Expert Review of Anticancer Therapy, 2004",cited-by,10.1586/14787210.2.3.413,Manipulation of immunity to and pathology of respiratory infections,"[['Robert', '', 'Snelgrove'], ['Andrew', '', 'Williams'], ['Callum', '', 'Thorpe'], ['Tracy', '', 'Hussell']]",Expert Review of Anticancer Therapy,2004,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.2.3.413']
10.1056/NEJM199709253371302,"Simor, A., , Influenza Outbreaks in Long‐Term–Care Facilities: How Can We Do Better?, Infection Control and Hospital Epidemiology, 2002",cited-by,10.1086/501971,Influenza Outbreaks in Long‐Term–Care Facilities: How Can We Do Better?,"[['Andrew', '', 'Simor']]",Infection Control and Hospital Epidemiology,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501971']
10.1056/NEJM199709253371302,"Plakokefalos, E., Markoulatos, P., Spyrou, N., et. al, Molecular and phylogenetic analysis of haemagglutinin and neuraminidase sequences from recent human influenza type A (H3N2) viral isolates in Southern Greece, Archives of Virology, 2001",cited-by,10.1007/s007050170041,Molecular and phylogenetic analysis of haemagglutinin and neuraminidase sequences from recent human influenza type A (H3N2) viral isolates in Southern Greece,"[['E.', 'T.', 'Plakokefalos'], ['P.', '', 'Markoulatos'], ['N.', '', 'Spyrou'], ['T.', 'A.', 'Bei'], ['N.', 'C.', 'Vamvakopoulos']]",Archives of Virology,2001,"[u'http://www.springerlink.com/index/g02fkr4ufxg76ccf.pdf', u'http://www.springerlink.com/content/g02fkr4ufxg76ccf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s007050170041', u'http://www.springerlink.com/index/pdf/10.1007/s007050170041']"
10.1056/NEJM199709253371302,"Neuzil, K., , Influenza: New insights into an old disease, Current Infectious Disease Reports, 2000",cited-by,10.1007/s11908-000-0039-3,Influenza: New insights into an old disease,"[['Kathleen', 'M.', 'Neuzil']]",Current Infectious Disease Reports,2000,"[u'http://www.springerlink.com/index/0765517834762225.pdf', u'http://www.springerlink.com/content/0765517834762225', u'http://www.springerlink.com/index/10.1007/s11908-000-0039-3', u'http://www.springerlink.com/index/pdf/10.1007/s11908-000-0039-3']"
10.1056/NEJM199709253371302,"Sahasrabudhe, A., Lawrence, L., Epa, V., et. al, Substrate, Inhibitor, or Antibody Stabilizes the Glu 119 Gly Mutant Influenza Virus Neuraminidase, Virology, 1998",cited-by,10.1006/viro.1998.9222,"Substrate, Inhibitor, or Antibody Stabilizes the Glu 119 Gly Mutant Influenza Virus Neuraminidase","[['Anjali', '', 'Sahasrabudhe'], ['Lynne', '', 'Lawrence'], ['V.', 'Chandana', 'Epa'], ['Joseph', 'N.', 'Varghese'], ['Peter', 'M.', 'Colman'], ['Jennifer', 'L.', 'McKimm-Breschkin']]",Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0042682298992224', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682298992224']"
10.1056/NEJM199709253371302,"Klumpp, K., , Recent advances in the discovery and development of anti-influenza drugs, Expert Opinion on Therapeutic Patents, 2004",cited-by,10.1517/13543776.14.8.1153,Recent advances in the discovery and development of anti-influenza drugs,"[['Klaus', '', 'Klumpp']]",Expert Opinion on Therapeutic Patents,2004,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543776.14.8.1153']
10.1056/NEJM199709253371302,"Colman, P., , Neuraminidase inhibitors as antivirals, Vaccine, 2002",cited-by,10.1016/S0264-410X(02)00132-9,Neuraminidase inhibitors as antivirals,"[['P.', 'M', 'Colman']]",Vaccine,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X02001329', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X02001329']"
10.1056/NEJM199709253371302,"Monto, A., Fendrick, A., , Developments in Influenza Prevention and Treatment: A Managed Care Perspective, Disease Management & Health Outcomes, 2000",cited-by,10.2165/00115677-200007050-00001,Developments in Influenza Prevention and Treatment: A Managed Care Perspective,"[['Arnold', 'S.', 'Monto'], ['A.', 'Mark', 'Fendrick']]",Disease Management & Health Outcomes,2000,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00115677-200007050-00001', u'http://diseasemanagement.adisonline.com/pt/re/dmo/pdfhandler.00115677-200007050-00001.pdf', u'http://diseasemanagement.adisonline.com/pt/re/dmo/fulltext.00115677-200007050-00001.htm']"
10.1056/NEJM199709253371302,"Drinka, P., Gravenstein, S., Schilling, M., et. al, Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols, , 0",cited-by,12341046Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols,Duration of Antiviral Prophylaxis During Nursing Home Outbreaks of Influenza A A Comparison of 2 Protocols,"[['Paul', 'J.', 'Drinka'], ['Stefan', '', 'Gravenstein'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Barbara', 'A.', 'Miller'], ['Peter', '', 'Shult']]",,0,"[u'http://archinte.ama-assn.org/cgi/reprint/158/19/2155.pdf', u'http://archinte.highwire.org/cgi/reprint/158/19/2155.pdf']"
10.1056/NEJM199709253371302,"Ishizuka, H., Yoshiba, S., Okabe, H., et. al, Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS8958, in Healthy Male Volunteers, Journal of Clinical Pharmacology, 2010",cited-by,10.1177/0091270009356297,"Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS8958, in Healthy Male Volunteers","[['Hitoshi', '', 'Ishizuka'], ['Satoshi', '', 'Yoshiba'], ['Hiromi', '', 'Okabe'], ['Kazutaka', '', 'Yoshihara']]",Journal of Clinical Pharmacology,2010,"[u'http://www.jclinpharm.org/cgi/doi/10.1177/0091270009356297', u'http://dx.doi.org/10.1177/0091270009356297']"
10.1056/NEJM199709253371302,"Ruf, B., Szucs, T., , Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy, Infection, 2009",cited-by,10.1007/s15010-009-8241-1,Reducing the Burden of Influenza-Associated Complications with Antiviral Therapy,"[['B.', 'R.', 'Ruf'], ['T.', '', 'Szucs']]",Infection,2009,"[u'http://www.springerlink.com/index/880245655hpk7483.pdf', u'http://www.springerlink.com/content/880245655hpk7483', u'http://www.springerlink.com/index/10.1007/s15010-009-8241-1', u'http://www.springerlink.com/index/pdf/10.1007/s15010-009-8241-1']"
10.1056/NEJM199709253371302,"Imuta, F., Toyoda, M., Toyoda, T., , New application method of zanamivir with a straw, Pediatrics International, 2003",cited-by,10.1046/j.1442-200X.2003.01724.x,New application method of zanamivir with a straw,"[['Fusae', '', 'Imuta'], ['Michiko', '', 'Toyoda'], ['Tetsuya', '', 'Toyoda']]",Pediatrics International,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1442-200X.2003.01724.x']
10.1056/NEJM199709253371302,"Kaiser, L., Couch, R., Galasso, G., et. al, First International Symposium on Influenza and Other Respiratory Viruses: summary and overview, Antiviral Research, 1999",cited-by,10.1016/S0166-3542(99)00034-0,First International Symposium on Influenza and Other Respiratory Viruses: summary and overview,"[['Laurent', '', 'Kaiser'], ['Robert', 'B', 'Couch'], ['George', 'J', 'Galasso'], ['W.', 'Paul', 'Glezen'], ['Robert', 'G', 'Webster'], ['Peter', 'F', 'Wright'], ['Frederick', 'G', 'Hayden']]",Antiviral Research,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166354299000340', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354299000340']"
10.1056/NEJM199709253371302,"Cianci, C., Krystal, M., , Development of antivirals against influenza, Expert Opinion on Investigational Drugs, 1998",cited-by,10.1517/13543784.7.2.149,Development of antivirals against influenza,"[['Christopher', '', 'Cianci'], ['Mark', '', 'Krystal']]",Expert Opinion on Investigational Drugs,1998,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.7.2.149']
10.1056/NEJM199709253371302,"Barbani, M., Gorgievski-Hrisoho, M., , Rapid detection of respiratory picornaviruses in nasopharyngeal aspirates by immunofluorescence assay, Journal of Clinical Virology, 2009",cited-by,10.1016/j.jcv.2009.05.008,Rapid detection of respiratory picornaviruses in nasopharyngeal aspirates by immunofluorescence assay,"[['Maria', 'Teresa', 'Barbani'], ['Meri', '', 'Gorgievski-Hrisoho']]",Journal of Clinical Virology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1386653209002030', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653209002030']"
10.1056/NEJM199709253371302,"Salzberger, B., Plentz, A., Ehrenstein, B., et. al, Influenza, Der Pneumologe, 2006",cited-by,10.1007/s10405-005-0074-8,Influenza,"[['B.', '', 'Salzberger'], ['A.', '', 'Plentz'], ['B.', '', 'Ehrenstein'], ['W.', '', 'Jilg']]",Der Pneumologe,2006,"[u'http://www.springerlink.com/content/7g3g89680n3t5q3n', u'http://www.springerlink.com/index/pdf/10.1007/s10405-005-0074-8', u'http://www.springerlink.com/index/10.1007/s10405-005-0074-8']"
10.1056/NEJM199709253371302,"Townsend, K., Eiland, L., , Combating Influenza with Antiviral Therapy in the Pediatric Population, Pharmacotherapy, 2006",cited-by,10.1592/phco.2006.26.1.95,Combating Influenza with Antiviral Therapy in the Pediatric Population,"[['Kara', 'A.', 'Townsend'], ['Lea', 'S.', 'Eiland']]",Pharmacotherapy,2006,[u'http://www.atypon-link.com/PPI/doi/abs/10.1592/phco.2006.26.1.95']
10.1056/NEJM199709253371302,"Genugten, M., Heijnen, M., , The expected number of hospitalisations and beds needed due to pandemic influenza on a regional level in the Netherlands, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.02.007,The expected number of hospitalisations and beds needed due to pandemic influenza on a regional level in the Netherlands,"[['Marianne', 'L. L van', 'Genugten'], ['Marie-Louise', 'A', 'Heijnen']]",Virus Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168170204001066', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001066']"
10.1056/NEJM199709253371302,"Schwarzinger, M., Lacombe, K., Carrat, F., , Economic evaluations of neuraminidase inhibitors to control influenza, , 2003",cited-by,10.1586/14737167.3.2.147,Economic evaluations of neuraminidase inhibitors to control influenza,"[['Michael', '', 'Schwarzinger'], ['Karine', '', 'Lacombe'], ['Fabrice', '', 'Carrat']]",,2003,[u'http://www.future-drugs.com/doi/abs/10.1586/14737167.3.2.147']
10.1056/NEJM199709253371302,"Kuijper, E., Meer, J., Jong, M., et. al, Usefulness of Gram Stain for Diagnosis of Lower Respiratory Tract Infection or Urinary Tract Infection and as an Aid in Guiding Treatment, Carcinogenesis, 2003",cited-by,10.1007/s10096-003-0892-8,Usefulness of Gram Stain for Diagnosis of Lower Respiratory Tract Infection or Urinary Tract Infection and as an Aid in Guiding Treatment,"[['E.', 'J.', 'Kuijper'], ['J.', 'van der', 'Meer'], ['M.', 'D. de', 'Jong'], ['P.', '', 'Speelman'], ['J.', '', 'Dankert']]",Carcinogenesis,2003,"[u'http://www.springerlink.com/index/hwdml44mxdu3dynr.pdf', u'http://www.springerlink.com/content/hwdml44mxdu3dynr']"
10.1056/NEJM199709253371302,"Höffken, G., Gillissen, A., , Efficacy and safety of zanamivir in patients with influenza - impact of age, severity of infections and specific risk factors, Medical Microbiology and Immunology, 2002",cited-by,10.1007/s00430-002-0140-3,"Efficacy and safety of zanamivir in patients with influenza - impact of age, severity of infections and specific risk factors","[['Gert', '', 'H\xc3\xb6ffken'], ['Adrian', '', 'Gillissen']]",Medical Microbiology and Immunology,2002,"[u'http://www.springerlink.com/content/xw6cyvhlgd0majnf', u'http://www.springerlink.com/index/xw6cyvhlgd0majnf.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00430-002-0140-3', u'http://www.springerlink.com/index/pdf/10.1007/s00430-002-0140-3']"
10.1056/NEJM199709253371302,"Hayden, F., , Influenza virus neuraminidase inhibitors: clinical aspects, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00358-2,Influenza virus neuraminidase inhibitors: clinical aspects,"[['Frederick', 'G.', 'Hayden']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003582', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003582']"
10.1056/NEJM199709253371302,"Kuehnert, M., Cardo, D., , Infections associated with health-care personnel: Vaccine-preventable diseases and bloodborne pathogens, Current Infectious Disease Reports, 2000",cited-by,10.1007/s11908-000-0047-3,Infections associated with health-care personnel: Vaccine-preventable diseases and bloodborne pathogens,"[['Matthew', 'J.', 'Kuehnert'], ['Denise', 'M.', 'Cardo']]",Current Infectious Disease Reports,2000,"[u'http://www.springerlink.com/content/w448u2457558425h', u'http://www.springerlink.com/index/w448u2457558425h.pdf', u'http://www.springerlink.com/index/pdf/10.1007/s11908-000-0047-3', u'http://www.springerlink.com/index/10.1007/s11908-000-0047-3']"
10.1001~jama.283.8.1016,MIST Study Group. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet. 1998;352:1877-1881.,references,NOT found in MAS
10.1001~jama.283.8.1016,"Monto AS, Fleming DM, Henry D, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis. 1999;180:254-261.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Calfee DP, Peng AW, Cass LMR, et al. Protective efficacy of intravenous zanamivir in experimental human influenza. 38th International Conference on Antimicrobial Agents and Chemotherapy; September 24-27, 1998; San Diego, Calif. Abstract A332.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Kim CU, Lew W, Williams MA, et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site. J Am Chem Soc. 1997;119:681-690.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Mendel DB, Tai CY, Escarpe PA, et al. Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection. Antimicrob Agents Chemother. 1998;42:640-646.",references,7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"[[u'DIRK', u'B.', u'MENDEL'], [u'CHUN', u'Y.', u'TAI'], [u'PAUL', u'A.', u'ESCARPE'], [u'WEIXING', u'', u'LI'], [u'ROBERT', u'W.', u'SIDWELL'], [u'JOHN', u'H.', u'HUFFMAN'], [u'CLIVE', u'', u'SWEET'], [u'KENNETH', u'J.', u'JAKEMAN'], [u'JAMES', u'', u'MERSON'], [u'STEVEN', u'A.', u'LACY'], [u'WILLARD', u'', u'LEW'], [u'MATTHEW', u'A.', u'WILLIAMS'], [u'LIJUN', u'', u'ZHANG'], [u'MING', u'S.', u'CHEN'], [u'NORBERT', u'', u'BISCHOFBERGER'], [u'CHOUNG', u'U.', u'KIM']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/640.pdf'],./output/10.1001~jama.283.8.1016/7023591
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Palese, P., , Influenza: old and new threats, Nature Medicine, 2004",cited-by,10.1038/nm1141,Influenza: old and new threats,"[['Peter', '', 'Palese']]",Nature Medicine,2004,"[u'http://dx.doi.org/10.1038/nm1141', u'http://www.nature.com/doifinder/10.1038/nm1141']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"McKimm-Breschkin, J., , Resistance of influenza viruses to neuraminidase inhibitors — a review, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00103-0,Resistance of influenza viruses to neuraminidase inhibitors — a review,"[['Jennifer', 'L.', 'McKimm-Breschkin']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001030', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-14.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001030']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Ives, J., Carr, J., Mendel, D., et. al, The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(02)00053-0,The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo,"[['J.', 'A. L.', 'Ives'], ['J.', 'A.', 'Carr'], ['D.', 'B.', 'Mendel'], ['C.', 'Y.', 'Tai'], ['R.', '', 'Lambkin'], ['L.', '', 'Kelly'], ['J.', 'S.', 'Oxford'], ['F.', 'G.', 'Hayden'], ['N.', 'A.', 'Roberts']]",Antiviral Research,2002,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-20.pdf', u'http://www.sciencedirect.com/science/article/pii/S0166354202000530', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-21.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354202000530']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"GOVORKOVA, E., LENEVA, I., GOLOUBEVA, O., et. al, Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.10.2723-2732.2001,"Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses","[['ELENA', 'A.', 'GOVORKOVA'], ['IRINA', 'A.', 'LENEVA'], ['OLGA', 'G.', 'GOLOUBEVA'], ['KAREN', '', 'BUSH'], ['ROBERT', 'G.', 'WEBSTER']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/10/2723.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.10.2723-2732.2001']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Clercq, E., , Strategies in the design of antiviral drugs, Nature Reviews Drug Discovery, 2002",cited-by,10.1038/nrd703,Strategies in the design of antiviral drugs,"[['Erik', 'De', 'Clercq']]",Nature Reviews Drug Discovery,2002,"[u'http://dx.doi.org/10.1038/nrd703', u'http://www.nature.com/doifinder/10.1038/nrd703']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Peters, P., Gravenstein, S., Norwood, P., et. al, Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population, Journal of The American Geriatrics Society, 2001",cited-by,10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[['Patrick', 'H.', 'Peters'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Norwood'], ['Veerle', 'De', 'Bock'], ['Anthony', 'Van', 'Couter'], ['Michael', '', 'Gibbens'], ['Tony-Andrea', 'Von', 'Planta'], ['Penelope', '', 'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Herlocher, M., Carr, J., Ives, J., et. al, Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00214-5,Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets,"[['M.', 'L', 'Herlocher'], ['J', '', 'Carr'], ['J', '', 'Ives'], ['S', '', 'Elias'], ['R', '', 'Truscon'], ['N', '', 'Roberts'], ['A.', 'S', 'Monto']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201002145', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201002145']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Govorkova, E., Ilyushina, N., Boltz, D., et. al, Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza Virus, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01312-06,Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza Virus,"[['Elena', 'A.', 'Govorkova'], ['Natalia', 'A.', 'Ilyushina'], ['David', 'A.', 'Boltz'], ['Alan', '', 'Douglas'], ['Neziha', '', 'Yilmaz'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2007,"[u'http://aac.asm.org/cgi/reprint/51/4/1414.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.01312-06']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Mishin, V., Hayden, F., Gubareva, L., , Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.11.4515-4520.2005,Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors,"[['Vasiliy', 'P.', 'Mishin'], ['Frederick', 'G.', 'Hayden'], ['Larisa', 'V.', 'Gubareva']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/11/4515.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.11.4515-4520.2005']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Furuta, Y., Takahashi, K., Fukuda, Y., et. al, In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.977-981.2002,In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705,"[['Y.', '', 'Furuta'], ['K.', '', 'Takahashi'], ['Y.', '', 'Fukuda'], ['M.', '', 'Kuno'], ['T.', '', 'Kamiyama'], ['K.', '', 'Kozaki'], ['N.', '', 'Nomura'], ['H.', '', 'Egawa'], ['S.', '', 'Minami'], ['Y.', '', 'Watanabe'], ['H.', '', 'Narita'], ['K.', '', 'Shiraki']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://journals.pasteur.ac.ir/aac02/46(4)/977.pdf', u'http://aac.asm.org/cgi/reprint/46/4/977.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.977-981.2002']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Bantia, S., Parker, C., Ananth, S., et. al, Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.4.1162-1167.2001,Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir,"[['S.', '', 'Bantia'], ['C.', 'D.', 'Parker'], ['S.', 'L.', 'Ananth'], ['L.', 'L.', 'Horn'], ['K.', '', 'Andries'], ['P.', '', 'Chand'], ['P.', 'L.', 'Kotian'], ['A.', '', 'Dehghani'], ['Y.', '', 'El-Kattan'], ['T.', '', 'Lin'], ['T.', 'L.', 'Hutchison'], ['J.', 'A.', 'Montgomery'], ['D.', 'L.', 'Kellog'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://faculty.tamu-commerce.edu/fmiskevich/Bsc-597MAMB/Bantia-%20anti-influenza%20drug%20design.pdf', u'http://aac.asm.org/cgi/reprint/45/4/1162.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1162-1167.2001']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"LI, W., ESCARPE, P., EISENBERG, E., et. al, Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071, , 1998",cited-by,11215168Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071,"[['WEIXING', '', 'LI'], ['PAUL', 'A.', 'ESCARPE'], ['EUGENE', 'J.', 'EISENBERG'], ['KENNETH', 'C.', 'CUNDY'], ['CLIVE', '', 'SWEET'], ['KENNETH', 'J.', 'JAKEMAN'], ['JAMES', '', 'MERSON'], ['WILLARD', '', 'LEW'], ['MATT', '', 'WILLIAMS'], ['LIJUN', '', 'ZHANG'], ['CHOUNG', 'U.', 'KIM'], ['NORBERT', '', 'BISCHOFBERGER'], ['MING', 'S.', 'CHEN'], ['DIRK', 'B.', 'MENDEL']]",,1998,[u'http://aac.asm.org/cgi/reprint/42/3/647.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Leneva, I., Roberts, N., Govorkova, E., et. al, The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00123-6,The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses,"[['Irina', 'A.', 'Leneva'], ['Noel', '', 'Roberts'], ['Elena', 'A.', 'Govorkova'], ['Olga', 'G.', 'Goloubeva'], ['Robert', 'G.', 'Webster']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001236', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001236']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Malakhov, M., Aschenbrenner, L., Smee, D., et. al, Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.50.4.1470-1479.2006,Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection,"[['Michael', 'P.', 'Malakhov'], ['Laura', 'M.', 'Aschenbrenner'], ['Donald', 'F.', 'Smee'], ['Miles', 'K.', 'Wandersee'], ['Robert', 'W.', 'Sidwell'], ['Larisa', 'V.', 'Gubareva'], ['Vasiliy', 'P.', 'Mishin'], ['Frederick', 'G.', 'Hayden'], ['Do', 'Hyong', 'Kim'], ['Alice', '', 'Ing'], ['Erin', 'R.', 'Campbell'], ['Mang', '', 'Yu'], ['Fang', '', 'Fang']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://aac.asm.org/cgi/reprint/50/4/1470.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.50.4.1470-1479.2006']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"NOYOLA, D., CLARK, B., O'DONNELL, F., et. al, Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens, , 2000",cited-by,"13918606Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens","Comparison of a New Neuraminidase Detection Assay with an Enzyme Immunoassay, Immunofluorescence, and Culture for Rapid Detection of Influenza A and B Viruses in Nasal Wash Specimens","[['DANIEL', 'E.', 'NOYOLA'], ['BRUCE', '', 'CLARK'], ['FREDERICK', 'T.', ""O'DONNELL""], ['ROBERT', 'L.', 'ATMAR'], ['JEWEL', '', 'GREER'], ['GAIL', 'J.', 'DEMMLER']]",,2000,[u'http://jcm.asm.org/cgi/reprint/38/3/1161.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Govorkova, E., Fang, H., Tan, M., et. al, Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4855-4863.2004,Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells,"[['Elena', 'A.', 'Govorkova'], ['Hong-Bin', '', 'Fang'], ['Ming', '', 'Tan'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4855.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4855-4863.2004']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Rameix-Welti, M., Agou, F., Buchy, P., et. al, Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir, Antimicrobial Agents and Chemotherapy, 2006",cited-by,10.1128/AAC.00645-06,Natural Variation Can Significantly Alter the Sensitivity of Influenza A (H5N1) Viruses to Oseltamivir,"[['M.', 'A.', 'Rameix-Welti'], ['F.', '', 'Agou'], ['P.', '', 'Buchy'], ['S.', '', 'Mardy'], ['J.', 'T.', 'Aubin'], ['M.', '', 'Veron'], ['S.', 'van der', 'Werf'], ['N.', '', 'Naffakh']]",Antimicrobial Agents and Chemotherapy,2006,"[u'http://www.ctcd.edu/science/tanderson/documents/OseltamivirSensitivityH5N1.pdf', u'http://aac.asm.org/cgi/reprint/50/11/3809.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00645-06']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Kati, W., Montgomery, D., Carrick, R., et. al, In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.1014-1021.2002,"In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication","[['Warren', 'M.', 'Kati'], ['Debra', '', 'Montgomery'], ['Robert', '', 'Carrick'], ['Larisa', '', 'Gubareva'], ['Clarence', '', 'Maring'], ['Keith', '', 'McDaniel'], ['Kevin', '', 'Steffy'], ['Akhteruzzaman', '', 'Molla'], ['Frederick', '', 'Hayden'], ['Dale', '', 'Kempf'], ['William', '', 'Kohlbrenner']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/1014.pdf', u'http://journals.pasteur.ac.ir/AAC02/46(4)/1014.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.1014-1021.2002']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sidwell, R., Barnard, D., Day, C., et. al, Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice, Antimicrobial Agents and Chemotherapy, 2007",cited-by,10.1128/AAC.01051-06,Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice,"[['Robert', 'W.', 'Sidwell'], ['Dale', 'L.', 'Barnard'], ['Craig', 'W.', 'Day'], ['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['John', 'D.', 'Morrey'], ['Yousuke', '', 'Furuta']]",Antimicrobial Agents and Chemotherapy,2007,[u'http://aac.asm.org/cgi/doi/10.1128/AAC.01051-06']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"SIDWELL, R., SMEE, D., HUFFMAN, J., et. al, In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.749-757.2001,In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201,"[['ROBERT', 'W.', 'SIDWELL'], ['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['DALE', 'L.', 'BARNARD'], ['KEVIN', 'W.', 'BAILEY'], ['JOHN', 'D.', 'MORREY'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/3/749.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.749-757.2001']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Molla, A., Kati, W., Carrick, R., et. al, In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675, Journal of Virology, 2002",cited-by,10.1128/JVI.76.11.5380-5386.2002,"In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675","[['Akhteruzzaman', '', 'Molla'], ['Warren', '', 'Kati'], ['Robert', '', 'Carrick'], ['Kevin', '', 'Steffy'], ['Yan', '', 'Shi'], ['Debra', '', 'Montgomery'], ['Nanette', '', 'Gusick'], ['Vincent', 'S.', 'Stoll'], ['Kent', 'D.', 'Stewart'], ['Teresa', 'I.', 'Ng'], ['Clarence', '', 'Maring'], ['Dale', 'J.', 'Kempf'], ['William', '', 'Kohlbrenner']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/11/5380.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.11.5380-5386.2002']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Trial, A., Welliver, R., Monto, A., et. al, Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts, , 2001",cited-by,6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[['A', 'Randomized Controlled', 'Trial'], ['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz'], ['Edwig', '', 'Schatteman'], ['Michael', '', 'Hassman'], ['James', '', 'Hedrick'], ['Helen', 'C.', 'Jackson'], ['Penelope', '', 'Ward'], ['John', 'S.', 'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Noah, D., Krug, R., , Influenza Virus Virulence and Its Molecular Determinants, Advances in Virus Research, 2005",cited-by,10.1016/S0065-3527(05)65004-X,Influenza Virus Virulence and Its Molecular Determinants,"[['Diana', 'L.', 'Noah'], ['Robert', 'M.', 'Krug']]",Advances in Virus Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S006535270565004X', u'http://linkinghub.elsevier.com/retrieve/pii/S006535270565004X']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Laver, W., Bischofberger, N., Webster, R., , The Origin and Control of Pandemic Influenza, , 2000",cited-by,10259737The Origin and Control of Pandemic Influenza,The Origin and Control of Pandemic Influenza,"[['W.', 'Graeme', 'Laver'], ['Norbert', '', 'Bischofberger'], ['Robert', 'G.', 'Webster']]",,2000,"[u'http://birdflubook.com/resources/LAVER173.pdf', u'http://muse.jhu.edu/about/publishers.html/journals/perspectives_in_biology_and_medicine/v043/43.2laver.html']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Yun, N., Linde, N., Zacks, M., et. al, Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1), Virology, 2008",cited-by,10.1016/j.virol.2007.12.029,"Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)","[['Nadezhda', 'E.', 'Yun'], ['Nathaniel', 'S.', 'Linde'], ['Michele', 'A.', 'Zacks'], ['Ian', 'G.', 'Barr'], ['Aeron', 'C.', 'Hurt'], ['Jeanon', 'N.', 'Smith'], ['Natallia', '', 'Dziuba'], ['Michael', 'R.', 'Holbrook'], ['Lifang', '', 'Zhang'], ['John', 'M.', 'Kilpatrick'], ['C.', 'Shane', 'Arnold'], ['Slobodan', '', 'Paessler']]",Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0042682207008562', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682207008562']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Alymova, I., Taylor, G., Takimoto, T., et. al, Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.5.1495-1502.2004,Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo,"[['Irina', 'V.', 'Alymova'], ['Garry', '', 'Taylor'], ['Toru', '', 'Takimoto'], ['Tsu-Hsing', '', 'Lin'], ['Pooran', '', 'Chand'], ['Y.', 'Sudhakara', 'Babu'], ['Chenghong', '', 'Li'], ['Xiaoping', '', 'Xiong'], ['Allen', '', 'Portner']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/5/1495.pdf', u'http://aac.highwire.org/cgi/reprint/48/5/1495.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.5.1495-1502.2004']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Schentag, J., Hill, G., Chu, T., et. al, Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects, Journal of Clinical Pharmacology, 2007",cited-by,10.1177/0091270007299761,Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects,"[['Jerome', 'J.', 'Schentag'], ['George', '', 'Hill'], ['Tom', '', 'Chu'], ['Craig', 'R.', 'Rayner']]",Journal of Clinical Pharmacology,2007,"[u'http://dx.doi.org/10.1177/0091270007299761', u'http://www.jclinpharm.org/cgi/doi/10.1177/0091270007299761']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sweet, C., Jakeman, K., Bush, K., et. al, Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.4.996-1004.2002,Oral Administration of Cyclopentane Neuraminidase Inhibitors Protects Ferrets against Influenza Virus Infection,"[['Clive', '', 'Sweet'], ['Kenneth', 'J.', 'Jakeman'], ['Karen', '', 'Bush'], ['Pamela', 'C.', 'Wagaman'], ['Linda', 'A.', 'Mckown'], ['Anthony', 'J.', 'Streeter'], ['Daksha', '', 'Desai-Krieger'], ['Pooran', '', 'Chand'], ['Yarlagadda', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/4/996.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.4.996-1004.2002']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Hung, H., Tseng, C., Yang, J., et. al, Aurintricarboxylic acid inhibits influenza virus neuraminidase, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.10.006,Aurintricarboxylic acid inhibits influenza virus neuraminidase,"[['Hui-Chen', '', 'Hung'], ['Ching-Ping', '', 'Tseng'], ['Jinn-Moon', '', 'Yang'], ['Yi-Wei', '', 'Ju'], ['Sung-Nain', '', 'Tseng'], ['Yen-Fu', '', 'Chen'], ['Yu-Sheng', '', 'Chao'], ['Hsing-Pang', '', 'Hsieh'], ['Shin-Ru', '', 'Shih'], ['John', 'T.-A.', 'Hsu']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208004300', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208004300']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Jackson, D., Barclay, W., Zurcher, T., , Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations, , 2005",cited-by,6548090Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,"[['David', '', 'Jackson'], ['Wendy', '', 'Barclay'], ['Thomas', '', 'Zurcher']]",,2005,[u'http://jac.oxfordjournals.org/cgi/reprint/55/2/162.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Robson, R., Buttimore, A., Lynn, K., et. al, The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis, , 2006",cited-by,10077451The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,"[['Richard', '', 'Robson'], ['Adrian', '', 'Buttimore'], ['Kelvin', '', 'Lynn'], ['Mike', '', 'Brewster'], ['Penelope', '', 'Ward']]",,2006,"[u'http://www.kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://ndt.oxfordjournals.org/cgi/reprint/21/9/2556.pdf']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Smee, D., Sidwell, R., Morrison, A., et. al, Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00168-1,Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201,"[['Donald', 'F', 'Smee'], ['Robert', 'W', 'Sidwell'], ['Ann', 'C', 'Morrison'], ['Kevin', 'W', 'Bailey'], ['Ellen', 'Z', 'Baum'], ['Linh', '', 'Ly'], ['Pamela', 'C', 'Wagaman']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001681', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001681']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Dreitlein, W., Maratos, J., Brocavich, J., , Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza, Clinical Therapeutics, 2001",cited-by,10.1016/S0149-2918(01)80042-4,Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza,"[['William', 'B.', 'Dreitlein'], ['Julia', '', 'Maratos'], ['Joseph', '', 'Brocavich']]",Clinical Therapeutics,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0149291801800424', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291801800424']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Holodniy, M., Penzak, S., Straight, T., et. al, Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid, Antimicrobial Agents and Chemotherapy, 2008",cited-by,10.1128/AAC.00047-08,Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid,"[['Mark', '', 'Holodniy'], ['Scott', 'R.', 'Penzak'], ['Timothy', 'M.', 'Straight'], ['Richard', 'T.', 'Davey'], ['Kelvin', 'K.', 'Lee'], ['Matthew', 'Bidwell', 'Goetz'], ['Dennis', 'W.', 'Raisch'], ['Francesca', '', 'Cunningham'], ['Emil', 'T.', 'Lin'], ['Noemi', '', 'Olivo'], ['Lawrence', 'R.', 'Deyton']]",Antimicrobial Agents and Chemotherapy,2008,"[u'http://aac.asm.org/cgi/reprint/52/9/3013.pdf', u'http://www.apuabrasil.org.br/arquivos/influenza25.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00047-08']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Krug, R., Aramini, J., , Emerging antiviral targets for influenza A virus, Trends in Pharmacological Sciences, 2009",cited-by,10.1016/j.tips.2009.03.002,Emerging antiviral targets for influenza A virus,"[['Robert', 'M.', 'Krug'], ['James', 'M.', 'Aramini']]",Trends in Pharmacological Sciences,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0165614709000558', u'http://linkinghub.elsevier.com/retrieve/pii/S0165614709000558']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Smee, D., Bailey, K., Wong, M., et. al, Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N, Antiviral Research, 2008",cited-by,10.1016/j.antiviral.2008.06.003,Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N,"[['Donald', 'F.', 'Smee'], ['Kevin', 'W.', 'Bailey'], ['Min-Hui', '', 'Wong'], ['Barry', 'R.', 'O\xe2\x80\x99Keefe'], ['Kirk', 'R.', 'Gustafson'], ['Vasiliy', 'P.', 'Mishin'], ['Larisa', 'V.', 'Gubareva']]",Antiviral Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208003239', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208003239']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Myc, A., Anderson, M., Jr, J., , Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents, Journal of Virological Methods, 1999",cited-by,10.1016/S0166-0934(98)00150-5,Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents,"[['Andrzej', '', 'Myc'], ['Marie', 'J', 'Anderson'], ['James', 'R Baker', 'Jr']]",Journal of Virological Methods,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0166093498001505', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093498001505']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Itzstein, M., Thomson, R., , Anti-Influenza Drugs: The Development of Sialidase Inhibitors, , 0",cited-by,10.1007/978-3-540-79086-0_5,Anti-Influenza Drugs: The Development of Sialidase Inhibitors,"[['Mark', 'von', 'Itzstein'], ['Robin', '', 'Thomson']]",,0,"[u'http://www.springerlink.com/index/q7q766196t171341.pdf', u'http://www.springerlink.com/content/q7q766196t171341']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Jancel, T., Penzak, S., , Antiviral Therapy in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia, Seminars in Hematology, 2009",cited-by,10.1053/j.seminhematol.2009.03.004,"Antiviral Therapy in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia","[['Timothy', '', 'Jancel'], ['Scott', 'R.', 'Penzak']]",Seminars in Hematology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0037196309000596', u'http://linkinghub.elsevier.com/retrieve/pii/S0037196309000596']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Brewster, M., Smith, J., Dutkowski, R., et. al, Active metabolite from Tamiflu ® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label study, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.05.080,"Active metabolite from Tamiflu ® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label study","[['M.', '', 'Brewster'], ['J.', 'R.', 'Smith'], ['R.', '', 'Dutkowski'], ['R.', '', 'Robson']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06006396', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06006396']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Carroll, T., Matzinger, S., Genesca, M., et. al, Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1, , 0",cited-by,12122205Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1,Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1,"[['Timothy', 'D.', 'Carroll'], ['Shannon', 'R.', 'Matzinger'], ['Meritxell', '', 'Genesca'], ['Linda', '', 'Fritts'], ['Roxana', '', 'Colon'], ['Michael', 'B.', 'McChesney'], ['Christopher', 'J.', 'Miller']]",,0,[u'http://www.jimmunol.org/cgi/reprint/180/4/2385.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"SAWABUCHI, T., SUZUKI, S., IWASE, K., et. al, Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza, Respirology, 2009",cited-by,10.1111/j.1440-1843.2009.01639.x,Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza,"[['Takako', '', 'SAWABUCHI'], ['Satoshi', '', 'SUZUKI'], ['Kazuhiro', '', 'IWASE'], ['Chika', '', 'ITO'], ['Dai', '', 'MIZUNO'], ['Hajime', '', 'TOGARI'], ['Isamu', '', 'WATANABE'], ['Sadiqur', 'R.', 'TALUKDER'], ['Junji', '', 'CHIDA'], ['Hiroshi', '', 'KIDO']]",Respirology,2009,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1440-1843.2009.01639.x']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Kulkarni, A., Weiss, A., Iyer, S., , Glycan-based high-affinity ligands for toxins and pathogen receptors, Medicinal Research Reviews, 2010",cited-by,10.1002/med.20196,Glycan-based high-affinity ligands for toxins and pathogen receptors,"[['Ashish', 'A.', 'Kulkarni'], ['Alison', 'A.', 'Weiss'], ['Suri', 'S.', 'Iyer']]",Medicinal Research Reviews,2010,[u'http://doi.wiley.com/10.1002/med.20196']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"D'Souza, C., Kanyalkar, M., Joshi, M., et. al, Probing molecular level interaction of oseltamivir with H5N1NA and model membranes by molecular docking, multinuclear NMR and DSC methods, Biochimica Et Biophysica Acta-biomembranes, 2009",cited-by,10.1016/j.bbamem.2008.11.014,"Probing molecular level interaction of oseltamivir with H5N1NA and model membranes by molecular docking, multinuclear NMR and DSC methods","[['Charlotte', '', ""D'Souza""], ['Meena', '', 'Kanyalkar'], ['Mamata', '', 'Joshi'], ['Evans', '', 'Coutinho'], ['Sudha', '', 'Srivastava']]",Biochimica Et Biophysica Acta-biomembranes,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0005273608003842', u'http://linkinghub.elsevier.com/retrieve/pii/S0005273608003842']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sauerbrei, A., Haertl, A., Brandstaedt, A., et. al, Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors, Medical Microbiology and Immunology, 2006",cited-by,10.1007/s00430-005-0002-x,Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors,"[['A.', '', 'Sauerbrei'], ['A.', '', 'Haertl'], ['A.', '', 'Brandstaedt'], ['M.', '', 'Schmidtke'], ['P.', '', 'Wutzler']]",Medical Microbiology and Immunology,2006,"[u'http://www.springerlink.com/index/m37932425096l606.pdf', u'http://www.springerlink.com/content/m37932425096l606', u'http://www.springerlink.com/index/10.1007/s00430-005-0002-x', u'http://www.springerlink.com/index/pdf/10.1007/s00430-005-0002-x']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Oxford, J., , Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza, Influenza and Other Respiratory Viruses, 2007",cited-by,10.1111/j.1750-2659.2006.00006.x,Antivirals for the treatment and prevention of epidemic and pandemic influenza: Antivirals for epidemic and pandemic influenza,"[['John', 'S.', 'Oxford']]",Influenza and Other Respiratory Viruses,2007,[u'http://doi.wiley.com/10.1111/j.1750-2659.2006.00006.x']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Lu, F., Tseng, S., Li, M., et. al, In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid, Archives of Virology, 2002",cited-by,10.1007/s705-002-8319-5,In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid,"[['F.-J.', '', 'Lu'], ['S.-N.', '', 'Tseng'], ['M.-L.', '', 'Li'], ['S.-R.', '', 'Shih']]",Archives of Virology,2002,"[u'http://www.springerlink.com/content/ajvvqnn6jcjmg9bc', u'http://www.springerlink.com/index/ajvvqnn6jcjmg9bc.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s705-002-8319-5', u'http://www.springerlink.com/index/pdf/10.1007/s705-002-8319-5']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Sidwell, R., , A consideration of animal models used for study of influenza virus inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00388-0,A consideration of animal models used for study of influenza virus inhibitors,"[['Robert', 'W', 'Sidwell']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003880', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003880']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Xu, Z., Li, H., Luo, H., et. al, Graphite nanosheets doped with Fe, Ni, and N, synthesized in one step, and their unique magnetic performance, Solid State Communications, 2011",cited-by,10.1016/j.ssc.2011.01.020,"Graphite nanosheets doped with Fe, Ni, and N, synthesized in one step, and their unique magnetic performance","[['Zhanwei', '', 'Xu'], ['Hejun', '', 'Li'], ['Huijuan', '', 'Luo'], ['Huihui', '', 'Sun'], ['Qinglin', '', 'Zhang'], ['Gaoxiang', '', 'Cao'], ['Kezhi', '', 'Li']]",Solid State Communications,2011,"[u'http://www.sciencedirect.com/science/article/pii/S0038109811000494', u'http://adsabs.harvard.edu/abs/2011SSCom.151..643X']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Welliver, R., Monto, A., Carewicz, O., , Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in, , 2010",cited-by,13851601Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,Household Contacts: A Randomized Controlled Trial Effectiveness of Oseltamivir in Preventing Influenza in,"[['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz']]",,2010,[u'http://jama.ama-assn.org/cgi/reprint/285/6/748.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Lindemann, L., Jacobsen, H., Schuhbauer, D., et. al, In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu ®) and active metabolite, European Journal of Pharmacology, 2010",cited-by,10.1016/j.ejphar.2009.11.020,In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu ®) and active metabolite,"[['Lothar', '', 'Lindemann'], ['Helmut', '', 'Jacobsen'], ['Diana', '', 'Schuhbauer'], ['Frederic', '', 'Knoflach'], ['Silvia', '', 'Gatti'], ['Joseph', 'G.', 'Wettstein'], ['Hansruedi', '', 'Loetscher'], ['Tom', '', 'Chu'], ['Martin', '', 'Ebeling'], ['James', 'C.', 'Paulson'], ['Eric', '', 'Prinssen'], ['Manfred', '', 'Brockhaus']]",European Journal of Pharmacology,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0014299909010358', u'http://linkinghub.elsevier.com/retrieve/pii/S0014299909010358']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Fusco, D., Liu, X., Savage, C., et. al, Echinacea purpurea aerial extract alters course of influenza infection in mice, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.03.047,Echinacea purpurea aerial extract alters course of influenza infection in mice,"[['Dahlene', '', 'Fusco'], ['Xinyan', '', 'Liu'], ['Caroline', '', 'Savage'], ['Ying', '', 'Taur'], ['Weilie', '', 'Xiao'], ['Edward', '', 'Kennelly'], ['Jianda', '', 'Yuan'], ['Barrie', '', 'Cassileth'], ['Mirella', '', 'Salvatore'], ['Genovefa', 'A.', 'Papanicolaou']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10004470', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10004470']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"West, M., Hanigan, M., , γ-Glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells, Archives of Biochemistry and Biophysics, 2010",cited-by,10.1016/j.abb.2010.08.019,γ-Glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells,"[['Matthew', 'B.', 'West'], ['Marie', 'H.', 'Hanigan']]",Archives of Biochemistry and Biophysics,2010,[u'http://www.sciencedirect.com/science/article/pii/S0003986110003656']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"D'Andrea, I., Santarelli, S., Alleva, E., et. al, P.1.f.004 Communal nest reduces vulnerability to depression-like behaviour and enhances brain dopamine function in adult male mice, European Neuropsychopharmacology, 2010",cited-by,10.1016/S0924-977X(10)70412-0,P.1.f.004 Communal nest reduces vulnerability to depression-like behaviour and enhances brain dopamine function in adult male mice,"[['I.', '', ""D'Andrea""], ['S.', '', 'Santarelli'], ['E.', '', 'Alleva'], ['I.', '', 'Branchi']]",European Neuropsychopharmacology,2010,[u'http://www.sciencedirect.com/science/article/pii/S0924977X10704120']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Meltzer, H., Karayal, O., Miceli, J., et. al, P.3.c.051 The effect of ziprasidone on the QTc interval when used in combination with lithium, valproate or lamotrigine, European Neuropsychopharmacology, 2010",cited-by,10.1016/S0924-977X(10)70721-5,"P.3.c.051 The effect of ziprasidone on the QTc interval when used in combination with lithium, valproate or lamotrigine","[['H.', '', 'Meltzer'], ['O.', 'N.', 'Karayal'], ['J.', '', 'Miceli'], ['S.', '', 'Kolluri'], ['C.', '', ""O'Gorman""]]",European Neuropsychopharmacology,2010,[u'http://www.sciencedirect.com/science/article/pii/S0924977X10707215']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Kissi, Y., Laaroussi, M., Gaabout, S., et. al, P.3.e.007 Sexual activity and marital relationships in Tunisian schizophrenic patients: comparison with healthy controls, European Neuropsychopharmacology, 2010",cited-by,10.1016/S0924-977X(10)70762-8,P.3.e.007 Sexual activity and marital relationships in Tunisian schizophrenic patients: comparison with healthy controls,"[['Y.', 'El', 'Kissi'], ['M.', '', 'Laaroussi'], ['S.', '', 'Gaabout'], ['M.', '', 'Ayachi'], ['J.', '', 'Nakhli'], ['B.', 'Ben Hadj', 'Ali']]",European Neuropsychopharmacology,2010,[u'http://www.sciencedirect.com/science/article/pii/S0924977X10707628']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"D'Souza, C., Kanyalkar, M., Joshi, M., et. al, Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods, Biochimica Et Biophysica Acta-biomembranes, 2009",cited-by,10.1016/j.bbamem.2009.04.014,"Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods","[['Charlotte', '', ""D'Souza""], ['Meena', '', 'Kanyalkar'], ['Mamata', '', 'Joshi'], ['Evans', '', 'Coutinho'], ['Sudha', '', 'Srivastava']]",Biochimica Et Biophysica Acta-biomembranes,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0005273609001345', u'http://linkinghub.elsevier.com/retrieve/pii/S0005273609001345']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Gassenmeier, K., Daniher, A., Furrer, S., , 1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor, , 2006",cited-by,10.1016/S0167-4501(06)80073-7,1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor,"[['Klaus', '', 'Gassenmeier'], ['Andrew', '', 'Daniher'], ['Stefan', '', 'Furrer']]",,2006,[u'http://www.sciencedirect.com/science/article/pii/S0167450106800737']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Lipatov, A., Govorkova, E., Webby, R., et. al, MINIREVIEW Influenza: Emergence and Control, , 2004",cited-by,12108822MINIREVIEW Influenza: Emergence and Control,MINIREVIEW Influenza: Emergence and Control,"[['Aleksandr', 'S.', 'Lipatov'], ['Elena', 'A.', 'Govorkova'], ['Richard', 'J.', 'Webby'], ['Hiroichi', '', 'Ozaki'], ['Malik', '', 'Peiris'], ['Yi', '', 'Guan'], ['Leo', '', 'Poon'], ['Robert', 'G.', 'Webster']]",,2004,"[u'http://jvi.highwire.org/cgi/reprint/78/17/8951.pdf', u'http://jvi.asm.org/cgi/reprint/78/17/8951.pdf']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Massarella, J., He, G., Dorr, A., et. al, The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers, Journal of Clinical Pharmacology, 2000",cited-by,10.1177/009127000004000804,The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64-0796/GS4104) in Healthy Adult and Elderly Volunteers,"[['Joseph', 'W.', 'Massarella'], ['George', 'Z.', 'He'], ['Albert', '', 'Dorr'], ['Keith', '', 'Nieforth'], ['Penelope', '', 'Ward'], ['Andy', '', 'Brown']]",Journal of Clinical Pharmacology,2000,[u'http://dx.doi.org/10.1177/009127000004000804']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Leitzke, S., , Die Therapie der Influenza mit Neuraminidase-Inhibitoren, Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz, 1999",cited-by,10.1007/s001030050275,Die Therapie der Influenza mit Neuraminidase-Inhibitoren,"[['S.', '', 'Leitzke']]",Bundesgesundheitsblatt-gesundheitsforschung-gesundheitsschutz,1999,"[u'http://www.springerlink.com/index/aubc4t0cmtk1megk.pdf', u'http://www.springerlink.com/content/aubc4t0cmtk1megk', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s001030050275', u'http://www.springerlink.com/index/pdf/10.1007/s001030050275']"
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Wenzel, R., , Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor, , 0",cited-by,12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,"[['Richard', 'P.', 'Wenzel']]",,0,[u'http://jama.ama-assn.org/cgi/reprint/283/8/1016.pdf']
7023591Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection,"Pleschka, S., Ludwig, S., Wolff, T., et. al, Anti-viral approaches against influenza viruses, , 0",cited-by,10.1007/978-0-387-31047-3_5,Anti-viral approaches against influenza viruses,"[['Stephan', '', 'Pleschka'], ['Stephan', '', 'Ludwig'], ['Thorsten', '', 'Wolff'], ['Oliver', '', 'Planz']]",,0,"[u'http://www.springerlink.com/index/um10454n7482018j.pdf', u'http://www.springerlink.com/content/um10454n7482018j']"
10.1001~jama.283.8.1016,"Wood ND, Aitken M, Sharp S, Evison H. Tolerability and pharmacokinetics of the neuraminidase inhibitor Ro 64-0802 (GS4071) following oral administration of the prodrug Ro 64-0796 (GS4104) to healthy male volunteers. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 28–October 1, 1997; Toronto, Ontario. Abstract A123.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza. JAMA. 1999;282:1240-1246.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med. 1999;341:1336-1346.",references,10.1056/NEJM199910283411802,Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza,"[[u'Frederick', u'G.', u'Hayden'], [u'Robert', u'L.', u'Atmar'], [u'Margo', u'', u'Schilling'], [u'Casey', u'', u'Johnson'], [u'Donald', u'', u'Poretz'], [u'David', u'', u'Paar'], [u'Les', u'', u'Huson'], [u'Penelope', u'', u'Ward'], [u'Roger', u'G.', u'Mills']]",New England Journal of Medicine,1999,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199910283411802'],./output/10.1001~jama.283.8.1016/10.1056~NEJM199910283411802
10.1056/NEJM199910283411802,"Nicholson, K., Wood, J., Zambon, M., , Influenza, Lancet, 2003",cited-by,10.1016/S0140-6736(03)14854-4,Influenza,"[['Karl', 'G', 'Nicholson'], ['John', 'M', 'Wood'], ['Maria', '', 'Zambon']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603148544', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603148544']"
10.1056/NEJM199910283411802,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, Lancet, 2000",cited-by,10.1016/S0140-6736(99)11433-8,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699114338', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699114338']"
10.1056/NEJM199910283411802,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']"
10.1056/NEJM199910283411802,"Woodhead, M., Blasi, F., Ewig, S., et. al, Guidelines for the management of adult lower respiratory tract infections, European Respiratory Journal, 2005",cited-by,10.1183/09031936.05.00055705,Guidelines for the management of adult lower respiratory tract infections,"[['M.', '', 'Woodhead'], ['F.', '', 'Blasi'], ['S.', '', 'Ewig'], ['G.', '', 'Huchon'], ['M.', '', 'Leven'], ['A.', '', 'Ortqviste'], ['T.', '', 'Schaberg'], ['A.', '', 'Torres'], ['G.', 'van der', 'Heijden'], ['T.', 'J. M.', 'Verheij']]",European Respiratory Journal,2005,"[u'http://www.sginf.ch/ssi-home/guidelines/cap-guidelines/pdf/eur_resp_j_2005.pdf', u'http://www.pneumonologia.gr/articlefiles/20070117_ERS_pneumonia.pdf', u'http://erj.ersjournals.com/cgi/reprint/26/6/1138.pdf', u'http://www.escmid.org/fileadmin/src/media/PDFs/4ESCMID_Library/2Medical_Guidelines/ESCMID_Guidelines/Guidelines_Adult_LRTI.pdf', u'http://erj.ersjournals.com/cgi/doi/10.1183/09031936.05.00055705']"
10.1056/NEJM199910283411802,"Elden, L., Nijhuis, M., Schipper, P., et. al, Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR, Journal of Clinical Microbiology, 2001",cited-by,10.1128/JCM.39.1.196-200.2001,Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR,"[['L.', 'J. R. van', 'Elden'], ['M.', '', 'Nijhuis'], ['P.', '', 'Schipper'], ['R.', '', 'Schuurman'], ['A.', 'M. van', 'Loon']]",Journal of Clinical Microbiology,2001,[u'http://jcm.asm.org/cgi/doi/10.1128/JCM.39.1.196-200.2001']
10.1056/NEJM199910283411802,"Tablan, O., Anderson, L., Besser, R., et. al, GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By, , 0",cited-by,"13520052GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By","GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003 Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Prepared By","[['Ofelia', 'C.', 'Tablan'], ['Larry', 'J.', 'Anderson'], ['Richard', '', 'Besser'], ['Carolyn', '', 'Bridges'], ['Rana', '', 'Hajjeh']]",,0,"[u'http://origin.cdc.gov/hicpac/pdf/guidelines/hapneu2003guidelines.pdf', u'http://www.cdc.gov/hicpac/pdf/guidelines/hapneu2003guidelines.pdf']"
10.1056/NEJM199910283411802,"Heikkinen, T., Järvinen, A., , The common cold, Lancet, 2003",cited-by,10.1016/S0140-6736(03)12162-9,The common cold,"[['Terho', '', 'Heikkinen'], ['Asko', '', 'J\xc3\xa4rvinen']]",Lancet,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0140673603121629', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673603121629']"
10.1056/NEJM199910283411802,"Moscona, A., , Neuraminidase Inhibitors for Influenza, , 2009",cited-by,5346198Neuraminidase Inhibitors for Influenza,Neuraminidase Inhibitors for Influenza,"[['Anne', '', 'Moscona']]",,2009,"[u'http://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'https://content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://intl-content.nejm.org/cgi/reprint/353/13/1363.pdf', u'http://www.columbia.edu/itc/hs/medical/pathophys/immunology/readings/Influenza_neuraminidase_inhib_rev.pdf', u'http://www.svinfectologia.org/influenza1%201363.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/111.pdf', u'http://www.cornellpediatrics.org/bm~doc/neuraminidase-inhibitors-moscona.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/Nueramidase%20Tx%20for%20Influenza%20Sep%202005.pdf', u'http://nejm.highwire.org/cgi/reprint/353/13/1363.pdf']"
10.1056/NEJM199910283411802,"Nichol, K., , Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza, , 2001",cited-by,2905336Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,"[['Kristin', 'L.', 'Nichol']]",,2001,"[u'http://archinte.ama-assn.org/cgi/reprint/161/5/749.pdf', u'http://tudor.szote.u-szeged.hu/webtext/letolt/anyag/CASPi_200212/day4/4.2.3.%20nichol%20paper.pdf']"
10.1056/NEJM199910283411802,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, , 0",cited-by,12760434Influenza virus neuraminidase inhibitors,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",,0,[u'http://www.birdflumanual.com/resources/Medical_References/files/antineuraminidase%20therapy%20lancet.pdf']
10.1056/NEJM199910283411802,"Salgado, C., Farr, B., Hall, K., et. al, Influenza in the acute hospital setting, Lancet Infectious Diseases, 2002",cited-by,10.1016/S1473-3099(02)00221-9,Influenza in the acute hospital setting,"[['Cassandra', 'D', 'Salgado'], ['Barry', 'M', 'Farr'], ['Keri', 'K', 'Hall'], ['Frederick', 'G', 'Hayden']]",Lancet Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1473309902002219', u'http://linkinghub.elsevier.com/retrieve/pii/S1473309902002219', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/preparedness/preparedness-13.pdf']"
10.1056/NEJM199910283411802,"Jefferson, T., Demicheli, V., Rivetti, D., et. al, Antivirals for influenza in healthy adults: systematic review, Lancet, 2006",cited-by,10.1016/S0140-6736(06)67970-1,Antivirals for influenza in healthy adults: systematic review,"[['T', '', 'Jefferson'], ['V', '', 'Demicheli'], ['D', '', 'Rivetti'], ['M', '', 'Jones'], ['C', 'Di', 'Pietrantonj'], ['A', '', 'Rivetti']]",Lancet,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0140673606679701', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-9.pdf', u'http://influenza.rhove.gob.mx/RetornoSudafrica/archivos/influenza_TB/Bibliografia/antiviral for influenza.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673606679701']"
10.1056/NEJM199910283411802,"Chemaly, R., Ghosh, S., Bodey, G., et. al, Respiratory Viral Infections in Adults With Hematologic Malignancies and Human Stem Cell Transplantation Recipients: A Retrospective Study at a Major Cancer Center, Medicine, 2006",cited-by,10.1097/01.md.0000232560.22098.4e,Respiratory Viral Infections in Adults With Hematologic Malignancies and Human Stem Cell Transplantation Recipients: A Retrospective Study at a Major Cancer Center,"[['Roy', 'F.', 'Chemaly'], ['Shubhra', '', 'Ghosh'], ['Gerald', 'P.', 'Bodey'], ['Nidhi', '', 'Rohatgi'], ['Amar', '', 'Safdar'], ['Michael', 'J.', 'Keating'], ['Richard', 'E.', 'Champlin'], ['Elizabeth', 'A.', 'Aguilera'], ['Jeffrey', 'J.', 'Tarrand'], ['Issam', 'I.', 'Raad']]",Medicine,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00005792-200609000-00003']
10.1056/NEJM199910283411802,"Peters, P., Gravenstein, S., Norwood, P., et. al, Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population, Journal of The American Geriatrics Society, 2001",cited-by,10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[['Patrick', 'H.', 'Peters'], ['Stefan', '', 'Gravenstein'], ['Paul', '', 'Norwood'], ['Veerle', 'De', 'Bock'], ['Anthony', 'Van', 'Couter'], ['Michael', '', 'Gibbens'], ['Tony-Andrea', 'Von', 'Planta'], ['Penelope', '', 'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x']
10.1056/NEJM199910283411802,"Cunney, R., Bialachowski, A., Thornley, D., et. al, An Outbreak of Influenza A in a Neonatal Intensive Care Unit, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501786,An Outbreak of Influenza A in a Neonatal Intensive Care Unit,"[['Robert', 'J.', 'Cunney'], ['Anne', '', 'Bialachowski'], ['Diane', '', 'Thornley'], ['Fiona', 'M.', 'Smaill'], ['Ross', 'A.', 'Pennie']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501786']
10.1056/NEJM199910283411802,"PELTOLA, V., MCCULLERS, J., , Respiratory viruses predisposing to bacterial infections: role of neuraminidase, Pediatric Infectious Disease Journal, 2004",cited-by,10.1097/01.inf.0000108197.81270.35,Respiratory viruses predisposing to bacterial infections: role of neuraminidase,"[['VILLE', 'T.', 'PELTOLA'], ['JONATHAN', 'A.', 'MCCULLERS']]",Pediatric Infectious Disease Journal,2004,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200401001-00013']
10.1056/NEJM199910283411802,"Bowles, S., Lee, W., Simor, A., et. al, Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999â2000, Journal of The American Geriatrics Society, 2002",cited-by,10.1046/j.1532-5415.2002.50153.x,"Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999â2000","[['Susan', 'K.', 'Bowles'], ['Wayne', '', 'Lee'], ['Andrew', 'E.', 'Simor'], ['Mary', '', 'Vearncombe'], ['Mark', '', 'Loeb'], ['Susan', '', 'Tamblyn'], ['Margaret', '', 'Fearon'], ['Yan', '', 'Li'], ['Allison', '', 'McGeer']]",Journal of The American Geriatrics Society,2002,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2002.50153.x']
10.1056/NEJM199910283411802,"Wang, M., Tai, C., Mendel, D., , Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.12.3809-3816.2002,Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir,"[['Michael', 'Z.', 'Wang'], ['Chun', 'Y.', 'Tai'], ['Dirk', 'B.', 'Mendel']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/12/3809.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.12.3809-3816.2002']"
10.1056/NEJM199910283411802,"Monto, A., , The role of antivirals in the control of influenza, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00075-6,The role of antivirals in the control of influenza,"[['Arnold', 'S.', 'Monto']]",Vaccine,2003,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-18.pdf', u'http://www.sciencedirect.com/science/article/pii/S0264410X03000756', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/prevention/prevention-8.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X03000756']"
10.1056/NEJM199910283411802,"Jefferson, T., Jones, M., Doshi, P., et. al, Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis, British Medical Journal, 2009",cited-by,10.1136/bmj.b5106,Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis,"[['Tom', '', 'Jefferson'], ['Mark', '', 'Jones'], ['Peter', '', 'Doshi'], ['Chris', 'Del', 'Mar']]",British Medical Journal,2009,"[u'http://www.bmj.com/cgi/reprint/339/dec07_2/b5106.pdf', u'http://dx.doi.org/10.1136/bmj.b5106', u'http://www.bmj.com/cgi/doi/10.1136/bmj.b5106']"
10.1056/NEJM199910283411802,"Lee, P., Matchar, D., Clements, D., et. al, Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults, , 2002",cited-by,5954845Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,"[['Patrick', 'Y.', 'Lee'], ['David', 'B.', 'Matchar'], ['Dennis', 'A.', 'Clements'], ['Joel', '', 'Huber'], ['John', 'D.', 'Hamilton'], ['Eric', 'D.', 'Peterson']]",,2002,[u'http://www.pforster.ch/yvaccin/DocumVaccinInfluenzaBAG/Lee_2002.pdf']
10.1056/NEJM199910283411802,"Bantia, S., Parker, C., Ananth, S., et. al, Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.4.1162-1167.2001,Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir,"[['S.', '', 'Bantia'], ['C.', 'D.', 'Parker'], ['S.', 'L.', 'Ananth'], ['L.', 'L.', 'Horn'], ['K.', '', 'Andries'], ['P.', '', 'Chand'], ['P.', 'L.', 'Kotian'], ['A.', '', 'Dehghani'], ['Y.', '', 'El-Kattan'], ['T.', '', 'Lin'], ['T.', 'L.', 'Hutchison'], ['J.', 'A.', 'Montgomery'], ['D.', 'L.', 'Kellog'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://faculty.tamu-commerce.edu/fmiskevich/Bsc-597MAMB/Bantia-%20anti-influenza%20drug%20design.pdf', u'http://aac.asm.org/cgi/reprint/45/4/1162.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1162-1167.2001']"
10.1056/NEJM199910283411802,"Gonzales, R., Sande, M., , Uncomplicated Acute Bronchitis, , 2000",cited-by,13127743Uncomplicated Acute Bronchitis,Uncomplicated Acute Bronchitis,"[['Ralph', '', 'Gonzales'], ['Merle', 'A.', 'Sande']]",,2000,[u'http://www.annals.org/content/133/12/981.full.pdf']
10.1056/NEJM199910283411802,", Antiviral Management of Seasonal and Pandemic Influenza, Journal of Infectious Diseases, 2006",cited-by,10.1086/507552,Antiviral Management of Seasonal and Pandemic Influenza,[],Journal of Infectious Diseases,2006,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/507552']
10.1056/NEJM199910283411802,"Rothberg, M., Rose, D., , Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis, American Journal of Medicine, 2005",cited-by,10.1016/j.amjmed.2004.03.044,Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis,"[['Michael', 'B.', 'Rothberg'], ['David', 'N.', 'Rose']]",American Journal of Medicine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0002934304006291', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-5.pdf', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/vaccination/vaccination-8.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934304006291']"
10.1056/NEJM199910283411802,"Stiver, G., , The treatment of influenza with antiviral drugs, , 0",cited-by,10332941The treatment of influenza with antiviral drugs,The treatment of influenza with antiviral drugs,"[['Grant', '', 'Stiver']]",,0,"[u'http://www.ualberta.ca/~mlalu/ref03.pdf', u'http://www.ualberta.ca/~mlalu/CMAJantiviral.pdf', u'http://www.cmaj.ca/cgi/reprint/168/1/49.pdf']"
10.1056/NEJM199910283411802,"Bantia, S., Arnold, C., Parker, C., et. al, Anti-influenza virus activity of peramivir in mice with single intramuscular injection, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2005.10.002,Anti-influenza virus activity of peramivir in mice with single intramuscular injection,"[['Shanta', '', 'Bantia'], ['C.', 'Shane', 'Arnold'], ['Cynthia', 'D.', 'Parker'], ['Ramanda', '', 'Upshaw'], ['Pooran', '', 'Chand']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205002263', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205002263']"
10.1056/NEJM199910283411802,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']"
10.1056/NEJM199910283411802,"Khan, K., , Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults, Clinical Infectious Diseases, 2001",cited-by,10.1086/324491,Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults,"[['Kamran', '', 'Khan']]",Clinical Infectious Diseases,2001,"[u'http://www.pceo.org/pubs/CID%20Article.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/324491']"
10.1056/NEJM199910283411802,"Horcajada, J., Pumarola, T., Martinez, J., et. al, A nosocomial outbreak of influenza during a period without influenza epidemic activity, European Respiratory Journal, 2003",cited-by,10.1183/09031936.03.00040503,A nosocomial outbreak of influenza during a period without influenza epidemic activity,"[['J.', 'P.', 'Horcajada'], ['T.', '', 'Pumarola'], ['J.', 'A.', 'Martinez'], ['G.', '', 'Tapias'], ['J.', 'M.', 'Bayas'], ['M.', 'de la', 'Prada'], ['F.', '', 'Garcia'], ['C.', '', 'Codina'], ['J.', 'M.', 'Gatell'], ['M.', 'T. Jimenez de', 'Anta']]",European Respiratory Journal,2003,"[u'http://erj.ersjournals.com/cgi/reprint/21/2/303.pdf', u'http://erj.ersjournals.com/cgi/doi/10.1183/09031936.03.00040503']"
10.1056/NEJM199910283411802,"SIDWELL, R., SMEE, D., HUFFMAN, J., et. al, In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.3.749-757.2001,In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201,"[['ROBERT', 'W.', 'SIDWELL'], ['DONALD', 'F.', 'SMEE'], ['JOHN', 'H.', 'HUFFMAN'], ['DALE', 'L.', 'BARNARD'], ['KEVIN', 'W.', 'BAILEY'], ['JOHN', 'D.', 'MORREY'], ['Y.', 'S.', 'Babu']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/3/749.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.3.749-757.2001']"
10.1056/NEJM199910283411802,"Tomblyn, M., Chiller, T., Einsele, H., et. al, Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective, Biology of Blood and Marrow Transplantation, 2009",cited-by,10.1016/j.bbmt.2009.06.019,Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective,"[['Marcie', '', 'Tomblyn'], ['Tom', '', 'Chiller'], ['Hermann', '', 'Einsele'], ['Ronald', '', 'Gress'], ['Kent', '', 'Sepkowitz'], ['Jan', '', 'Storek'], ['John', 'R.', 'Wingard'], ['Jo-Anne', 'H.', 'Young'], ['Michael', 'A.', 'Boeckh']]",Biology of Blood and Marrow Transplantation,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1083879109003000', u'http://linkinghub.elsevier.com/retrieve/pii/S1083879109003000']"
10.1056/NEJM199910283411802,"Vu, D., Peck, A., Nichols, W., et. al, Safety and Tolerability of Oseltamivir Prophylaxis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Case‐Control Study, Clinical Infectious Diseases, 2007",cited-by,10.1086/518985,Safety and Tolerability of Oseltamivir Prophylaxis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Case‐Control Study,"[['Debie', '', 'Vu'], ['Angela', 'J.', 'Peck'], ['W.', 'Garrett', 'Nichols'], ['Cara', '', 'Varley'], ['Janet', 'A.', 'Englund'], ['Lawrence', '', 'Corey'], ['Michael', '', 'Boeckh']]",Clinical Infectious Diseases,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/518985']
10.1056/NEJM199910283411802,"Lee, C., Loeb, M., Phillips, A., et. al, Zanamivir Use During Transmission of Amantadine‐Resistant Influenza A in a Nursing Home, Infection Control and Hospital Epidemiology, 2000",cited-by,10.1086/501727,Zanamivir Use During Transmission of Amantadine‐Resistant Influenza A in a Nursing Home,"[['Christine', '', 'Lee'], ['Mark', '', 'Loeb'], ['Anne', '', 'Phillips'], ['Judy', '', 'Nesbitt'], ['Karen', '', 'Smith'], ['Margaret', '', 'Fearon'], ['Margaret', 'A.', 'McArthur'], ['Tony', '', 'Mazzulli'], ['Yan', '', 'Li'], ['Allison', '', 'McGeer']]",Infection Control and Hospital Epidemiology,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501727']
10.1056/NEJM199910283411802,"Hindiyeh, M., Goulding, C., Morgan, H., et. al, Evaluation of BioStar® FLU OIA® assay for rapid detection of influenza A and B viruses in respiratory specimens, Journal of Clinical Virology, 2000",cited-by,10.1016/S1386-6532(00)00081-0,Evaluation of BioStar® FLU OIA® assay for rapid detection of influenza A and B viruses in respiratory specimens,"[['M', '', 'Hindiyeh'], ['C', '', 'Goulding'], ['H', '', 'Morgan'], ['B', '', 'Kenyon'], ['J', '', 'Langer'], ['L', '', 'Fox'], ['G', '', 'Dean'], ['D', '', 'Woolstenhulme'], ['A', '', 'Turnbow'], ['E', '', 'Billetdeaux'], ['S', '', 'Shakib'], ['C', '', 'Gordon'], ['A', '', 'Powers'], ['G', '', 'Vardeny'], ['M', '', 'Johnson'], ['L', '', 'Skodack-Jones'], ['K', '', 'Carroll']]",Journal of Clinical Virology,2000,"[u'http://www.sciencedirect.com/science/article/pii/S1386653200000810', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653200000810']"
10.1056/NEJM199910283411802,"Turner, D., Wailoo, A., Cooper, N., et. al, The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age, Vaccine, 2006",cited-by,10.1016/j.vaccine.2004.12.033,The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age,"[['D.', 'A.', 'Turner'], ['A.', 'J.', 'Wailoo'], ['N.', 'J.', 'Cooper'], ['A.', 'J.', 'Sutton'], ['K.', 'R.', 'Abrams'], ['K.', 'G.', 'Nicholson']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0500890X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0500890X']"
10.1056/NEJM199910283411802,"Stein, J., Louie, J., Flanders, S., et. al, Performance Characteristics of Clinical Diagnosis, a Clinical Decision Rule, and a Rapid Influenza Test in the Detection of Influenza Infection in a Community Sample of Adults, Annals of Emergency Medicine, 2005",cited-by,10.1016/j.annemergmed.2005.05.020,"Performance Characteristics of Clinical Diagnosis, a Clinical Decision Rule, and a Rapid Influenza Test in the Detection of Influenza Infection in a Community Sample of Adults","[['John', '', 'Stein'], ['Janice', '', 'Louie'], ['Scott', '', 'Flanders'], ['Judith', '', 'Maselli'], ['Jill', 'K.', 'Hacker'], ['W.', 'Lawrence', 'Drew'], ['Ralph', '', 'Gonzales']]",Annals of Emergency Medicine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0196064405007031', u'http://linkinghub.elsevier.com/retrieve/pii/S0196064405007031']"
10.1056/NEJM199910283411802,"Kaiser, L., Henry, D., Flack, N., et. al, Short‐Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo‐Controlled Study, Clinical Infectious Diseases, 2000",cited-by,10.1086/313696,Short‐Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo‐Controlled Study,"[['Laurent', '', 'Kaiser'], ['Dan', '', 'Henry'], ['Nancy', 'P.', 'Flack'], ['Oliver', '', 'Keene'], ['Frederick', 'G.', 'Hayden']]",Clinical Infectious Diseases,2000,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/313696']
10.1056/NEJM199910283411802,"Langley, J., Faughnan, M., , Prevention of influenza in the general population, , 2004",cited-by,14345011Prevention of influenza in the general population,Prevention of influenza in the general population,"[['Joanne', 'M.', 'Langley'], ['Marie', 'E.', 'Faughnan']]",,2004,[u'http://www.cmaj.ca/cgi/reprint/171/10/1213.pdf']
10.1056/NEJM199910283411802,"Sander, B., Nizam, A., Garrison, L., et. al, Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model, Value in Health, 2009",cited-by,10.1111/j.1524-4733.2008.00437.x,Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model,"[['Beate', '', 'Sander'], ['Azhar', '', 'Nizam'], ['Louis', 'P.', 'Garrison'], ['Maarten', 'J.', 'Postma'], ['M.', 'Elizabeth', 'Halloran'], ['Ira', 'M.', 'Longini']]",Value in Health,2009,"[u'http://www.sciencedirect.com/science/article/pii/S1098301510606997', u'http://blackwell-synergy.com/doi/abs/10.1111/j.1524-4733.2008.00437.x']"
10.1056/NEJM199910283411802,"Trial, A., Welliver, R., Monto, A., et. al, Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts, , 2001",cited-by,6450415Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[['A', 'Randomized Controlled', 'Trial'], ['Robert', '', 'Welliver'], ['Arnold', 'S.', 'Monto'], ['Otmar', '', 'Carewicz'], ['Edwig', '', 'Schatteman'], ['Michael', '', 'Hassman'], ['James', '', 'Hedrick'], ['Helen', 'C.', 'Jackson'], ['Penelope', '', 'Ward'], ['John', 'S.', 'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf']
10.1056/NEJM199910283411802,"Aoki, F., Doucette, K., , Oseltamivir: a clinical and pharmacological perspective, Expert Opinion on Pharmacotherapy, 2001",cited-by,10.1517/14656566.2.10.1671,Oseltamivir: a clinical and pharmacological perspective,"[['Fred', 'Y', 'Aoki'], ['Karen', 'E', 'Doucette']]",Expert Opinion on Pharmacotherapy,2001,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.2.10.1671']
10.1056/NEJM199910283411802,"Billings, J., Hertz, M., Wendt, C., , Community respiratory virus infections following lung transplantation, Transplant Infectious Disease, 2001",cited-by,10.1034/j.1399-3062.2001.003003138.x,Community respiratory virus infections following lung transplantation,"[['J.', 'L.', 'Billings'], ['M.', 'I.', 'Hertz'], ['C.', 'H.', 'Wendt']]",Transplant Infectious Disease,2001,[u'http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-3062.2001.003003138.x']
10.1056/NEJM199910283411802,"Bouvier, N., Lowen, A., Palese, P., , Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol, Journal of Virology, 2008",cited-by,10.1128/JVI.01226-08,Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol,"[['Nicole', 'M.', 'Bouvier'], ['Anice', 'C.', 'Lowen'], ['Peter', '', 'Palese']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/20/10052.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01226-08']"
10.1056/NEJM199910283411802,"Gravenstein, S., Drinka, P., Osterweil, D., et. al, Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.006,Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population,"[['Stefan', '', 'Gravenstein'], ['Paul', '', 'Drinka'], ['Dan', '', 'Osterweil'], ['Margo', '', 'Schilling'], ['Peggy', '', 'Krause'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult'], ['Arvydas', '', 'Ambrozaitis'], ['Ruth', '', 'Kandel'], ['Ellen', '', 'Binder'], ['Janet', '', 'Hammond'], ['Janet', '', 'McElhaney'], ['Nancy', '', 'Flack'], ['Janet', '', 'Daly'], ['Oliver', '', 'Keene']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005323', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005323']"
10.1056/NEJM199910283411802,"Rothberg, M., He, S., Rose, D., , Management of influenza symptoms in healthy adults, Journal of General Internal Medicine, 2003",cited-by,10.1046/j.1525-1497.2003.20822.x,Management of influenza symptoms in healthy adults,"[['Michael', 'B.', 'Rothberg'], ['Shunian', '', 'He'], ['David', 'N.', 'Rose']]",Journal of General Internal Medicine,2003,"[u'http://www.springerlink.com/index/c2hlvw3483877856.pdf', u'http://www.springerlink.com/content/c2hlvw3483877856', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1525-1497.2003.20822.x']"
10.1056/NEJM199910283411802,"McKimm-Breschkin, J., , Neuraminidase inhibitors for the treatment and prevention of influenza, Expert Opinion on Pharmacotherapy, 2002",cited-by,10.1517/14656566.3.2.103,Neuraminidase inhibitors for the treatment and prevention of influenza,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Expert Opinion on Pharmacotherapy,2002,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.3.2.103']
10.1056/NEJM199910283411802,"TAUBENBERGER, J., LAYNE, S., , Diagnosis of Influenza Virus: Coming to Grips With the Molecular Era, Molecular Diagnosis, 2001",cited-by,10.2165/00066982-200106040-00010,Diagnosis of Influenza Virus: Coming to Grips With the Molecular Era,"[['JEFFERY', 'K.', 'TAUBENBERGER'], ['SCOTT', 'P.', 'LAYNE']]",Molecular Diagnosis,2001,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00066982-200106040-00010', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/diagnosis/diagnosis-1.pdf']"
10.1056/NEJM199910283411802,"Gust, I., Hampson, A., Lavanchy, D., , Planning for the next pandemic of influenza, Reviews in Medical Virology, 2001",cited-by,10.1002/rmv.301,Planning for the next pandemic of influenza,"[['Ian', 'D.', 'Gust'], ['Alan', 'W.', 'Hampson'], ['Daniel', '', 'Lavanchy']]",Reviews in Medical Virology,2001,[u'http://doi.wiley.com/10.1002/rmv.301']
10.1056/NEJM199910283411802,"McCaw, J., Wood, J., McCaw, C., et. al, Impact of Emerging Antiviral Drug Resistance on Influenza Containment and Spread: Influence of Subclinical Infection and Strategic Use of a Stockpile Containing One or Two Drugs, PLOS One, 2008",cited-by,10.1371/journal.pone.0002362.g008,Impact of Emerging Antiviral Drug Resistance on Influenza Containment and Spread: Influence of Subclinical Infection and Strategic Use of a Stockpile Containing One or Two Drugs,"[['James', 'M.', 'McCaw'], ['James', 'G.', 'Wood'], ['Christopher', 'T.', 'McCaw'], ['Jodie', '', 'McVernon']]",PLOS One,2008,"[u'http://mathmodelling.sph.unimelb.edu.au/publications/McCaw-PLoSONE-2008.pdf', u'http://dx.plos.org/10.1371/journal.pone.0002362', u'http://dx.plos.org/10.1371/journal.pone.0002362.g001', u'http://dx.plos.org/10.1371/journal.pone.0002362.g002', u'http://dx.plos.org/10.1371/journal.pone.0002362.g003', u'http://dx.plos.org/10.1371/journal.pone.0002362.g004', u'http://dx.plos.org/10.1371/journal.pone.0002362.g005', u'http://dx.plos.org/10.1371/journal.pone.0002362.g006', u'http://dx.plos.org/10.1371/journal.pone.0002362.g007', u'http://dx.plos.org/10.1371/journal.pone.0002362.g008']"
10.1056/NEJM199910283411802,"Keech, M., Beardsworth, P., , The Impact of Influenza on Working Days Lost: A Review of the Literature, Pharmacoeconomics, 2008",cited-by,10.2165/00019053-200826110-00004,The Impact of Influenza on Working Days Lost: A Review of the Literature,"[['Martin', '', 'Keech'], ['Paul', '', 'Beardsworth']]",Pharmacoeconomics,2008,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00019053-200826110-00004', u'http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200826110-00004.htm', u'http://pharmacoeconomics.adisonline.com/pt/re/phe/pdfhandler.00019053-200826110-00004.pdf']"
10.1056/NEJM199910283411802,"Schentag, J., Hill, G., Chu, T., et. al, Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects, Journal of Clinical Pharmacology, 2007",cited-by,10.1177/0091270007299761,Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects,"[['Jerome', 'J.', 'Schentag'], ['George', '', 'Hill'], ['Tom', '', 'Chu'], ['Craig', 'R.', 'Rayner']]",Journal of Clinical Pharmacology,2007,"[u'http://dx.doi.org/10.1177/0091270007299761', u'http://www.jclinpharm.org/cgi/doi/10.1177/0091270007299761']"
10.1056/NEJM199910283411802,"Fleming, D., Elliot, A., , The impact of influenza on the health and health care utilisation of elderly people, Vaccine, 2005",cited-by,10.1016/j.vaccine.2005.04.018,The impact of influenza on the health and health care utilisation of elderly people,"[['Douglas', 'M.', 'Fleming'], ['Alex', 'J.', 'Elliot']]",Vaccine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X05004585', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/124.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X05004585']"
10.1056/NEJM199910283411802,"Gavin, P., Thomson, R., , Review of Rapid Diagnostic Tests for Influenza, , 2003",cited-by,5357707Review of Rapid Diagnostic Tests for Influenza,Review of Rapid Diagnostic Tests for Influenza,"[['Patrick', 'J', 'Gavin'], ['Richard', 'B', 'Thomson']]",,2003,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/diagnosis/diagnosis-4.pdf']
10.1056/NEJM199910283411802,"Ison, M., Hayden, F., , Therapeutic options for the management of influenza, Current Opinion in Pharmacology, 2001",cited-by,10.1016/S1471-4892(01)00084-4,Therapeutic options for the management of influenza,"[['Michael', 'G', 'Ison'], ['Frederick', 'G', 'Hayden']]",Current Opinion in Pharmacology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1471489201000844', u'http://linkinghub.elsevier.com/retrieve/pii/S1471489201000844']"
10.1056/NEJM199910283411802,"Dunn, J., Gordon, C., Kelley, C., et. al, Comparison of the Denka-Seiken INFLU AB-Quick and BD Directigen Flu AB Kits with Direct Fluorescent-Antibody Staining and Shell Vial Culture Methods for Rapid Detection of Influenza Viruses, , 0",cited-by,10896149Comparison of the Denka-Seiken INFLU AB-Quick and BD Directigen Flu AB Kits with Direct Fluorescent-Antibody Staining and Shell Vial Culture Methods for Rapid Detection of Influenza Viruses,Comparison of the Denka-Seiken INFLU AB-Quick and BD Directigen Flu AB Kits with Direct Fluorescent-Antibody Staining and Shell Vial Culture Methods for Rapid Detection of Influenza Viruses,"[['James', 'J.', 'Dunn'], ['Chris', '', 'Gordon'], ['Christy', '', 'Kelley'], ['Karen', 'C.', 'Carroll']]",,0,[u'http://jcm.asm.org/cgi/reprint/41/5/2180.pdf']
10.1056/NEJM199910283411802,"Cinti, S., , Pandemic Influenza: Are We Ready?, Disaster Management & Response, 2005",cited-by,10.1016/j.dmr.2005.05.002,Pandemic Influenza: Are We Ready?,"[['Sandro', '', 'Cinti']]",Disaster Management & Response,2005,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/preparedness/preparedness-7.pdf', u'http://www.sciencedirect.com/science/article/pii/S154024870500026X', u'http://linkinghub.elsevier.com/retrieve/pii/S154024870500026X']"
10.1056/NEJM199910283411802,"Englund, J., , Antiviral therapy of influenza, Seminars in Pediatric Infectious Diseases, 2002",cited-by,10.1053/spid.2002.122999,Antiviral therapy of influenza,"[['Janet', 'A.', 'Englund']]",Seminars in Pediatric Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1045187002500571', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187002500571']"
10.1056/NEJM199910283411802,"SAGRERA, X., GINOVART, G., RASPALL, F., et. al, Outbreaks of influenza A virus infection in neonatal intensive care units, Pediatric Infectious Disease Journal, 2002",cited-by,10.1097/00006454-200203000-00007,Outbreaks of influenza A virus infection in neonatal intensive care units,"[['XAVIER', '', 'SAGRERA'], ['GEMMA', '', 'GINOVART'], ['FREDERIC', '', 'RASPALL'], ['NURIA', '', 'RABELLA'], ['PERE', '', 'SALA'], ['MONTSERRAT', '', 'SIERRA'], ['XAVIER', '', 'DEMESTRE'], ['CLARA', '', 'VILA']]",Pediatric Infectious Disease Journal,2002,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200203000-00007']
10.1056/NEJM199910283411802,"Fisk, J., Doble, S., , Construction and validation of a fatigue impact scale for daily administration (D-FIS), Quality of Life Research, 2002",cited-by,10.1023/A:1015295106602,Construction and validation of a fatigue impact scale for daily administration (D-FIS),"[['John', 'D.', 'Fisk'], ['Susan', 'E.', 'Doble']]",Quality of Life Research,2002,"[u'http://www.springerlink.com/content/44axnxe0ragn6bdn', u'http://www.springerlink.com/index/44axnxe0ragn6bdn.pdf']"
10.1056/NEJM199910283411802,"Jr, J., Michaelis, M., Doerr, H., , The threat of avian influenza A (H5N1). Part III: antiviral therapy, Medical Microbiology and Immunology, 2007",cited-by,10.1007/s00430-007-0048-z,The threat of avian influenza A (H5N1). Part III: antiviral therapy,"[['Jindrich', 'Cinatl', 'Jr'], ['Martin', '', 'Michaelis'], ['Hans', 'W.', 'Doerr']]",Medical Microbiology and Immunology,2007,"[u'http://www.springerlink.com/index/41xpm470518281m7.pdf', u'http://www.springerlink.com/content/41xpm470518281m7', u'http://www.springerlink.com/index/10.1007/s00430-007-0048-z', u'http://www.springerlink.com/index/pdf/10.1007/s00430-007-0048-z']"
10.1056/NEJM199910283411802,"Robson, R., Buttimore, A., Lynn, K., et. al, The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis, , 2006",cited-by,10077451The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis,"[['Richard', '', 'Robson'], ['Adrian', '', 'Buttimore'], ['Kelvin', '', 'Lynn'], ['Mike', '', 'Brewster'], ['Penelope', '', 'Ward']]",,2006,"[u'http://www.kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://kcercoalition.com/pdf/pharmacokinetics.pdf', u'http://ndt.oxfordjournals.org/cgi/reprint/21/9/2556.pdf']"
10.1056/NEJM199910283411802,"McKimm-Breschkin, J., , Management of Influenza Virus Infections with Neuraminidase Inhibitors, Treatments in Respiratory Medicine, 2005",cited-by,10.2165/00151829-200504020-00004,Management of Influenza Virus Infections with Neuraminidase Inhibitors,"[['Jennifer', 'L', 'McKimm-Breschkin']]",Treatments in Respiratory Medicine,2005,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00151829-200504020-00004']
10.1056/NEJM199910283411802,"Drinka, P., Krause, P., Nest, L., et. al, Delays in the Application of Outbreak Control Prophylaxis for Influenza A in a Nursing Home, Infection Control and Hospital Epidemiology, 2002",cited-by,10.1086/501978,Delays in the Application of Outbreak Control Prophylaxis for Influenza A in a Nursing Home,"[['Paul', 'J.', 'Drinka'], ['Peggy', '', 'Krause'], ['Lori', '', 'Nest'], ['Stefan', '', 'Gravenstein'], ['Brian', '', 'Goodman'], ['Peter', '', 'Shult']]",Infection Control and Hospital Epidemiology,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501978']
10.1056/NEJM199910283411802,"Dharnidharka, V., Harmon, W., , Management of pediatric postrenal transplantation infections, Seminars in Nephrology, 2001",cited-by,10.1053/snep.2001.24947,Management of pediatric postrenal transplantation infections,"[['Vikas', 'R.', 'Dharnidharka'], ['William', 'E.', 'Harmon']]",Seminars in Nephrology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0270929501700514', u'http://www.mosby.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=asnep0210521']"
10.1056/NEJM199910283411802,"Lee, V., Phua, K., Chen, M., et. al, Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore, , 0",cited-by,"12330234Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore","Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore","[['Vernon', 'J.', 'Lee'], ['Kai', 'Hong', 'Phua'], ['Mark', 'I.', 'Chen'], ['Angela', '', 'Chow'], ['Stefan', '', 'Ma'], ['Kee', 'Tai', 'Goh'], ['Yee', 'Sin', 'Leo']]",,0,[u'http://www.spp.nus.edu.sg/Handler.ashx?path=Data/Site/SiteDocuments/wp/2006/wp06-04.pdf']
10.1056/NEJM199910283411802,"Ellis, C., McEwen, R., , Who should receive Tamiflu for swine flu?, British Medical Journal, 2009",cited-by,10.1136/bmj.b2698,Who should receive Tamiflu for swine flu?,"[['Christopher', '', 'Ellis'], ['Ruth', '', 'McEwen']]",British Medical Journal,2009,"[u'http://www.bmj.com/cgi/doi/10.1136/bmj.b2698', u'http://dx.doi.org/10.1136/bmj.b2698']"
10.1056/NEJM199910283411802,"McClaren, J., , Oseltamivir Prophylactic Regimens Prevent H5N1 Influenza Morbidity and Mortality in a Ferret Model, Journal of Infectious Diseases, 2008",cited-by,10.1086/586711,Oseltamivir Prophylactic Regimens Prevent H5N1 Influenza Morbidity and Mortality in a Ferret Model,"[['Jennifer', '', 'McClaren']]",Journal of Infectious Diseases,2008,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/586711']
10.1056/NEJM199910283411802,"Wutzler, P., Kossow, K., Lode, H., et. al, Antiviral treatment and prophylaxis of influenza in primary care: German recommendations, Journal of Clinical Virology, 2004",cited-by,10.1016/j.jcv.2004.05.009,Antiviral treatment and prophylaxis of influenza in primary care: German recommendations,"[['P.', '', 'Wutzler'], ['K.-D.', '', 'Kossow'], ['H.', '', 'Lode'], ['B.', 'R.', 'Ruf'], ['H.', '', 'Scholz'], ['G.', 'E.', 'Vogel']]",Journal of Clinical Virology,2004,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-17.pdf', u'http://www.sciencedirect.com/science/article/pii/S1386653204001611', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/prevention/prevention-7.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653204001611']"
10.1056/NEJM199910283411802,"Cheng, S., Vainionpaa, R., Zhao, P., et. al, Detection of influenza B in clinical specimens: comparison of high throughput RT-PCR and culture confirmation, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.02.018,Detection of influenza B in clinical specimens: comparison of high throughput RT-PCR and culture confirmation,"[['Sheau-Mei', '', 'Cheng'], ['Raija', '', 'Vainionpaa'], ['Ping', '', 'Zhao'], ['Fenglan', '', 'Li'], ['Aizhong', '', 'Hu'], ['Bruce', '', 'Forrest'], ['Ruth', '', 'Rappaport']]",Virus Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168170204001170', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001170']"
10.1056/NEJM199910283411802,"Dreitlein, W., Maratos, J., Brocavich, J., , Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza, Clinical Therapeutics, 2001",cited-by,10.1016/S0149-2918(01)80042-4,Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza,"[['William', 'B.', 'Dreitlein'], ['Julia', '', 'Maratos'], ['Joseph', '', 'Brocavich']]",Clinical Therapeutics,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0149291801800424', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291801800424']"
10.1056/NEJM199910283411802,"Gloster, T., Davies, G., , Glycosidase inhibition: assessing mimicry of the transition state, Organic & Biomolecular Chemistry, 2010",cited-by,10.1039/b915870g,Glycosidase inhibition: assessing mimicry of the transition state,"[['Tracey', 'M.', 'Gloster'], ['Gideon', 'J.', 'Davies']]",Organic & Biomolecular Chemistry,2010,[u'http://xlink.rsc.org/?DOI=b915870g']
10.1056/NEJM199910283411802,"Wattanagoon, Y., Stepniewska, K., Lindegardh, N., et. al, Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers, Antimicrobial Agents and Chemotherapy, 2009",cited-by,10.1128/AAC.00588-08,Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers,"[['Y.', '', 'Wattanagoon'], ['K.', '', 'Stepniewska'], ['N.', '', 'Lindegardh'], ['S.', '', 'Pukrittayakamee'], ['U.', '', 'Silachamroon'], ['W.', '', 'Piyaphanee'], ['T.', '', 'Singtoroj'], ['W.', '', 'Hanpithakpong'], ['G.', '', 'Davies'], ['J.', '', 'Tarning'], ['W.', '', 'Pongtavornpinyo'], ['C.', '', 'Fukuda'], ['P.', '', 'Singhasivanon'], ['N.', 'P. J.', 'Day'], ['N.', 'J.', 'White']]",Antimicrobial Agents and Chemotherapy,2009,"[u'http://aac.asm.org/cgi/reprint/53/3/945.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.00588-08']"
10.1056/NEJM199910283411802,"Kandel, R., Hartshorn, K., , Novel strategies for prevention and treatment of influenza, Expert Opinion on Therapeutic Targets, 2005",cited-by,10.1517/14728222.9.1.1,Novel strategies for prevention and treatment of influenza,"[['Ruth', '', 'Kandel'], ['Kevan', 'L', 'Hartshorn']]",Expert Opinion on Therapeutic Targets,2005,[u'http://www.informapharmascience.com/doi/abs/10.1517/14728222.9.1.1']
10.1056/NEJM199910283411802,"Gillissen, A., Höffken, G., , Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment, Medical Microbiology and Immunology, 2002",cited-by,10.1007/s00430-002-0139-9,Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment,"[['Adrian', '', 'Gillissen'], ['Gert', '', 'H\xc3\xb6ffken']]",Medical Microbiology and Immunology,2002,"[u'http://www.springerlink.com/content/ne9acyfcbbr8ca48', u'http://www.springerlink.com/index/ne9acyfcbbr8ca48.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00430-002-0139-9', u'http://www.springerlink.com/index/pdf/10.1007/s00430-002-0139-9']"
10.1056/NEJM199910283411802,"Blumenshine, P., Reingold, A., Egerter, S., et. al, Pandemic Influenza Planning in the United States from a Health Disparities Perspective, Emerging Infectious Diseases, 2008",cited-by,10.3201/eid1405.071301,Pandemic Influenza Planning in the United States from a Health Disparities Perspective,"[['Philip', '', 'Blumenshine'], ['Arthur', '', 'Reingold'], ['Susan', '', 'Egerter'], ['Robin', '', 'Mockenhaupt'], ['Paula', '', 'Braveman'], ['James', '', 'Marks']]",Emerging Infectious Diseases,2008,"[u'http://www.cdc.gov/eid/content/14/5/pdfs/07-1301.pdf', u'http://www.nhchc.org/PandemicInfluenzaandHD.pdf', u'http://www.cdc.gov/EID/content/14/5/709.htm']"
10.1056/NEJM199910283411802,"Gavin, P., Thomson, R., , Review of Rapid Diagnostic Tests for Influenza, Clinical and Applied Immunology Reviews, 2004",cited-by,10.1016/S1529-1049(03)00064-3,Review of Rapid Diagnostic Tests for Influenza,"[['Patrick', 'J.', 'Gavin'], ['Richard', 'B.', 'Thomson']]",Clinical and Applied Immunology Reviews,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1529104903000643', u'http://linkinghub.elsevier.com/retrieve/pii/S1529104903000643']"
10.1056/NEJM199910283411802,"Suess, T., Buchholz, U., Dupke, S., et. al, Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009, American Journal of Epidemiology, 2010",cited-by,10.1093/aje/kwq071,"Shedding and Transmission of Novel Influenza Virus A/H1N1 Infection in Households--Germany, 2009","[['T.', '', 'Suess'], ['U.', '', 'Buchholz'], ['S.', '', 'Dupke'], ['R.', '', 'Grunow'], ['Matthias', 'an der', 'Heiden'], ['A.', '', 'Heider'], ['B.', '', 'Biere'], ['B.', '', 'Schweiger'], ['W.', '', 'Haas'], ['G.', '', 'Krause']]",American Journal of Epidemiology,2010,[u'http://aje.oxfordjournals.org/cgi/doi/10.1093/aje/kwq071']
10.1056/NEJM199910283411802,"McVernon, J., Mathews, J., , Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning, Influenza and Other Respiratory Viruses, 2007",cited-by,10.1111/j.1750-2659.2007.00008.x,Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning,"[['J', '', 'McVernon'], ['JD', '', 'Mathews']]",Influenza and Other Respiratory Viruses,2007,"[u'http://mathmodelling.sph.unimelb.edu.au/publications/McVernon-InfluenzaandOtherRespiratoryViruses-2007.pdf', u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1750-2659.2007.00008.x']"
10.1056/NEJM199910283411802,"Cinti, S., Chenoweth, C., Monto, A., , Preparing for Pandemic Influenza: Should Hospitals Stockpile Oseltamivir?, Infection Control and Hospital Epidemiology, 2005",cited-by,10.1086/502507,Preparing for Pandemic Influenza: Should Hospitals Stockpile Oseltamivir?,"[['Sandro', '', 'Cinti'], ['Carol', '', 'Chenoweth'], ['Arnold', 'S.', 'Monto']]",Infection Control and Hospital Epidemiology,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/502507']
10.1056/NEJM199910283411802,"McCullers, J., , Antiviral therapy of influenza, Expert Opinion on Investigational Drugs, 2005",cited-by,10.1517/13543784.14.3.305,Antiviral therapy of influenza,"[['Jonathan', 'A', 'McCullers']]",Expert Opinion on Investigational Drugs,2005,[u'http://www.informapharmascience.com/doi/abs/10.1517/13543784.14.3.305']
10.1056/NEJM199910283411802,"Monto, A., , Antivirals and Influenza: Frequency of Resistance, Pediatric Infectious Disease Journal, 2008",cited-by,10.1097/INF.0b013e318168b739,Antivirals and Influenza: Frequency of Resistance,"[['Arnold', 'S.', 'Monto']]",Pediatric Infectious Disease Journal,2008,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200810001-00015']
10.1056/NEJM199910283411802,"LaForce, C., Man, C., Henderson, F., et. al, Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial, Clinical Therapeutics, 2007",cited-by,10.1016/j.clinthera.2007.08.023,"Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial","[['Craig', '', 'LaForce'], ['Choy', 'Y.', 'Man'], ['Frederick', 'W.', 'Henderson'], ['Janet', 'E.', 'McElhaney'], ['Frank', 'C.', 'Hampel'], ['Robert', '', 'Bettis'], ['Laila', '', 'Kudule'], ['Julia', '', 'Harris'], ['Philip', '', 'Yates'], ['Margaret', '', 'Tisdale'], ['Alison', '', 'Webster']]",Clinical Therapeutics,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0149291807002585', u'http://linkinghub.elsevier.com/retrieve/pii/S0149291807002585']"
10.1056/NEJM199910283411802,"Abed, Y., Boivin, G., , Treatment of respiratory virus infections, Antiviral Research, 2006",cited-by,10.1016/j.antiviral.2006.01.006,Treatment of respiratory virus infections,"[['Yacine', '', 'Abed'], ['Guy', '', 'Boivin']]",Antiviral Research,2006,"[u'http://www.sciencedirect.com/science/article/pii/S016635420600026X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420600026X']"
10.1056/NEJM199910283411802,"Ambrozaitis, A., Gravenstein, S., Essen, G., et. al, Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population, Journal of The American Medical Directors Association, 2005",cited-by,10.1016/j.jamda.2005.08.007,Inhaled Zanamivir Versus Placebo for the Prevention of Influenza Outbreaks in an Unvaccinated Long-term Care Population,"[['Arvydas', '', 'Ambrozaitis'], ['Stefan', '', 'Gravenstein'], ['Gerrit', 'A. van', 'Essen'], ['Ethan', '', 'Rubinstein'], ['Ligita', '', 'Balciuniene'], ['Ausra', '', 'Stikleryte'], ['Catriona', '', 'Crawford'], ['Michael', '', 'Elliott'], ['Peter', '', 'Shult']]",Journal of The American Medical Directors Association,2005,"[u'http://www.sciencedirect.com/science/article/pii/S1525861005005335', u'http://linkinghub.elsevier.com/retrieve/pii/S1525861005005335']"
10.1056/NEJM199910283411802,"Olshaker, J., , Influenza, Emergency Medicine Clinics of North America, 2003",cited-by,10.1016/S0733-8627(03)00018-X,Influenza,"[['Jonathan', 'S', 'Olshaker']]",Emergency Medicine Clinics of North America,2003,"[u'http://www.sciencedirect.com/science/article/pii/S073386270300018X', u'http://linkinghub.elsevier.com/retrieve/pii/S073386270300018X']"
10.1056/NEJM199910283411802,"Oliveira, E., Lee, B., Colice, G., , Influenza in the Intensive Care Unit, Journal of Intensive Care Medicine, 2003",cited-by,10.1177/0885066602250368,Influenza in the Intensive Care Unit,"[['Eduardo', 'C.', 'Oliveira'], ['Burton', '', 'Lee'], ['Gene', 'L.', 'Colice']]",Journal of Intensive Care Medicine,2003,"[u'http://jic.sagepub.com/cgi/doi/10.1177/0885066602250368', u'http://dx.doi.org/10.1177/0885066602250368']"
10.1056/NEJM199910283411802,"Waugh, S., Pillay, D., Carrington, D., et. al, Antiviral prophylaxis and treatment (excluding HIV therapy), Journal of Clinical Virology, 2002",cited-by,10.1016/S1386-6532(02)00151-8,Antiviral prophylaxis and treatment (excluding HIV therapy),"[['S.', 'M. L.', 'Waugh'], ['D.', '', 'Pillay'], ['D.', '', 'Carrington'], ['W.', 'F.', 'Carman']]",Journal of Clinical Virology,2002,"[u'http://www.clinical-virology.org/pdfs/propho.pdf', u'http://www.sciencedirect.com/science/article/pii/S1386653202001518', u'http://www.clinical-virology.org/pdfs/antiviral_p.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653202001518']"
10.1056/NEJM199910283411802,"Horváth, A., Andersen, I., Junker, K., et. al, Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies, Antiviral Research, 2001",cited-by,10.1016/S0166-3542(01)00158-9,Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies,"[['A', '', 'Horv\xc3\xa1th'], ['I', '', 'Andersen'], ['K', '', 'Junker'], ['B', 'Lyck', 'Fogh-Schultz'], ['E', 'Holm', 'Nielsen'], ['S', '', 'Gizurarson'], ['O', '', 'Andersen'], ['J', '', 'K\xc3\xa1rm\xc3\xa1n'], ['E', '', 'Rajnav\xc3\xb6lgyi'], ['A', '', 'Erdei'], ['S.-E', '', 'Svehag']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001589', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001589']"
10.1056/NEJM199910283411802,"Oxford, J., Balasingam, S., Lambkin, R., , A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community, , 0",cited-by,10240609A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community,A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community,"[['John', '', 'Oxford'], ['Shobana', '', 'Balasingam'], ['Rob', '', 'Lambkin']]",,0,"[u'http://birdflubook.org/resources/oxford133.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkh037v1.pdf', u'http://birdflubook.com/resources/oxford133.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/53/2/133.pdf']"
10.1056/NEJM199910283411802,"Apisarnthanarak, A., Warren, D., Fraser, V., , Issues Relevant to the Adoption and Modification of Hospital Infection‐Control Recommendations for Avian Influenza (H5N1 Infection) in Developing Countries, Clinical Infectious Diseases, 2007",cited-by,10.1086/522538,Issues Relevant to the Adoption and Modification of Hospital Infection‐Control Recommendations for Avian Influenza (H5N1 Infection) in Developing Countries,"[['Anucha', '', 'Apisarnthanarak'], ['David', 'K.', 'Warren'], ['Victoria', 'J.', 'Fraser']]",Clinical Infectious Diseases,2007,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/522538']
10.1056/NEJM199910283411802,"Simor, A., , Influenza Outbreaks in Long‐Term–Care Facilities: How Can We Do Better?, Infection Control and Hospital Epidemiology, 2002",cited-by,10.1086/501971,Influenza Outbreaks in Long‐Term–Care Facilities: How Can We Do Better?,"[['Andrew', '', 'Simor']]",Infection Control and Hospital Epidemiology,2002,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/501971']
10.1056/NEJM199910283411802,"Neuzil, K., , Influenza: New insights into an old disease, Current Infectious Disease Reports, 2000",cited-by,10.1007/s11908-000-0039-3,Influenza: New insights into an old disease,"[['Kathleen', 'M.', 'Neuzil']]",Current Infectious Disease Reports,2000,"[u'http://www.springerlink.com/index/0765517834762225.pdf', u'http://www.springerlink.com/content/0765517834762225', u'http://www.springerlink.com/index/10.1007/s11908-000-0039-3', u'http://www.springerlink.com/index/pdf/10.1007/s11908-000-0039-3']"
10.1056/NEJM199910283411802,"Lee, V., Yap, J., Tay, J., et. al, Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009, BMC Infectious Diseases, 2010",cited-by,10.1186/1471-2334-10-164,Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009,"[['Vernon', 'J', 'Lee'], ['Jonathan', '', 'Yap'], ['Joshua', 'K', 'Tay'], ['Ian', '', 'Barr'], ['Qiuhan', '', 'Gao'], ['Hanley', 'J', 'Ho'], ['Boon', 'Huan', 'Tan'], ['Paul', 'M', 'Kelly'], ['Paul', 'A', 'Tambyah'], ['Anne', '', 'Kelso'], ['Mark', 'I', 'Chen']]",BMC Infectious Diseases,2010,"[u'http://www.biomedcentral.com/content/pdf/1471-2334-10-164.pdf', u'http://www.springerlink.com/content/j66k40n630622t70', u'http://www.biomedcentral.com/1471-2334/10/164', u'http://www.springerlink.com/index/j66k40n630622t70.pdf']"
10.1056/NEJM199910283411802,"Grayson, M., Johnson, P., , Australia's influenza containment plan and the swine flu epidemic in Victoria, , 2009",cited-by,11562927Australia's influenza containment plan and the swine flu epidemic in Victoria,Australia's influenza containment plan and the swine flu epidemic in Victoria,"[['M', 'Lindsay', 'Grayson'], ['Paul', 'D R', 'Johnson']]",,2009,"[u'https://www.moh.gov.sg/mohcorp/uploadedFiles/Web_Parts/Home/Grayson%20MJA%202009%20editorial%20Victoria%20flu.pdf', u'http://www.moh.gov.sg/mohcorp/uploadedFiles/Web_Parts/Home/Grayson%20MJA%202009%20editorial%20Victoria%20flu.pdf', u'http://www.mja.com.au/public/issues/191_03_030809/gra10697_fm.pdf']"
10.1056/NEJM199910283411802,"Sander, B., Nizam, A., Garrison, L., et. al, Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic MicrosimulationTransmission Model, , 2008",cited-by,5157075Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic MicrosimulationTransmission Model,Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic MicrosimulationTransmission Model,"[['Beate', '', 'Sander'], ['Azhar', '', 'Nizam'], ['Louis', 'P.', 'Garrison'], ['Maarten', 'J.', 'Postma'], ['M.', 'Elizabeth', 'Halloran'], ['Ira', 'M.', 'Longini']]",,2008,"[u'http://share.eldoc.ub.rug.nl/FILES/root2/2009/Econevofi/Sander_2009_Value_Health.pdf', u'http://www.sff.fmns.rug.nl/downloads/2008/630_sander_2008.pdf']"
10.1056/NEJM199910283411802,"Suzuki, E., Ichihara, K., , The course of fever following influenza virus infection in children treated with oseltamivir, Journal of Medical Virology, 2008",cited-by,10.1002/jmv.21144,The course of fever following influenza virus infection in children treated with oseltamivir,"[['Eitaro', '', 'Suzuki'], ['Kiyoshi', '', 'Ichihara']]",Journal of Medical Virology,2008,[u'http://doi.wiley.com/10.1002/jmv.21144']
10.1056/NEJM199910283411802,"Shi, L., Xiong, H., He, J., et. al, Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus  in vitro  and  in vivo, Archives of Virology, 2007",cited-by,10.1007/s00705-007-0974-5,"Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus  in vitro  and  in vivo","[['L.', '', 'Shi'], ['H.', '', 'Xiong'], ['J.', '', 'He'], ['H.', '', 'Deng'], ['Q.', '', 'Li'], ['Q.', '', 'Zhong'], ['W.', '', 'Hou'], ['L.', '', 'Cheng'], ['H.', '', 'Xiao'], ['Z.', '', 'Yang']]",Archives of Virology,2007,"[u'http://www.arbidol.org/arbidol-2007-china.pdf', u'http://www.springerlink.com/content/t6675872681r1848', u'http://www.springerlink.com/index/t6675872681r1848.pdf', u'http://www.springerlink.com/index/10.1007/s00705-007-0974-5', u'http://www.springerlink.com/index/pdf/10.1007/s00705-007-0974-5']"
10.1056/NEJM199910283411802,"Adedipe, A., Lowenstein, R., , Infectious Emergencies in the Elderly, Emergency Medicine Clinics of North America, 2006",cited-by,10.1016/j.emc.2006.01.006,Infectious Emergencies in the Elderly,"[['Adeyinka', '', 'Adedipe'], ['Robert', '', 'Lowenstein']]",Emergency Medicine Clinics of North America,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0733862706000071', u'http://linkinghub.elsevier.com/retrieve/pii/S0733862706000071']"
10.1056/NEJM199910283411802,"Fock, R., Bergmann, H., Bussmann, H., et. al, Conceptional considerations for a German influenza pandemic preparedness plan, Medical Microbiology and Immunology, 2002",cited-by,10.1007/s00430-002-0145-y,Conceptional considerations for a German influenza pandemic preparedness plan,"[['R.', '', 'Fock'], ['H.', '', 'Bergmann'], ['H.', '', 'Bussmann'], ['G.', '', 'Fell'], ['E.-J.', '', 'Finke'], ['U.', '', 'Koch'], ['M.', '', 'Niedrig'], ['M.', '', 'Peters'], ['D.', '', 'Scholz'], ['A.', '', 'Wirtz']]",Medical Microbiology and Immunology,2002,"[u'http://www.springerlink.com/content/pv8fte1p3w8fuf1u', u'http://www.springerlink.com/index/pv8fte1p3w8fuf1u.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00430-002-0145-y', u'http://www.springerlink.com/index/pdf/10.1007/s00430-002-0145-y']"
10.1001~jama.283.8.1016,"Protecting Human Research Subjects. Washington, DC: US Government Printing Office; 1993. National Institutes of Health Publication 93-3470.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Mahy BW, Kangro HO, eds. Virology Methods Manual. New York, NY: Harcourt Brace; 1996:25-46.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Lenette EH, Schmidt NJ, eds. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections. 5th ed. Washington, DC: American Public Health Association; 1979:603-605.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics. 1982;38: 29-41.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Aoki F, Osterhaus A, Rimmelzwaan G, Kinnersley N, Ward P. Oral GS4104 successfully reduces duration and severity of naturally acquired influenza. 38th International Conference on Antimicrobial Agents and Chemotherapy; September 24-27, 1998; San Diego, Calif: Abstract LB-5.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112:798-813.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics. Arch Intern Med. 1982; 142:85-89.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. Oxford, England: Blackwell; 1998: 219-266.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Kaiser L, Hayden FG, Hammond JM, Keene O. Efficacy of inhaled zanamivir in reducing complications and antibiotic use in influenza. 39th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Francisco, Calif. Abstract A1903.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Smith AP, Thomas M, Brockman P, Kent J, Nicholson KG. Effect of influenza B virus infection on human performance. BMJ. 1993;306:760-761.",references,10.1136/bmj.306.6880.760,Effect of influenza B virus infection on human performance,"[[u'A', u'P', u'Smith'], [u'M', u'', u'Thomas'], [u'P', u'', u'Brockman'], [u'J', u'', u'Kent'], [u'K', u'G', u'Nicholson']]",British Medical Journal,1993,"[u'http://www.bmj.com/cgi/doi/10.1136/bmj.306.6880.760', u'http://dx.doi.org/']",./output/10.1001~jama.283.8.1016/10.1136~bmj.306.6880.760
10.1136/bmj.306.6880.760,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1136/bmj.306.6880.760,"Nichol, K., , Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza, , 2001",cited-by,2905336Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,"[['Kristin', 'L.', 'Nichol']]",,2001,"[u'http://archinte.ama-assn.org/cgi/reprint/161/5/749.pdf', u'http://tudor.szote.u-szeged.hu/webtext/letolt/anyag/CASPi_200212/day4/4.2.3.%20nichol%20paper.pdf']"
10.1136/bmj.306.6880.760,"Yirmiya, R., Weidenfeld, J., Pollak, Y., et. al, Cytokines, “Depression Due to A General Medical Condition,” and Antidepressant Drugs, , 0",cited-by,10.1007/978-0-585-37970-8_16,"Cytokines, “Depression Due to A General Medical Condition,” and Antidepressant Drugs","[['Raz', '', 'Yirmiya'], ['Joseph', '', 'Weidenfeld'], ['Yehuda', '', 'Pollak'], ['Michal', '', 'Morag'], ['Avraham', '', 'Morag'], ['Ronit', '', 'Avitsur'], ['Ohr', '', 'Barak'], ['Edna', '', 'Cohen'], ['Yehuda', '', 'Shavit'], ['Haim', '', 'Ovadia']]",,0,"[u'http://www.springerlink.com/index/jw2v456q221000r1.pdf', u'http://www.springerlink.com/content/jw2v456q221000r1']"
10.1136/bmj.306.6880.760,"Keech, M., Scott, A., Ryan, P., , The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population, Occupational Medicine-oxford, 1998",cited-by,10.1093/occmed/48.2.85,The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population,"[['M.', '', 'Keech'], ['A.', 'J.', 'Scott'], ['P.', 'J. J.', 'Ryan']]",Occupational Medicine-oxford,1998,"[u'http://occmed.oxfordjournals.org/cgi/reprint/48/2/85.pdf', u'http://occmed.oxfordjournals.org/cgi/doi/10.1093/occmed/48.2.85']"
10.1136/bmj.306.6880.760,"Nichol, K., Mallon, K., Mendelman, P., , Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00029-X,"Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine","[['Kristin', 'L', 'Nichol'], ['Kenneth', 'P', 'Mallon'], ['Paul', 'M', 'Mendelman']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0300029X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0300029X']"
10.1136/bmj.306.6880.760,"Blank, P., Schwenkglenks, M., Szucs, T., , Vaccination coverage rates in eleven European countries during two consecutive influenza seasons, Journal of Infection, 2009",cited-by,10.1016/j.jinf.2009.04.001,Vaccination coverage rates in eleven European countries during two consecutive influenza seasons,"[['Patricia', 'R.', 'Blank'], ['Matthias', '', 'Schwenkglenks'], ['Thomas', 'D.', 'Szucs']]",Journal of Infection,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0163445309001157', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445309001157']"
10.1136/bmj.306.6880.760,"Nichol, K., D’Heilly, S., Ehlinger, E., , Colds and Influenza‐Like Illnesses in University Students: Impact on Health, Academic and Work Performance, and Health Care Use, Clinical Infectious Diseases, 2005",cited-by,10.1086/429237,"Colds and Influenza‐Like Illnesses in University Students: Impact on Health, Academic and Work Performance, and Health Care Use","[['Kristin', 'L.', 'Nichol'], ['Sarah', '', 'D\xe2\x80\x99Heilly'], ['Edward', '', 'Ehlinger']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/429237']
10.1136/bmj.306.6880.760,"Pollak, Y., Orion, E., Goshen, I., et. al, Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis’, Brain Behavior and Immunity, 2002",cited-by,10.1016/S0889-1591(02)00010-7,Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis’,"[['Y', '', 'Pollak'], ['E', '', 'Orion'], ['I', '', 'Goshen'], ['H', '', 'Ovadia'], ['R', '', 'Yirmiya']]",Brain Behavior and Immunity,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0889159102000107', u'http://linkinghub.elsevier.com/retrieve/pii/S0889159102000107']"
10.1136/bmj.306.6880.760,"Hall, S., Smith, A., , Investigation of the effects and aftereffects of naturally occurring upper respiratory tract illnesses on mood and performance, Physiology & Behavior, 1996",cited-by,10.1016/0031-9384(95)02112-4,Investigation of the effects and aftereffects of naturally occurring upper respiratory tract illnesses on mood and performance,"[['Sara', '', 'Hall'], ['Andrew', '', 'Smith']]",Physiology & Behavior,1996,"[u'http://www.sciencedirect.com/science/article/pii/0031938495021124', u'http://linkinghub.elsevier.com/retrieve/pii/0031938495021124']"
10.1136/bmj.306.6880.760,"Keech, M., Beardsworth, P., , The Impact of Influenza on Working Days Lost: A Review of the Literature, Pharmacoeconomics, 2008",cited-by,10.2165/00019053-200826110-00004,The Impact of Influenza on Working Days Lost: A Review of the Literature,"[['Martin', '', 'Keech'], ['Paul', '', 'Beardsworth']]",Pharmacoeconomics,2008,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00019053-200826110-00004', u'http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200826110-00004.htm', u'http://pharmacoeconomics.adisonline.com/pt/re/phe/pdfhandler.00019053-200826110-00004.pdf']"
10.1136/bmj.306.6880.760,"Smith, A., Thomas, M., Kent, J., et. al, EFFECTS OF THE COMMON COLD ON MOOD AND PERFORMANCE, Psychoneuroendocrinology, 1998",cited-by,10.1016/S0306-4530(98)00042-0,EFFECTS OF THE COMMON COLD ON MOOD AND PERFORMANCE,"[['Andrew', '', 'Smith'], ['Marie', '', 'Thomas'], ['Julie', '', 'Kent'], ['Karl', '', 'Nicholson']]",Psychoneuroendocrinology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0306453098000420', u'http://linkinghub.elsevier.com/retrieve/pii/S0306453098000420']"
10.1136/bmj.306.6880.760,"MacLullich, A., Ferguson, K., Miller, T., et. al, Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses, Journal of Psychosomatic Research, 2008",cited-by,10.1016/j.jpsychores.2008.05.019,Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses,"[['Alasdair', 'M. J.', 'MacLullich'], ['Karen', 'J.', 'Ferguson'], ['Thomas', '', 'Miller'], ['Sophia', 'E. J. A. de', 'Rooij'], ['Colm', '', 'Cunningham']]",Journal of Psychosomatic Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0022399908002407', u'http://linkinghub.elsevier.com/retrieve/pii/S0022399908002407']"
10.1136/bmj.306.6880.760,"Nichol, K., , Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults, Vaccine, 1999",cited-by,10.1016/S0264-410X(99)00110-3,Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults,"[['Kristin', 'L', 'Nichol']]",Vaccine,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X99001103', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X99001103']"
10.1136/bmj.306.6880.760,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004']
10.1136/bmj.306.6880.760,"Bucks, R., Gidron, Y., Harris, P., et. al, Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: A prospective study, Brain Behavior and Immunity, 2008",cited-by,10.1016/j.bbi.2007.09.005,"Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: A prospective study","[['Romola', 'S.', 'Bucks'], ['Yori', '', 'Gidron'], ['Petra', '', 'Harris'], ['Jessica', '', 'Teeling'], ['Keith', 'A.', 'Wesnes'], ['V.', 'Hugh', 'Perry']]",Brain Behavior and Immunity,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0889159107002462', u'http://linkinghub.elsevier.com/retrieve/pii/S0889159107002462']"
10.1136/bmj.306.6880.760,"Poland, G., Johnson, D., , Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season, American Journal of Medicine, 2008",cited-by,10.1016/j.amjmed.2008.05.002,Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season,"[['Gregory', 'A.', 'Poland'], ['David', 'R.', 'Johnson']]",American Journal of Medicine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0002934308004658', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934308004658']"
10.1136/bmj.306.6880.760,"Engler, R., Nelson, M., Klote, M., et. al, Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses, , 0",cited-by,"13620392Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses","Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses","[['Renata', 'J. M.', 'Engler'], ['Michael', 'R.', 'Nelson'], ['Mary', 'M.', 'Klote'], ['Mark', 'J.', 'VanRaden'], ['Chiung-Yu', '', 'Huang'], ['Nancy', 'J.', 'Cox'], ['Alexander', '', 'Klimov'], ['Wendy', 'A.', 'Keitel'], ['Kristin', 'L.', 'Nichol'], ['Warner', 'W.', 'Carr'], ['John', 'J.', 'Treanor']]",,0,[u'http://archinte.highwire.org/cgi/reprint/168/22/2405.pdf']
10.1136/bmj.306.6880.760,"LaVela, S., Goldstein, B., Smith, B., et. al, Working with symptoms of a respiratory infection: Staff who care for high-risk individuals, American Journal of Infection Control, 2007",cited-by,10.1016/j.ajic.2006.12.005,Working with symptoms of a respiratory infection: Staff who care for high-risk individuals,"[['Sherri', '', 'LaVela'], ['Barry', '', 'Goldstein'], ['Bridget', '', 'Smith'], ['Frances', 'M.', 'Weaver']]",American Journal of Infection Control,2007,"[u'http://www.sciencedirect.com/science/article/pii/S019665530700096X', u'http://linkinghub.elsevier.com/retrieve/pii/S019665530700096X']"
10.1136/bmj.306.6880.760,"Chalmers, C., , Understanding healthcare worker uptake of influenza vaccination: a survey, British Journal of Infection Control, 2006",cited-by,10.1177/14690446060070020501,Understanding healthcare worker uptake of influenza vaccination: a survey,"[['C.', '', 'Chalmers']]",British Journal of Infection Control,2006,"[u'http://bji.sagepub.com/cgi/doi/10.1177/14690446060070020501', u'http://dx.doi.org/10.1177/14690446060070020501']"
10.1136/bmj.306.6880.760,"Fleming, D., , The management of influenza in people of working age, Occupational Medicine-oxford, 2002",cited-by,10.1093/occmed/52.5.259,The management of influenza in people of working age,"[['D.', 'M.', 'Fleming']]",Occupational Medicine-oxford,2002,"[u'http://occmed.oxfordjournals.org/cgi/reprint/52/5/259.pdf', u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.259']"
10.1136/bmj.306.6880.760,"Souza, M., , Influenza, Journal of Exotic Pet Medicine, 2011",cited-by,10.1053/j.jepm.2010.11.003,Influenza,"[['Marcy', 'J.', 'Souza']]",Journal of Exotic Pet Medicine,2011,"[u'http://www.sheffield.ac.uk/content/1/c6/01/28/99/flu1.pdf', u'http://www.sciencedirect.com/science/article/pii/S1557506310002090']"
10.1136/bmj.306.6880.760,"Chalmers, C., , Double-blind peer reviewed paper The role of healthcare workers in influenza prevention: Part one, British Journal of Infection Control, 2006",cited-by,10.1177/14690446060070010601,Double-blind peer reviewed paper The role of healthcare workers in influenza prevention: Part one,"[['C.', '', 'Chalmers']]",British Journal of Infection Control,2006,"[u'http://bji.sagepub.com/cgi/doi/10.1177/14690446060070010601', u'http://dx.doi.org/10.1177/14690446060070010601']"
10.1136/bmj.306.6880.760,"Smith, A., Thomas, M., Whitney, H., , Effects of upper respiratory tract illnesses on mood and performance over the working day, Ergonomics, 2000",cited-by,10.1080/001401300404724,Effects of upper respiratory tract illnesses on mood and performance over the working day,"[['Andrew', '', 'Smith'], ['Marie', '', 'Thomas'], ['Helen', '', 'Whitney']]",Ergonomics,2000,[u'http://dx.doi.org/10.1080/001401300404724']
10.1136/bmj.306.6880.760,"Thomas, M., Whitney, H., , After-effects of the common cold on mood and performance, Ergonomics, 2000",cited-by,10.1080/001401300421789,After-effects of the common cold on mood and performance,"[['Marie', '', 'Thomas'], ['Helen', '', 'Whitney']]",Ergonomics,2000,[u'http://dx.doi.org/10.1080/001401300421789']
10.1136/bmj.306.6880.760,"Wenzel, R., , Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor, , 0",cited-by,12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,"[['Richard', 'P.', 'Wenzel']]",,0,[u'http://jama.ama-assn.org/cgi/reprint/283/8/1016.pdf']
10.1001~jama.283.8.1016,"Keech M, Scott AJ, Ryan PJ. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med. 1998;48:85-90.",references,10.1093/occmed/48.2.85,The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population,"[[u'M.', u'', u'Keech'], [u'A.', u'J.', u'Scott'], [u'P.', u'J. J.', u'Ryan']]",Occupational Medicine-oxford,1998,"[u'http://occmed.oxfordjournals.org/cgi/reprint/48/2/85.pdf', u'http://occmed.oxfordjournals.org/cgi/doi/10.1093/occmed/48.2.85']",./output/10.1001~jama.283.8.1016/10.1093~occmed~48.2.85
10.1093/occmed/48.2.85,"Nicholson, K., Aoki, F., Osterhaus, A., et. al, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 2000",cited-by,10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[['KG', '', 'Nicholson'], ['FY', '', 'Aoki'], ['ADME', '', 'Osterhaus'], ['S', '', 'Trottier'], ['O', '', 'Carewicz'], ['CH', '', 'Mercier'], ['A', '', 'Rode'], ['N', '', 'Kinnersley'], ['P', '', 'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
10.1093/occmed/48.2.85,"Nichol, K., , Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza, , 2001",cited-by,2905336Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza,"[['Kristin', 'L.', 'Nichol']]",,2001,"[u'http://archinte.ama-assn.org/cgi/reprint/161/5/749.pdf', u'http://tudor.szote.u-szeged.hu/webtext/letolt/anyag/CASPi_200212/day4/4.2.3.%20nichol%20paper.pdf']"
10.1093/occmed/48.2.85,"HEDRICK, J., BARZILAI, A., BEHRE, U., et. al, Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial, Pediatric Infectious Disease Journal, 2000",cited-by,10.1097/00006454-200005000-00005,Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial,"[['JAMES', 'A.', 'HEDRICK'], ['ASHER', '', 'BARZILAI'], ['ULRICH', '', 'BEHRE'], ['FREDERICK', 'W.', 'HENDERSON'], ['JANET', '', 'HAMMOND'], ['LUCY', '', 'REILLY'], ['OLIVER', '', 'KEENE']]",Pediatric Infectious Disease Journal,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200005000-00005']
10.1093/occmed/48.2.85,"Neuzil, K., Hohlbein, C., Zhu, Y., , Illness Among Schoolchildren During Influenza Season Effect on School Absenteeism, Parental Absenteeism From Work, and Secondary Illness in Families, , 2002",cited-by,"13610716Illness Among Schoolchildren During Influenza Season Effect on School Absenteeism, Parental Absenteeism From Work, and Secondary Illness in Families","Illness Among Schoolchildren During Influenza Season Effect on School Absenteeism, Parental Absenteeism From Work, and Secondary Illness in Families","[['Kathleen', 'M.', 'Neuzil'], ['Cynthia', '', 'Hohlbein'], ['Yuwei', '', 'Zhu']]",,2002,"[u'http://archpedi.ama-assn.org/cgi/reprint/156/10/986.pdf', u'http://archpedi.highwire.org/cgi/reprint/156/10/986.pdf']"
10.1093/occmed/48.2.85,"Nichol, K., Mallon, K., Mendelman, P., , Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine, Vaccine, 2003",cited-by,10.1016/S0264-410X(03)00029-X,"Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine","[['Kristin', 'L', 'Nichol'], ['Kenneth', 'P', 'Mallon'], ['Paul', 'M', 'Mendelman']]",Vaccine,2003,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0300029X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0300029X']"
10.1093/occmed/48.2.85,"Lee, P., Matchar, D., Clements, D., et. al, Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults, , 2002",cited-by,5954845Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults,"[['Patrick', 'Y.', 'Lee'], ['David', 'B.', 'Matchar'], ['Dennis', 'A.', 'Clements'], ['Joel', '', 'Huber'], ['John', 'D.', 'Hamilton'], ['Eric', 'D.', 'Peterson']]",,2002,[u'http://www.pforster.ch/yvaccin/DocumVaccinInfluenzaBAG/Lee_2002.pdf']
10.1093/occmed/48.2.85,"Rothberg, M., Rose, D., , Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis, American Journal of Medicine, 2005",cited-by,10.1016/j.amjmed.2004.03.044,Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis,"[['Michael', 'B.', 'Rothberg'], ['David', 'N.', 'Rose']]",American Journal of Medicine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0002934304006291', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-5.pdf', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/vaccination/vaccination-8.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934304006291']"
10.1093/occmed/48.2.85,"Govorkova, E., Fang, H., Tan, M., et. al, Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells, Antimicrobial Agents and Chemotherapy, 2004",cited-by,10.1128/AAC.48.12.4855-4863.2004,Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells,"[['Elena', 'A.', 'Govorkova'], ['Hong-Bin', '', 'Fang'], ['Ming', '', 'Tan'], ['Robert', 'G.', 'Webster']]",Antimicrobial Agents and Chemotherapy,2004,"[u'http://aac.asm.org/cgi/reprint/48/12/4855.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.48.12.4855-4863.2004']"
10.1093/occmed/48.2.85,"Khan, K., , Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults, Clinical Infectious Diseases, 2001",cited-by,10.1086/324491,Cost‐Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults,"[['Kamran', '', 'Khan']]",Clinical Infectious Diseases,2001,"[u'http://www.pceo.org/pubs/CID%20Article.pdf', u'http://www.journals.uchicago.edu/doi/abs/10.1086/324491']"
10.1093/occmed/48.2.85,"Akazawa, M., Sindelar, J., Paltiel, A., , Economic Costs of Influenza-Related Work Absenteeism, Value in Health, 2003",cited-by,10.1046/j.1524-4733.2003.00209.x,Economic Costs of Influenza-Related Work Absenteeism,"[['Manabu', '', 'Akazawa'], ['Jody', 'L.', 'Sindelar'], ['A.', 'David', 'Paltiel']]",Value in Health,2003,"[u'http://www.sciencedirect.com/science/article/pii/S1098301510601404', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1524-4733.2003.00209.x']"
10.1093/occmed/48.2.85,"Simmerman, J., Lertiendumrong, J., Dowell, S., et. al, The cost of influenza in Thailand, Vaccine, 2006",cited-by,10.1016/j.vaccine.2005.12.060,The cost of influenza in Thailand,"[['James', 'Mark', 'Simmerman'], ['Jongkol', '', 'Lertiendumrong'], ['Scott', 'F.', 'Dowell'], ['Timothy', '', 'Uyeki'], ['Sonja', 'J.', 'Olsen'], ['Malinee', '', 'Chittaganpitch'], ['Supamit', '', 'Chunsutthiwat'], ['Viroj', '', 'Tangcharoensathien']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X0600020X', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X0600020X']"
10.1093/occmed/48.2.85,"Ryan, J., Zoellner, Y., Gradl, B., et. al, Establishing the health and economic impact of influenza vaccination within the European Union 25 countries, Vaccine, 2006",cited-by,10.1016/j.vaccine.2006.07.042,Establishing the health and economic impact of influenza vaccination within the European Union 25 countries,"[['James', '', 'Ryan'], ['York', '', 'Zoellner'], ['Birgit', '', 'Gradl'], ['Bram', '', 'Palache'], ['Jeroen', '', 'Medema']]",Vaccine,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X06008954', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X06008954']"
10.1093/occmed/48.2.85,"Thompson, W., Meltzer, M., Reeve, G., et. al, Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults, , 2007",cited-by,5478601Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults,Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults,"[['William', 'W.', 'Thompson'], ['Martin', 'I.', 'Meltzer'], ['Gordon', 'R.', 'Reeve'], ['Walter', 'J.', 'Talamonti'], ['Nancy', 'J.', 'Cox'], ['Heather', 'A.', 'Lilac'], ['Keiji', '', 'Fukuda']]",,2007,[u'http://www.beforeyoutakethatpill.com/2008/12/bridges_flu_shots.pdf']
10.1093/occmed/48.2.85,"Hannouna, C., Megas, F., Piercy, J., , Immunogenicity and protective efficacy of influenza vaccination, Virus Research, 2004",cited-by,10.1016/S0168-1702(04)00124-8,Immunogenicity and protective efficacy of influenza vaccination,"[['Claude', '', 'Hannouna'], ['Francoise', '', 'Megas'], ['James', '', 'Piercy']]",Virus Research,2004,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/vaccination/vaccination-21.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001248']"
10.1093/occmed/48.2.85,"Barringer, T., Kirk, J., Santaniello, A., et. al, Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life A Randomized, Double-Blind, Placebo-Controlled Trial, , 0",cited-by,"11019403Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life A Randomized, Double-Blind, Placebo-Controlled Trial","Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life A Randomized, Double-Blind, Placebo-Controlled Trial","[['Thomas', 'A.', 'Barringer'], ['Julienne', 'K.', 'Kirk'], ['Amy', 'C.', 'Santaniello'], ['Kristie', 'Long', 'Foley'], ['Robert', '', 'Michielutte']]",,0,"[u'http://www.annals.org/content/138/5/365.full.pdf', u'http://www.spectracell.com/media/082fullpaper2003annintmedmicronutrient-deficiency-and-infectious-disease.pdf']"
10.1093/occmed/48.2.85,"Rothberg, M., He, S., Rose, D., , Management of influenza symptoms in healthy adults, Journal of General Internal Medicine, 2003",cited-by,10.1046/j.1525-1497.2003.20822.x,Management of influenza symptoms in healthy adults,"[['Michael', 'B.', 'Rothberg'], ['Shunian', '', 'He'], ['David', 'N.', 'Rose']]",Journal of General Internal Medicine,2003,"[u'http://www.springerlink.com/index/c2hlvw3483877856.pdf', u'http://www.springerlink.com/content/c2hlvw3483877856', u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1525-1497.2003.20822.x']"
10.1093/occmed/48.2.85,"Nichol, K., D’Heilly, S., Ehlinger, E., , Colds and Influenza‐Like Illnesses in University Students: Impact on Health, Academic and Work Performance, and Health Care Use, Clinical Infectious Diseases, 2005",cited-by,10.1086/429237,"Colds and Influenza‐Like Illnesses in University Students: Impact on Health, Academic and Work Performance, and Health Care Use","[['Kristin', 'L.', 'Nichol'], ['Sarah', '', 'D\xe2\x80\x99Heilly'], ['Edward', '', 'Ehlinger']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/429237']
10.1093/occmed/48.2.85,"O'Reilly, F., Stevens, A., , Sickness absence due to influenza, Occupational Medicine-oxford, 2002",cited-by,10.1093/occmed/52.5.265,Sickness absence due to influenza,"[['F.', 'W.', ""O'Reilly""], ['A.', 'B.', 'Stevens']]",Occupational Medicine-oxford,2002,"[u'http://www.cepis.ops-oms.org/bvsacd/cd49/265.pdf', u'http://www.cepis.ops-oms.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://www.bvsde.ops-oms.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://bvsde.per.paho.org/foro_hispano/BVS/bvsacd/cd49/265.pdf', u'http://bvsde.per.paho.org/bvsacd/cd49/265.pdf', u'http://www.bvsde.paho.org/bvsacd/cd49/265.pdf', u'http://www.opas.org.br/gentequefazsaude/bvsde/bvsacd/cd49/265.pdf', u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.265']"
10.1093/occmed/48.2.85,"Keech, M., Beardsworth, P., , The Impact of Influenza on Working Days Lost: A Review of the Literature, Pharmacoeconomics, 2008",cited-by,10.2165/00019053-200826110-00004,The Impact of Influenza on Working Days Lost: A Review of the Literature,"[['Martin', '', 'Keech'], ['Paul', '', 'Beardsworth']]",Pharmacoeconomics,2008,"[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00019053-200826110-00004', u'http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200826110-00004.htm', u'http://pharmacoeconomics.adisonline.com/pt/re/phe/pdfhandler.00019053-200826110-00004.pdf']"
10.1093/occmed/48.2.85,"Aballéa, S., Chancellor, J., Martin, M., et. al, The Cost-Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: An International Model, Value in Health, 2007",cited-by,10.1111/j.1524-4733.2006.00157.x,The Cost-Effectiveness of Influenza Vaccination for People Aged 50 to 64 Years: An International Model,"[['Samuel', '', 'Aball\xc3\xa9a'], ['Jeremy', '', 'Chancellor'], ['Monique', '', 'Martin'], ['Peter', '', 'Wutzler'], ['Fabrice', '', 'Carrat'], ['Roberto', '', 'Gasparini'], ['Joao', '', 'Toniolo-Neto'], ['Michael', '', 'Drummond'], ['Milton', '', 'Weinstein']]",Value in Health,2007,"[u'http://www.sciencedirect.com/science/article/pii/S1098301510604585', u'http://www.blackwell-synergy.com/doi/abs/10.1111/j.1524-4733.2006.00157.x']"
10.1093/occmed/48.2.85,"Postma, M., Jansema, P., Genugten, M., , Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults, Vaccine, 2005",cited-by,10.1016/j.vaccine.2005.06.007,Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults,"[['Maarten', 'J.', 'Postma'], ['Paul', '', 'Jansema'], ['Marianne', 'L. L. van', 'Genugten']]",Vaccine,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X05005852', u'http://www.sff.fmns.rug.nl/downloads/2005/401_postma_2005.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X05005852']"
10.1093/occmed/48.2.85,"Ehlinger, E., , Burden of Influenza‐Like Illness and Effectiveness of Influenza Vaccination among Working Adults Aged 50–64 Years, Clinical Infectious Diseases, 2009",cited-by,10.1086/595842,Burden of Influenza‐Like Illness and Effectiveness of Influenza Vaccination among Working Adults Aged 50–64 Years,"[['Edward', '', 'Ehlinger']]",Clinical Infectious Diseases,2009,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/595842']
10.1093/occmed/48.2.85,"Bettis, R., Iacuzio, D., Jung, T., et. al, Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents, Clinical Drug Investigation, 2006",cited-by,10.2165/00044011-200626060-00004,"Impact of Influenza Treatment with Oseltamivir on Health, Sleep and Daily Activities of Otherwise Healthy Adults and Adolescents","[['Robert', '', 'Bettis'], ['Dominick', '', 'Iacuzio'], ['Thomas', '', 'Jung'], ['Rudolf', '', 'Fuchs'], ['Rick', '', 'Aultman'], ['Marlene', '', 'Gyldmark']]",Clinical Drug Investigation,2006,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200626060-00004']
10.1093/occmed/48.2.85,"Morales, A., Martinez, M., Tasset-Tisseau, A., et. al, Costs and Benefits of Influenza Vaccination and Work Productivity in a Colombian Company from the Employer's Perspective, Value in Health, 2004",cited-by,10.1111/j.1524-4733.2004.74006.x,Costs and Benefits of Influenza Vaccination and Work Productivity in a Colombian Company from the Employer's Perspective,"[['Alvaro', '', 'Morales'], ['Maria', 'M.', 'Martinez'], ['Anne', '', 'Tasset-Tisseau'], ['Elena', '', 'Rey'], ['Florence', '', 'Baron-Papillon'], ['Alain', '', 'Follet']]",Value in Health,2004,"[u'http://www.sciencedirect.com/science/article/pii/S1098301510602033', u'http://www.blackwell-synergy.com/links/doi/10.1111%2Fj.1524-4733.2004.74006.x']"
10.1093/occmed/48.2.85,"Holm, M., Gyldmark, M., Hansen, E., , Pharmacoeconomic assessment of oseltamivir in treating influenza – the case of otherwise healthy Danish adolescents and adults, Pharmacy World & Science, 2004",cited-by,10.1007/s11096-004-0559-2,Pharmacoeconomic assessment of oseltamivir in treating influenza – the case of otherwise healthy Danish adolescents and adults,"[['Majbrit', 'Vindt', 'Holm'], ['Marlene', '', 'Gyldmark'], ['Ebba', 'Holme', 'Hansen']]",Pharmacy World & Science,2004,"[u'http://www.springerlink.com/content/m52624t326485235', u'http://www.springerlink.com/index/m52624t326485235.pdf', u'http://www.springerlink.com/index/10.1007/s11096-004-0559-2', u'http://www.springerlink.com/index/pdf/10.1007/s11096-004-0559-2']"
10.1093/occmed/48.2.85,"Poland, G., Johnson, D., , Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season, American Journal of Medicine, 2008",cited-by,10.1016/j.amjmed.2008.05.002,Increasing Influenza Vaccination Rates: The Need to Vaccinate Throughout the Entire Influenza Season,"[['Gregory', 'A.', 'Poland'], ['David', 'R.', 'Johnson']]",American Journal of Medicine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0002934308004658', u'http://linkinghub.elsevier.com/retrieve/pii/S0002934308004658']"
10.1093/occmed/48.2.85,"Larson, E., , Warned, but Not Well Armed: Preventing Viral Upper Respiratory Infections in Households, Public Health Nursing, 2007",cited-by,10.1111/j.1525-1446.2006.00607.x,"Warned, but Not Well Armed: Preventing Viral Upper Respiratory Infections in Households","[['Elaine', 'L.', 'Larson']]",Public Health Nursing,2007,[u'http://blackwell-synergy.com/doi/abs/10.1111/j.1525-1446.2006.00607.x']
10.1093/occmed/48.2.85,"Samad, A., Usul, M., Zakaria, D., et. al, Workplace Vaccination against Influenza in Malaysia: Does the Employer Benefit?, Journal of Occupational Health, 2006",cited-by,10.1539/joh.48.1,Workplace Vaccination against Influenza in Malaysia: Does the Employer Benefit?,"[['Abu', 'H.', 'Samad'], ['Mohd', 'H. B. H. J.', 'Usul'], ['Dalilah', '', 'Zakaria'], ['Raman', '', 'Ismail'], ['Anne', '', 'Tasset-Tisseau'], ['Florence', '', 'Baron-Papillon'], ['Alain', '', 'Follet']]",Journal of Occupational Health,2006,"[u'http://joh.med.uoeh-u.ac.jp/pdf/E48/E48_1_01.pdf', u'http://joi.jlc.jst.go.jp/JST.JSTAGE/joh/48.1?from=CrossRef']"
10.1093/occmed/48.2.85,"Groth, N., Montomoli, E., Gentile, C., et. al, Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial, Vaccine, 2009",cited-by,10.1016/j.vaccine.2008.11.003,"Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial","[['N.', '', 'Groth'], ['E.', '', 'Montomoli'], ['C.', '', 'Gentile'], ['I.', '', 'Manini'], ['R.', '', 'Bugarini'], ['A.', '', 'Podda']]",Vaccine,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X08015065', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08015065']"
10.1093/occmed/48.2.85,"Gums, J., Pelletier, E., Blumentals, W., , Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children, Expert Opinion on Pharmacotherapy, 2008",cited-by,10.1517/14656566.9.2.151,"Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children","[['John', 'G', 'Gums'], ['Elise', 'M', 'Pelletier'], ['William', 'A', 'Blumentals']]",Expert Opinion on Pharmacotherapy,2008,[u'http://www.informapharmascience.com/doi/abs/10.1517/14656566.9.2.151']
10.1093/occmed/48.2.85,"Newall, A., Scuffham, P., Kelly, H., et. al, The cost-effectiveness of a universal influenza vaccination program for adults aged 50–64 years in Australia, Vaccine, 2008",cited-by,10.1016/j.vaccine.2008.01.050,The cost-effectiveness of a universal influenza vaccination program for adults aged 50–64 years in Australia,"[['Anthony', 'T.', 'Newall'], ['Paul', 'A.', 'Scuffham'], ['Heath', '', 'Kelly'], ['Stuart', '', 'Harsley'], ['C.', 'Raina', 'MacIntyre']]",Vaccine,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X08001205', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X08001205']"
10.1093/occmed/48.2.85,"D’Heilly, S., Nichol, K., , Work‐Site–Based Influenza Vaccination in Healthcare and Non‐Healthcare Settings, Infection Control and Hospital Epidemiology, 2004",cited-by,10.1086/502324,Work‐Site–Based Influenza Vaccination in Healthcare and Non‐Healthcare Settings,"[['Sarah', 'J.', 'D\xe2\x80\x99Heilly'], ['Kristin', 'L.', 'Nichol']]",Infection Control and Hospital Epidemiology,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/502324']
10.1093/occmed/48.2.85,"Narasimhan, S., Harish, M., , A new spectral estimator based on discrete cosine transform and modified group delay, , 2003",cited-by,10.1109/TENCON.2003.1273436,A new spectral estimator based on discrete cosine transform and modified group delay,"[['S.', 'V.', 'Narasimhan'], ['M.', '', 'Harish']]",,2003,"[u'http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=1273436', u'http://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=01273436']"
10.1093/occmed/48.2.85,"Lovell, V., , Valuing Good Health: An Estimate of Costs and Savings for the Healthy Families Act, , 0",cited-by,10821395Valuing Good Health: An Estimate of Costs and Savings for the Healthy Families Act,Valuing Good Health: An Estimate of Costs and Savings for the Healthy Families Act,"[['Vicky', '', 'Lovell']]",,0,"[u'http://www.iwpr.org/pdf/PrePub_B248.pdf', u'http://paidsickdaysca.org/learn/IWPR_ValuingGoodHealth.pdf', u'http://www.iwpr.org/pdf/B248.pdf']"
10.1093/occmed/48.2.85,"Engler, R., Nelson, M., Klote, M., et. al, Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses, , 0",cited-by,"13620392Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses","Half vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005) Age, Dose, and Sex Effects on Immune Responses","[['Renata', 'J. M.', 'Engler'], ['Michael', 'R.', 'Nelson'], ['Mary', 'M.', 'Klote'], ['Mark', 'J.', 'VanRaden'], ['Chiung-Yu', '', 'Huang'], ['Nancy', 'J.', 'Cox'], ['Alexander', '', 'Klimov'], ['Wendy', 'A.', 'Keitel'], ['Kristin', 'L.', 'Nichol'], ['Warner', 'W.', 'Carr'], ['John', 'J.', 'Treanor']]",,0,[u'http://archinte.highwire.org/cgi/reprint/168/22/2405.pdf']
10.1093/occmed/48.2.85,"Vernet, G., , Use of molecular assays for the diagnosis of influenza, Expert Review of Anti-infective Therapy, 2007",cited-by,10.1586/14787210.5.1.89,Use of molecular assays for the diagnosis of influenza,"[['Guy', '', 'Vernet']]",Expert Review of Anti-infective Therapy,2007,[u'http://www.future-drugs.com/doi/abs/10.1586/14787210.5.1.89']
10.1093/occmed/48.2.85,"Newton, D., Treanor, J., Menegus, M., , Clinical and Laboratory Diagnosis of Influenza Virus Infections, , 0",cited-by,12962526Clinical and Laboratory Diagnosis of Influenza Virus Infections,Clinical and Laboratory Diagnosis of Influenza Virus Infections,"[['Duane', 'W.', 'Newton'], ['John', 'J.', 'Treanor'], ['Marilyn', 'A.', 'Menegus']]",,0,[u'http://www.hcplive.com/_micro/ajmc/_picture/folder_12/AMSub5_2000NewtS265_75.pdf']
10.1093/occmed/48.2.85,"Monto, A., , Preventing Influenza in Healthy Adults: The Evolving Story, , 2010",cited-by,13512707Preventing Influenza in Healthy Adults: The Evolving Story,Preventing Influenza in Healthy Adults: The Evolving Story,"[['Arnold', 'S.', 'Monto']]",,2010,"[u'http://jama.ama-assn.org/cgi/reprint/284/13/1655.pdf', u'http://jama.highwire.org/cgi/reprint/284/13/1655.pdf']"
10.1093/occmed/48.2.85,"Lovell, V., , Valuing Good Health in California: The Costs and Benefits of the Healthy Families, Healthy Workplaces Act of 2008, , 2008",cited-by,"5137586Valuing Good Health in California: The Costs and Benefits of the Healthy Families, Healthy Workplaces Act of 2008","Valuing Good Health in California: The Costs and Benefits of the Healthy Families, Healthy Workplaces Act of 2008","[['Vicky', '', 'Lovell']]",,2008,"[u'http://paidsickdaysca.org/learn/IWPR_CA_report.pdf', u'http://www.iwpr.org/pdf/B259capsd.pdf']"
10.1093/occmed/48.2.85,"Palmer, L., Rousculp, M., Johnston, S., et. al, Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.05.011,Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study,"[['Liisa', 'A.', 'Palmer'], ['Matthew', 'D.', 'Rousculp'], ['Stephen', 'S.', 'Johnston'], ['Parthiv', 'J.', 'Mahadevia'], ['Kristin', 'L.', 'Nichol']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10006766', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10006766']"
10.1093/occmed/48.2.85,"Colombo, G., Ferro, A., Vinci, M., et. al, Cost-benefit analysis of influenza vaccination in a public healthcare unit, Therapeutics and Clinical Risk Management, 2006",cited-by,10.2147/tcrm.2006.2.2.219,Cost-benefit analysis of influenza vaccination in a public healthcare unit,"[['Giorgio', 'L', 'Colombo'], ['Antonio', '', 'Ferro'], ['Marta', '', 'Vinci'], ['Maria', '', 'Zordan'], ['Giulio', '', 'Serra']]",Therapeutics and Clinical Risk Management,2006,[u'http://www.extenza-eps.com/DMP/doi/abs/10.2147/tcrm.2006.2.2.219']
10.1093/occmed/48.2.85,"Fleming, D., , The management of influenza in people of working age, Occupational Medicine-oxford, 2002",cited-by,10.1093/occmed/52.5.259,The management of influenza in people of working age,"[['D.', 'M.', 'Fleming']]",Occupational Medicine-oxford,2002,"[u'http://occmed.oxfordjournals.org/cgi/reprint/52/5/259.pdf', u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.259']"
10.1093/occmed/48.2.85,"Hübner, N., Hübner, C., Wodny, M., et. al, Effectiveness of alcohol-based hand disinfectants in a public administration: Impact on health and work performance related to acute respiratory symptoms and diarrhoea, BMC Infectious Diseases, 2010",cited-by,10.1186/1471-2334-10-250,Effectiveness of alcohol-based hand disinfectants in a public administration: Impact on health and work performance related to acute respiratory symptoms and diarrhoea,"[['Nils-Olaf', '', 'H\xc3\xbcbner'], ['Claudia', '', 'H\xc3\xbcbner'], ['Michael', '', 'Wodny'], ['G\xc3\xbcnter', '', 'Kampf'], ['Axel', '', 'Kramer']]",BMC Infectious Diseases,2010,"[u'http://www.biomedcentral.com/1471-2334/10/250', u'http://www.biomedcentral.com/content/pdf/1471-2334-10-250.pdf', u'http://www.springerlink.com/content/24775762m4h34468', u'http://www.springerlink.com/index/24775762m4h34468.pdf']"
10.1093/occmed/48.2.85,"Lee, B., Bailey, R., Wiringa, A., et. al, Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza, Vaccine, 2010",cited-by,10.1016/j.vaccine.2010.07.003,Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza,"[['Bruce', 'Y.', 'Lee'], ['Rachel', 'R.', 'Bailey'], ['Ann', 'E.', 'Wiringa'], ['Abena', '', 'Afriyie'], ['Angela', 'R.', 'Wateska'], ['Kenneth', 'J.', 'Smith'], ['Richard', 'K.', 'Zimmerman']]",Vaccine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0264410X10009783', u'http://linkinghub.elsevier.com/retrieve/pii/S0264410X10009783']"
10.1093/occmed/48.2.85,"Xue, Y., Kristiansen, I., Blasio, B., , Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave, BMC Public Health, 2010",cited-by,10.1186/1471-2458-10-724,Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave,"[['Yiting', '', 'Xue'], ['Ivar', 'S\xc3\xb8nb\xc3\xb8', 'Kristiansen'], ['Birgitte', 'Freiesleben de', 'Blasio']]",BMC Public Health,2010,"[u'http://www.springerlink.com/index/u5362057p8412881.pdf', u'http://www.springerlink.com/content/u5362057p8412881', u'http://www.biomedcentral.com/content/pdf/1471-2458-10-724.pdf', u'http://www.biomedcentral.com/1471-2458/10/724']"
10.1093/occmed/48.2.85,"Sendi, P., Locher, R., Bucheli, B., et. al, The decision to get vaccinated against influenza, American Journal of Medicine, 2004",cited-by,10.1016/j.amjmed.2004.02.023,The decision to get vaccinated against influenza,"[['Pedram', '', 'Sendi'], ['Rebecca', '', 'Locher'], ['Bruno', '', 'Bucheli'], ['Manuel', '', 'Battegay']]",American Journal of Medicine,2004,"[u'http://www.sciencedirect.com/science/article/pii/S000293430400169X', u'http://linkinghub.elsevier.com/retrieve/pii/S000293430400169X']"
10.1093/occmed/48.2.85,"Liu, Y., Huang, L., Wang, J., , Reduction of Acute Respiratory Illness (ARI) due to a Voluntary Workplace Influenza Vaccination Program: Who are More Likely to Get the Benefit?, Journal of Occupational Health, 2004",cited-by,10.1539/joh.46.455,Reduction of Acute Respiratory Illness (ARI) due to a Voluntary Workplace Influenza Vaccination Program: Who are More Likely to Get the Benefit?,"[['Yi-Hung', '', 'Liu'], ['Li-Min', '', 'Huang'], ['Jung-Der', '', 'Wang']]",Journal of Occupational Health,2004,[u'http://joi.jlc.jst.go.jp/JST.JSTAGE/joh/46.455?from=CrossRef']
10.1093/occmed/48.2.85,"Lovell, V., , Valuing Good Health in San Francisco: The Costs and Benefits of a Proposed Paid Sick Days Policy, , 0",cited-by,5311694Valuing Good Health in San Francisco: The Costs and Benefits of a Proposed Paid Sick Days Policy,Valuing Good Health in San Francisco: The Costs and Benefits of a Proposed Paid Sick Days Policy,"[['Vicky', '', 'Lovell']]",,0,[u'http://www.iwpr.org/pdf/B252.pdf']
10.1093/occmed/48.2.85,"Lovell, V., , Valuing Good Health in Massachusetts: An Estimate of Costs and Savings for the Paid Sick Days Act 1, , 0",cited-by,10818092Valuing Good Health in Massachusetts: An Estimate of Costs and Savings for the Paid Sick Days Act 1,Valuing Good Health in Massachusetts: An Estimate of Costs and Savings for the Paid Sick Days Act 1,"[['Vicky', '', 'Lovell']]",,0,"[u'http://www.iwpr.org/pdf/B249.pdf', u'http://www.gbls.org/employment/PDS_Acostest_3_may_05.pdf']"
10.1093/occmed/48.2.85,"Souza, M., , Influenza, Journal of Exotic Pet Medicine, 2011",cited-by,10.1053/j.jepm.2010.11.003,Influenza,"[['Marcy', 'J.', 'Souza']]",Journal of Exotic Pet Medicine,2011,"[u'http://www.sheffield.ac.uk/content/1/c6/01/28/99/flu1.pdf', u'http://www.sciencedirect.com/science/article/pii/S1557506310002090']"
10.1093/occmed/48.2.85,"Wang, L., Zhang, R., Liu, G., et. al, Chinese herbs in treatment of influenza: A randomized, double-blind, placebo-controlled trial, Respiratory Medicine, 2010",cited-by,10.1016/j.rmed.2010.05.015,"Chinese herbs in treatment of influenza: A randomized, double-blind, placebo-controlled trial","[['Lei', '', 'Wang'], ['Rui-Ming', '', 'Zhang'], ['Gui-Ying', '', 'Liu'], ['Bao-Lin', '', 'Wei'], ['Yang', '', 'Wang'], ['Hong-Yan', '', 'Cai'], ['Feng-Sen', '', 'Li'], ['Yan-Ling', '', 'Xu'], ['Si-Ping', '', 'Zheng'], ['Gang', '', 'Wang']]",Respiratory Medicine,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0954611110002519', u'http://linkinghub.elsevier.com/retrieve/pii/S0954611110002519']"
10.1093/occmed/48.2.85,"JANCIN, B., , Screening Key to Managing Hepatic Risks in Rheumatology, , 2010",cited-by,10.1016/S1541-9800(10)70193-9,Screening Key to Managing Hepatic Risks in Rheumatology,"[['BRUCE', '', 'JANCIN']]",,2010,[u'http://www.sciencedirect.com/science/article/pii/S1541980010701939']
10.1093/occmed/48.2.85,"Li, O., Chan, M., Leung, C., et. al, Full Factorial Analysis of Mammalian and Avian Influenza Polymerase Subunits Suggests a Role of an Efficient Polymerase for Virus Adaptation, PLOS One, 2009",cited-by,10.1371/journal.pone.0005658,Full Factorial Analysis of Mammalian and Avian Influenza Polymerase Subunits Suggests a Role of an Efficient Polymerase for Virus Adaptation,"[['Olive', 'T. W.', 'Li'], ['Michael', 'C. W.', 'Chan'], ['Cynthia', 'S. W.', 'Leung'], ['Renee', 'W. Y.', 'Chan'], ['Yi', '', 'Guan'], ['John', 'M.', 'Nicholls'], ['Leo', 'L. M.', 'Poon'], ['Ding', 'Xiang', 'Liu']]",PLOS One,2009,"[u'http://adsabs.harvard.edu/abs/2009PLoSO...4.5658L', u'http://dx.doi.org/10.1371/journal.pone.0005658']"
10.1093/occmed/48.2.85,"Fernández, J., , Análisis de un modelo económico de una estrategia poblacional de vacunación gripal en trabajadores sanos, Revista Espanola De Salud Publica, 2006",cited-by,10.1590/S1135-57272006000300002,Análisis de un modelo económico de una estrategia poblacional de vacunación gripal en trabajadores sanos,"[['Jesus', 'Mart\xc3\xadn', 'Fern\xc3\xa1ndez']]",Revista Espanola De Salud Publica,2006,"[u'http://redalyc.uaemex.mx/redalyc/pdf/170/17080302.pdf', u'http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272006000300002&lng=es&nrm=iso&tlng=es']"
10.1093/occmed/48.2.85,"Llach, X., Gamisans, M., Tudel, J., et. al, Estudio de costes de la gripe, Atencion Primaria, 2006",cited-by,10.1157/13092984,Estudio de costes de la gripe,"[['Xavier', 'Badia', 'Llach'], ['Montserrat', 'Roset', 'Gamisans'], ['Jos\xc3\xa9', 'M. Franc\xc3\xa9s', 'Tudel'], ['Concha', '\xc3\x81lvarez', 'Sanz'], ['Carlos', 'Rubio', 'Terr\xc3\xa9s']]",Atencion Primaria,2006,"[u'http://www.sciencedirect.com/science/article/pii/S0212656706704954', u'http://linkinghub.elsevier.com/retrieve/pii/S0212656706704954']"
10.1093/occmed/48.2.85,"Schwarzinger, M., Housset, B., Carrat, F., , Rapid flu test and neuraminidase inhibitors in healthy adults: a cost-benefit analysis, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00328-4,Rapid flu test and neuraminidase inhibitors in healthy adults: a cost-benefit analysis,"[['Michael', '', 'Schwarzinger'], ['Bruno', '', 'Housset'], ['Fabrice', '', 'Carrat']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003284', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003284']"
10.1093/occmed/48.2.85,"Mrabkt, N., Lahlou, H., Benjilali, B., , Effet de quelques extraits du ciste ladanifère du Maroc ( Cistus ladaniferus L.) sur la croissance de quatre champignons, Cryptogamie Mycologie, 1999",cited-by,10.1016/S0181-1584(99)80005-0,Effet de quelques extraits du ciste ladanifère du Maroc ( Cistus ladaniferus L.) sur la croissance de quatre champignons,"[['Najat', '', 'Mrabkt'], ['Houria', '', 'Lahlou'], ['Bachir', '', 'Benjilali']]",Cryptogamie Mycologie,1999,[u'http://www.sciencedirect.com/science/article/pii/S0181158499800050']
10.1093/occmed/48.2.85,"Miller, K., Williams, C., , Women's Policy Research Valuing Good Health in New Hampshire: The Costs and Benefits of Paid Sick Days, , 0",cited-by,10127171Women's Policy Research Valuing Good Health in New Hampshire: The Costs and Benefits of Paid Sick Days,Women's Policy Research Valuing Good Health in New Hampshire: The Costs and Benefits of Paid Sick Days,"[['Kevin', '', 'Miller'], ['Claudia', '', 'Williams']]",,0,"[u'http://www.nhwomen.org/pdf/B276NH.pdf', u'http://www.iwpr.org/pdf/B276NH.pdf', u'http://www.iwpr.org/pdf/B281Maine.pdf', u'http://www.iwpr.org/pdf/B268Mass.pdf']"
10.1093/occmed/48.2.85,"Miller, K., Williams, C., , Women's Policy Research Valuing Good Health in North Carolina: The Costs and Benefits of Paid Sick Days, , 0",cited-by,11590495Women's Policy Research Valuing Good Health in North Carolina: The Costs and Benefits of Paid Sick Days,Women's Policy Research Valuing Good Health in North Carolina: The Costs and Benefits of Paid Sick Days,"[['Kevin', '', 'Miller'], ['Claudia', '', 'Williams']]",,0,[u'http://www.iwpr.org/pdf/B273NCCBA.pdf']
10.1093/occmed/48.2.85,"Whyne, D., Pass, P., , PANDEMIC INFLUENZA: A CALL TO ACTION, , 0",cited-by,12385527PANDEMIC INFLUENZA: A CALL TO ACTION,PANDEMIC INFLUENZA: A CALL TO ACTION,"[['Diane', 'M.', 'Whyne'], ['Peggy', 'A.', 'Pass']]",,0,[u'http://www.jhasin.com/files/articlefiles/pdf/ASN_5_2_p43_61.pdf']
10.1093/occmed/48.2.85,"Wenzel, R., , Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor, , 0",cited-by,12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,"[['Richard', 'P.', 'Wenzel']]",,0,[u'http://jama.ama-assn.org/cgi/reprint/283/8/1016.pdf']
10.1093/occmed/48.2.85,"Tutt, A., , A THEORY OF OPTIMAL SICK PAY, , 0",cited-by,13129195A THEORY OF OPTIMAL SICK PAY,A THEORY OF OPTIMAL SICK PAY,"[['Andrew', '', 'Tutt']]",,0,[u'http://dukespace.lib.duke.edu/dspace/bitstream/10161/1428/1/Tutt%2c%20Andrew.pdf']
10.1093/occmed/48.2.85,"HMED, F., INGLETON, J., RANKS, D., , INFLUENZA VACCINATION FOR HEALTHY YOUNG ADULTS, , 0",cited-by,13495419INFLUENZA VACCINATION FOR HEALTHY YOUNG ADULTS,INFLUENZA VACCINATION FOR HEALTHY YOUNG ADULTS,"[['F', 'ARUQUE A', 'HMED'], ['J', 'AMES A. S', 'INGLETON'], ['DELE', 'L. F', 'RANKS']]",,0,[u'http://content.nejm.org/cgi/reprint/345/21/1543.pdf?ck=nck']
10.1093/occmed/48.2.85,"Liu, J., Shi, L., Khan, M., et. al, Trends of out-of-pocket expenditure for influenza in China health and nutrition survey during 1989–2006, International Journal of Public Health, 0",cited-by,10.1007/s00038-011-0251-y,Trends of out-of-pocket expenditure for influenza in China health and nutrition survey during 1989–2006,"[['Jinan', '', 'Liu'], ['Lizheng', '', 'Shi'], ['Mahmud', '', 'Khan'], ['Lingzhong', '', 'Xu'], ['Liya', '', 'Wang']]",International Journal of Public Health,0,"[u'http://www.springerlink.com/index/8q14143356h42208.pdf', u'http://www.springerlink.com/content/8q14143356h42208']"
10.1001~jama.283.8.1016,"Galbraith AW, Oxford JS, Schild GC, Watson GI. Study of 1-adamantanamine hydrochloride used propyhlactically during the Hong Kong influenza epidemic in the family environment. Bull World Health Organ. 1969;41:677-682.",references,NOT found in MAS
10.1001~jama.283.8.1016,"TogoY,HornickRB,FelittiVJ,etal.Evaluationofthe therapeuticefficacyofamantadineinpatientswithnaturallyoccurringA2influenza.JAMA.1970;211:1149-1156.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Galbraith AW, Oxford JS, Schild GC, Potter CW, Watson GI. Therapeutic effect of 1-adamantanamine hydrochloride in naturally occurring influenza A2-Hong Kong infection. Lancet. 1971;1:113-115.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Van Voris LP, Betts RF, Hayden FG, Christmas WA, Douglas RG Jr. Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA. 1981; 245:1128-1131.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Younkin SW, Betts RF, Roth FK, Douglas RG Jr. Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine. Antimicrob Agents Chemother. 1983;23:577-582.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Hayden FG, Monto AS. Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults. Antimicrob Agents Chemother. 1986;29:339-341.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Hayden FG, Sperber SJ, Belshe RB, Clover RD, Hay AJ, Pyke S. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother. 1991;35:1741-1747.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Wiltshire HR, Muir J, Lambkin R, Davies S. Distribution of the influenza neuraminidase inhibitor GS4071 following oral administration of its prodrug GS4104 in ferrets. European Society for Clinical Virology; August 30–September 2, 1998; Hamburg, Germany. Abstract A218.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Monto AS, Arden NH. Implications of viral resistance to amantadine in control of influenza A. Clin Infect Dis. 1992;15:362-367.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Degelau J, Somani SK, Cooper SL, Guay DR, Crossley KB. Amantadine-resistant influenza A in a nursing facility. Arch Intern Med. 1992;152:390-392.",references,NOT found in MAS
10.1001~jama.283.8.1016,"Gubareva LV, Robinson MJ, Bethell RC, Webster RG. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Aeu5Ac2en. J Virol. 1997; 71:3385-3390.",references,13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"[[u'LARISA', u'V.', u'GUBAREVA'], [u'MATTHEW', u'J.', u'ROBINSON'], [u'RICHARD', u'C.', u'BETHELL'], [u'ANDROBERT', u'G.', u'WEBSTER']]",,1997,[u'http://jvi.asm.org/cgi/reprint/71/5/3385.pdf'],./output/10.1001~jama.283.8.1016/13142809
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Kiso, M., Mitamura, K., Sakai-Tagawa, Y., et. al, Resistant influenza A viruses in children treated with oseltamivir: descriptive study, Lancet, 2004",cited-by,10.1016/S0140-6736(04)16934-1,Resistant influenza A viruses in children treated with oseltamivir: descriptive study,"[['Maki', '', 'Kiso'], ['Keiko', '', 'Mitamura'], ['Yuko', '', 'Sakai-Tagawa'], ['Kyoko', '', 'Shiraishi'], ['Chiharu', '', 'Kawakami'], ['Kazuhiro', '', 'Kimura'], ['Frederick', 'G', 'Hayden'], ['Norio', '', 'Sugaya'], ['Yoshihiro', '', 'Kawaoka']]",Lancet,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0140673604169341', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-19.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673604169341']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, Lancet, 2000",cited-by,10.1016/S0140-6736(99)11433-8,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699114338', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699114338']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Shay, D., Broder, K., Iskander, J., et. al, Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, , 2007",cited-by,"13129215Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","[['David', 'K.', 'Shay'], ['Karen', '', 'Broder'], ['John', 'K.', 'Iskander'], ['Timothy', 'M.', 'Uyeki'], ['Joseph', 'S.', 'Bresee'], ['Nancy', 'J.', 'Cox'], ['James', '', 'LeDuc'], ['Stephen', '', 'Cochi'], ['Gina', '', 'Mootrey']]",,2007,"[u'http://ftp.cdc.gov/pub/publications/mmwr/rr/rr5707.pdf', u'http://bret.mc.vanderbilt.edu/microbiology/html/Harper_2005.pdf']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"McKimm-Breschkin, J., , Resistance of influenza viruses to neuraminidase inhibitors — a review, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00103-0,Resistance of influenza viruses to neuraminidase inhibitors — a review,"[['Jennifer', 'L.', 'McKimm-Breschkin']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001030', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-14.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001030']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Gubareva, L., Kaiser, L., Hayden, F., , Influenza virus neuraminidase inhibitors, , 0",cited-by,12760434Influenza virus neuraminidase inhibitors,Influenza virus neuraminidase inhibitors,"[['Larisa', 'V', 'Gubareva'], ['Laurent', '', 'Kaiser'], ['Frederick', 'G', 'Hayden']]",,0,[u'http://www.birdflumanual.com/resources/Medical_References/files/antineuraminidase%20therapy%20lancet.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"McKimm-Breschkin, J., Trivedi, T., Hampson, A., et. al, Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir, Antimicrobial Agents and Chemotherapy, 2003",cited-by,10.1128/AAC.47.7.2264-2272.2003,Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir,"[['J.', '', 'McKimm-Breschkin'], ['T.', '', 'Trivedi'], ['A.', '', 'Hampson'], ['A.', '', 'Hay'], ['A.', '', 'Klimov'], ['M.', '', 'Tashiro'], ['F.', '', 'Hayden'], ['M.', '', 'Zambon']]",Antimicrobial Agents and Chemotherapy,2003,"[u'http://aac.highwire.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.47.7.2264-2272.2003']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Yen, H., Herlocher, L., Hoffmann, E., et. al, Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.10.4075-4084.2005,Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility,"[['Hui-Ling', '', 'Yen'], ['Louise', 'M.', 'Herlocher'], ['Erich', '', 'Hoffmann'], ['Mikhail', 'N.', 'Matrosovich'], ['Arnold', 'S.', 'Monto'], ['Robert', 'G.', 'Webster'], ['Elena', 'A.', 'Govorkova']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/10/4075.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.10.4075-4084.2005']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Gubareva, L., , Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.02.034,Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors,"[['Larisa', 'V.', 'Gubareva']]",Virus Research,2004,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-19.pdf', u'http://www.sciencedirect.com/science/article/pii/S0168170204001339', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-20.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001339']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"TAI, C., ESCARPE, P., SIDWELL, R., et. al, Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071, , 0",cited-by,11599893Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071,"[['CHUN', 'Y.', 'TAI'], ['PAUL', 'A.', 'ESCARPE'], ['ROBERT', 'W.', 'SIDWELL'], ['MATTHEW', 'A.', 'WILLIAMS'], ['WILLARD', '', 'LEW'], ['HUIWEI', '', 'WU'], ['CHOUNG', 'U.', 'KIM'], ['DIRK', 'B.', 'MENDEL']]",,0,[u'http://aac.asm.org/cgi/reprint/42/12/3234.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"GUBAREVA, L., WEBSTER, R., HAYDEN, F., , Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants, Antimicrobial Agents and Chemotherapy, 2001",cited-by,10.1128/AAC.45.12.3403-3408.2001,"Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants","[['LARISA', 'V.', 'GUBAREVA'], ['ROBERT', 'G.', 'WEBSTER'], ['FREDERICK', 'G.', 'HAYDEN']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/12/3403.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.12.3403-3408.2001']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Barnett, J., Lewis, A., Cadman, A., et. al, Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies, Antimicrobial Agents and Chemotherapy, 2000",cited-by,10.1128/AAC.44.1.78-87.2000,Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies,"[['J.', 'M.', 'Barnett'], ['A.', 'P.', 'Lewis'], ['A.', '', 'Cadman'], ['D.', '', 'Gor'], ['M.', '', 'Dempsey'], ['M.', '', 'Walters'], ['A.', '', 'Candlin'], ['M.', '', 'Tisdale'], ['Groot', 'de', 'R'], ['P.', 'J.', 'Morley'], ['I.', 'J.', 'Owens'], ['G.', 'F.', 'Rimmelzwaan'], ['R.', 'J.', 'Fenton'], ['E.', 'C. J.', 'Claas'], ['A.', 'D. M. E.', 'Osterhaus']]",Antimicrobial Agents and Chemotherapy,2000,"[u'http://aac.asm.org/cgi/reprint/44/1/78.pdf', u'http://publishing.eur.nl/ir/repub/asset/9217/10602727.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.44.1.78-87.2000']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Varghese, J., Smith, P., Sollis, S., et. al, Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase, Structure, 1998",cited-by,10.1016/S0969-2126(98)00075-6,Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase,"[['Joseph', 'N', 'Varghese'], ['Paul', 'W', 'Smith'], ['Steven', 'L', 'Sollis'], ['Tony', 'J', 'Blick'], ['Anjali', '', 'Sahasrabudhe'], ['Jennifer', 'L', 'McKimm-Breschkin'], ['Peter', 'M', 'Colman']]",Structure,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0969212698000756', u'http://linkinghub.elsevier.com/retrieve/pii/S0969212698000756']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Gubareva, L., Webster, R., Hayden, F., , Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00192-9,Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay,"[['Larisa', 'V.', 'Gubareva'], ['Robert', 'G.', 'Webster'], ['Frederick', 'G.', 'Hayden']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001929', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001929']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Herlocher, M., Carr, J., Ives, J., et. al, Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets, Antiviral Research, 2002",cited-by,10.1016/S0166-3542(01)00214-5,Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets,"[['M.', 'L', 'Herlocher'], ['J', '', 'Carr'], ['J', '', 'Ives'], ['S', '', 'Elias'], ['R', '', 'Truscon'], ['N', '', 'Roberts'], ['A.', 'S', 'Monto']]",Antiviral Research,2002,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201002145', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201002145']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Mishin, V., Hayden, F., Gubareva, L., , Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors, Antimicrobial Agents and Chemotherapy, 2005",cited-by,10.1128/AAC.49.11.4515-4520.2005,Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors,"[['Vasiliy', 'P.', 'Mishin'], ['Frederick', 'G.', 'Hayden'], ['Larisa', 'V.', 'Gubareva']]",Antimicrobial Agents and Chemotherapy,2005,"[u'http://aac.asm.org/cgi/reprint/49/11/4515.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.49.11.4515-4520.2005']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Wang, M., Tai, C., Mendel, D., , Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir, Antimicrobial Agents and Chemotherapy, 2002",cited-by,10.1128/AAC.46.12.3809-3816.2002,Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir,"[['Michael', 'Z.', 'Wang'], ['Chun', 'Y.', 'Tai'], ['Dirk', 'B.', 'Mendel']]",Antimicrobial Agents and Chemotherapy,2002,"[u'http://aac.asm.org/cgi/reprint/46/12/3809.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.46.12.3809-3816.2002']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"MCKIMM-BRESCHKIN, J., SAHASRABUDHE, A., BLICK, T., et. al, Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors, , 1998",cited-by,13896013Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors,Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors,"[['JENNIFER', 'L.', 'MCKIMM-BRESCHKIN'], ['ANJALI', '', 'SAHASRABUDHE'], ['TONY', 'J.', 'BLICK'], ['MANDY', '', 'MCDONALD'], ['PETER', 'M.', 'COLMAN'], ['GRAHAM', 'J.', 'HART'], ['RICHARD', 'C.', 'BETHELL'], ['JOSEPH', 'N.', 'VARGHESE']]",,1998,[u'http://jvi.asm.org/cgi/reprint/72/3/2456.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Hurt, A., Barr, I., Hartel, G., et. al, Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir, Antiviral Research, 2004",cited-by,10.1016/j.antiviral.2003.11.008,Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir,"[['Aeron', 'C.', 'Hurt'], ['Ian', 'G.', 'Barr'], ['Gunter', '', 'Hartel'], ['Alan', 'W.', 'Hampson']]",Antiviral Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0166354203002961', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354203002961']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Blick, T., Sahasrabudhe, A., McDonald, M., et. al, The Interaction of Neuraminidase and Hemagglutinin Mutations in Influenza Virus in Resistance to 4-Guanidino-Neu5Ac2en, Virology, 1998",cited-by,10.1006/viro.1998.9194,The Interaction of Neuraminidase and Hemagglutinin Mutations in Influenza Virus in Resistance to 4-Guanidino-Neu5Ac2en,"[['Tony', 'J.', 'Blick'], ['Anjali', '', 'Sahasrabudhe'], ['Mandy', '', 'McDonald'], ['Ian', 'J.', 'Owens'], ['Peter', 'J.', 'Morley'], ['Robert', 'J.', 'Fenton'], ['Jennifer', 'L.', 'McKimm-Breschkin']]",Virology,1998,"[u'http://www.sciencedirect.com/science/article/pii/S0042682298991942', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682298991942']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Sidwell, R., Smee, D., , In vitro and in vivo assay systems for study of influenza virus inhibitors, Antiviral Research, 2000",cited-by,10.1016/S0166-3542(00)00125-X,In vitro and in vivo assay systems for study of influenza virus inhibitors,"[['Robert', 'W.', 'Sidwell'], ['Donald', 'F.', 'Smee']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S016635420000125X', u'http://linkinghub.elsevier.com/retrieve/pii/S016635420000125X']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Ferraris, O., Lina, B., , Mutations of neuraminidase implicated in neuraminidase inhibitors resistance, Journal of Clinical Virology, 2008",cited-by,10.1016/j.jcv.2007.10.020,Mutations of neuraminidase implicated in neuraminidase inhibitors resistance,"[['Olivier', '', 'Ferraris'], ['Bruno', '', 'Lina']]",Journal of Clinical Virology,2008,"[u'http://www.sciencedirect.com/science/article/pii/S1386653207003903', u'http://linkinghub.elsevier.com/retrieve/pii/S1386653207003903']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Brown, E., , Influenza virus genetics, Biomedicine & Pharmacotherapy, 2000",cited-by,10.1016/S0753-3322(00)89026-5,Influenza virus genetics,"[['E.', 'G.', 'Brown']]",Biomedicine & Pharmacotherapy,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0753332200890265', u'http://linkinghub.elsevier.com/retrieve/pii/S0753332200890265']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Ferraris, O., Kessler, N., Lina, B., , Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice, Antiviral Research, 2005",cited-by,10.1016/j.antiviral.2005.07.004,Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice,"[['O.', '', 'Ferraris'], ['N.', '', 'Kessler'], ['B.', '', 'Lina']]",Antiviral Research,2005,"[u'http://www.sciencedirect.com/science/article/pii/S0166354205001427', u'http://birdflubook.com/resources/0Ferrarisxxx.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354205001427']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"OH, S., MCCAFFERY, J., EICHELBERGER, M., , Dose-Dependent Changes in Influenza Virus-Infected Dendritic Cells Result in Increased Allogeneic T-Cell Proliferation at Low, but Not High, Doses of Virus, Journal of Virology, 2000",cited-by,10.1128/JVI.74.12.5460-5469.2000,"Dose-Dependent Changes in Influenza Virus-Infected Dendritic Cells Result in Increased Allogeneic T-Cell Proliferation at Low, but Not High, Doses of Virus","[['SANGKON', '', 'OH'], ['J.', 'MICHAEL', 'MCCAFFERY'], ['MARYNA', 'C.', 'EICHELBERGER']]",Journal of Virology,2000,"[u'http://jvi.asm.org/cgi/reprint/74/12/5460.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.74.12.5460-5469.2000']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Barnett, J., Cadman, A., Burrell, F., et. al, In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir, Virology, 1999",cited-by,10.1006/viro.1999.0058,In Vitro Selection and Characterisation of Influenza B/Beijing/1/87 Isolates with Altered Susceptibility to Zanamivir,"[['J.', 'M.', 'Barnett'], ['A.', '', 'Cadman'], ['F.', 'M.', 'Burrell'], ['S.', 'H.', 'Madar'], ['A.', 'P.', 'Lewis'], ['M.', '', 'Tisdale'], ['R.', '', 'Bethell']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299900582', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299900582']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Deyde, V., Okomo-Adhiambo, M., Sheu, T., et. al, Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.08.008,Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses,"[['Varough', 'M.', 'Deyde'], ['Margaret', '', 'Okomo-Adhiambo'], ['Tiffany', 'G.', 'Sheu'], ['Teresa', 'R.', 'Wallis'], ['Alicia', '', 'Fry'], ['Nila', '', 'Dharan'], ['Alexander', 'I.', 'Klimov'], ['Larisa', 'V.', 'Gubareva']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354208003902', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354208003902']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Molla, A., Kati, W., Carrick, R., et. al, In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675, Journal of Virology, 2002",cited-by,10.1128/JVI.76.11.5380-5386.2002,"In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675","[['Akhteruzzaman', '', 'Molla'], ['Warren', '', 'Kati'], ['Robert', '', 'Carrick'], ['Kevin', '', 'Steffy'], ['Yan', '', 'Shi'], ['Debra', '', 'Montgomery'], ['Nanette', '', 'Gusick'], ['Vincent', 'S.', 'Stoll'], ['Kent', 'D.', 'Stewart'], ['Teresa', 'I.', 'Ng'], ['Clarence', '', 'Maring'], ['Dale', 'J.', 'Kempf'], ['William', '', 'Kohlbrenner']]",Journal of Virology,2002,"[u'http://jvi.asm.org/cgi/reprint/76/11/5380.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.76.11.5380-5386.2002']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Zurcher, T., Yates, P., Daly, J., et. al, Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro, , 2006",cited-by,6952646Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro,Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro,"[['Thomas', '', 'Zurcher'], ['Phillip', 'J.', 'Yates'], ['Janet', '', 'Daly'], ['Anjali', '', 'Sahasrabudhe'], ['Matthew', '', 'Walters'], ['Laura', '', 'Dash'], ['Margaret', '', 'Tisdale']]",,2006,"[u'http://jac.oxfordjournals.org/cgi/reprint/58/4/723.pdf', u'http://jac.oxfordjournals.org/cgi/reprint/dkl321v1.pdf']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Laver, W., Bischofberger, N., Webster, R., , The Origin and Control of Pandemic Influenza, , 2000",cited-by,10259737The Origin and Control of Pandemic Influenza,The Origin and Control of Pandemic Influenza,"[['W.', 'Graeme', 'Laver'], ['Norbert', '', 'Bischofberger'], ['Robert', 'G.', 'Webster']]",,2000,"[u'http://birdflubook.com/resources/LAVER173.pdf', u'http://muse.jhu.edu/about/publishers.html/journals/perspectives_in_biology_and_medicine/v043/43.2laver.html']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Bouvier, N., Lowen, A., Palese, P., , Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol, Journal of Virology, 2008",cited-by,10.1128/JVI.01226-08,Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol,"[['Nicole', 'M.', 'Bouvier'], ['Anice', 'C.', 'Lowen'], ['Peter', '', 'Palese']]",Journal of Virology,2008,"[u'http://jvi.asm.org/cgi/reprint/82/20/10052.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.01226-08']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Mendel, D., Sidwell, R., , Influenza virus resistance to neuraminidase inhibitors, Drug Resistance Updates, 1998",cited-by,10.1016/S1368-7646(98)80038-1,Influenza virus resistance to neuraminidase inhibitors,"[['Dirk', 'B.', 'Mendel'], ['Robert', 'W.', 'Sidwell']]",Drug Resistance Updates,1998,"[u'http://www.sciencedirect.com/science/article/pii/S1368764698800381', u'http://linkinghub.elsevier.com/retrieve/pii/S1368764698800381']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Barnard, D., , Animal models for the study of influenza pathogenesis and therapy, Antiviral Research, 2009",cited-by,10.1016/j.antiviral.2008.12.014,Animal models for the study of influenza pathogenesis and therapy,"[['Dale', 'L.', 'Barnard']]",Antiviral Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0166354209000187', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354209000187']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Ison, M., Hayden, F., , Therapeutic options for the management of influenza, Current Opinion in Pharmacology, 2001",cited-by,10.1016/S1471-4892(01)00084-4,Therapeutic options for the management of influenza,"[['Michael', 'G', 'Ison'], ['Frederick', 'G', 'Hayden']]",Current Opinion in Pharmacology,2001,"[u'http://www.sciencedirect.com/science/article/pii/S1471489201000844', u'http://linkinghub.elsevier.com/retrieve/pii/S1471489201000844']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Baz, M., Abed, Y., Boivin, G., , Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir, Antiviral Research, 2007",cited-by,10.1016/j.antiviral.2006.10.012,Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir,"[['Mariana', '', 'Baz'], ['Yacine', '', 'Abed'], ['Guy', '', 'Boivin']]",Antiviral Research,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0166354206003196', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354206003196']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Okamatsu, M., Saito, T., Yamamoto, Y., et. al, Low pathogenicity H5N2 avian influenza outbreak in Japan during the 2005–2006, Veterinary Microbiology, 2007",cited-by,10.1016/j.vetmic.2007.04.025,Low pathogenicity H5N2 avian influenza outbreak in Japan during the 2005–2006,"[['Masatoshi', '', 'Okamatsu'], ['Takehiko', '', 'Saito'], ['Yu', '', 'Yamamoto'], ['Masaji', '', 'Mase'], ['Satoko', '', 'Tsuduku'], ['Kikuyasu', '', 'Nakamura'], ['Kenji', '', 'Tsukamoto'], ['Shigeo', '', 'Yamaguchi']]",Veterinary Microbiology,2007,"[u'http://www.sciencedirect.com/science/article/pii/S0378113507001824', u'http://linkinghub.elsevier.com/retrieve/pii/S0378113507001824']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Englund, J., , Antiviral therapy of influenza, Seminars in Pediatric Infectious Diseases, 2002",cited-by,10.1053/spid.2002.122999,Antiviral therapy of influenza,"[['Janet', 'A.', 'Englund']]",Seminars in Pediatric Infectious Diseases,2002,"[u'http://www.sciencedirect.com/science/article/pii/S1045187002500571', u'http://linkinghub.elsevier.com/retrieve/pii/S1045187002500571']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Lee, J., Pascua, P., Song, M., et. al, Isolation and Genetic Characterization of H5N2 Influenza Viruses from Pigs in Korea, Journal of Virology, 2009",cited-by,10.1128/JVI.02403-09,Isolation and Genetic Characterization of H5N2 Influenza Viruses from Pigs in Korea,"[['Jun', 'Han', 'Lee'], ['P.', 'N. Q.', 'Pascua'], ['M.-S.', '', 'Song'], ['Y.', 'H.', 'Baek'], ['C.-J.', '', 'Kim'], ['H.-W.', '', 'Choi'], ['M.-H.', '', 'Sung'], ['R.', 'J.', 'Webby'], ['R.', 'G.', 'Webster'], ['H.', '', 'Poo'], ['Y.', 'K.', 'Choi']]",Journal of Virology,2009,"[u'http://jvi.asm.org/cgi/reprint/83/9/4205.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02403-08', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.02403-09']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Carr, M., Sayre, N., Duffy, M., et. al, Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses, Journal of Virological Methods, 2008",cited-by,10.1016/j.jviromet.2008.07.011,Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses,"[['Michael', 'J.', 'Carr'], ['Naomi', '', 'Sayre'], ['Margaret', '', 'Duffy'], ['Jeff', '', 'Connell'], ['William', 'W.', 'Hall']]",Journal of Virological Methods,2008,"[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-4.pdf', u'http://www.sciencedirect.com/science/article/pii/S016609340800253X', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-3.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S016609340800253X']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Jackson, D., Barclay, W., Zurcher, T., , Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations, , 2005",cited-by,6548090Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations,"[['David', '', 'Jackson'], ['Wendy', '', 'Barclay'], ['Thomas', '', 'Zurcher']]",,2005,[u'http://jac.oxfordjournals.org/cgi/reprint/55/2/162.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Hatakeyama, S., Sakai-Tagawa, Y., Kiso, M., et. al, Enhanced Expression of an 2,6Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase Inhibitor, , 2005",cited-by,"6784417Enhanced Expression of an 2,6Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase Inhibitor","Enhanced Expression of an 2,6Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase Inhibitor","[['Shuji', '', 'Hatakeyama'], ['Yuko', '', 'Sakai-Tagawa'], ['Maki', '', 'Kiso'], ['Hideo', '', 'Goto'], ['Chiharu', '', 'Kawakami'], ['Keiko', '', 'Mitamura'], ['Norio', '', 'Sugaya'], ['Yasuo', '', 'Suzuki'], ['Yoshihiro', '', 'Kawaoka']]",,2005,[u'http://jcm.asm.org/cgi/reprint/43/8/4139.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Mungall, B., Xu, X., Klimov, A., , Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000–2002 influenza seasons, Virus Research, 2004",cited-by,10.1016/j.virusres.2004.02.033,Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000–2002 influenza seasons,"[['Bruce', 'A', 'Mungall'], ['Xiyan', '', 'Xu'], ['Alexander', '', 'Klimov']]",Virus Research,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0168170204001327', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170204001327']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Okomo-Adhiambo, M., Nguyen, H., Sleeman, K., et. al, Host cell selection of influenza neuraminidase variants: Implications for drug resistance monitoring in A(H1N1) viruses, Antiviral Research, 2010",cited-by,10.1016/j.antiviral.2009.11.005,Host cell selection of influenza neuraminidase variants: Implications for drug resistance monitoring in A(H1N1) viruses,"[['Margaret', '', 'Okomo-Adhiambo'], ['Ha', 'T.', 'Nguyen'], ['Katrina', '', 'Sleeman'], ['Tiffany', 'G.', 'Sheu'], ['Varough', 'M.', 'Deyde'], ['Rebecca', 'J.', 'Garten'], ['Xiyan', '', 'Xu'], ['Michael', 'W.', 'Shaw'], ['Alexander', 'I.', 'Klimov'], ['Larisa', 'V.', 'Gubareva']]",Antiviral Research,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0166354209005348', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354209005348', u'http://download.thelancet.com/flatcontentassets/H1N1-flu/virology/virology-58.pdf']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Nayak, D., Reichl, U., , Neuraminidase activity assays for monitoring MDCK cell culture derived influenza virus, Journal of Virological Methods, 2004",cited-by,10.1016/j.jviromet.2004.07.005,Neuraminidase activity assays for monitoring MDCK cell culture derived influenza virus,"[['Deba', 'Prasad', 'Nayak'], ['Udo', '', 'Reichl']]",Journal of Virological Methods,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0166093404002010', u'http://linkinghub.elsevier.com/retrieve/pii/S0166093404002010']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Oh, S., Eichelberger, M., , Influenza Virus Neuraminidase Alters Allogeneic T Cell Proliferation, Virology, 1999",cited-by,10.1006/viro.1999.0019,Influenza Virus Neuraminidase Alters Allogeneic T Cell Proliferation,"[['SangKon', '', 'Oh'], ['Maryna', 'C.', 'Eichelberger']]",Virology,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0042682299900193', u'http://linkinghub.elsevier.com/retrieve/pii/S0042682299900193']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Nakazawa, M., Kadowaki, S., Watanabe, I., et. al, PA subunit of RNA polymerase as a promising target for anti-influenza virus agents, Antiviral Research, 2008",cited-by,10.1016/j.antiviral.2007.12.010,PA subunit of RNA polymerase as a promising target for anti-influenza virus agents,"[['Misako', '', 'Nakazawa'], ['Shin-etsu', '', 'Kadowaki'], ['Izumi', '', 'Watanabe'], ['Youko', '', 'Kadowaki'], ['Masaya', '', 'Takei'], ['Hideyuki', '', 'Fukuda']]",Antiviral Research,2008,"[u'http://www.sciencedirect.com/science/article/pii/S0166354207005062', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354207005062']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Itzstein, M., Thomson, R., , Anti-Influenza Drugs: The Development of Sialidase Inhibitors, , 0",cited-by,10.1007/978-3-540-79086-0_5,Anti-Influenza Drugs: The Development of Sialidase Inhibitors,"[['Mark', 'von', 'Itzstein'], ['Robin', '', 'Thomson']]",,0,"[u'http://www.springerlink.com/index/q7q766196t171341.pdf', u'http://www.springerlink.com/content/q7q766196t171341']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Arias, C., Escalera-Zamudio, M., Río, M., et. al, Molecular Anatomy of 2009 Influenza Virus A (H1N1), Archives of Medical Research, 2009",cited-by,10.1016/j.arcmed.2009.10.007,Molecular Anatomy of 2009 Influenza Virus A (H1N1),"[['Carlos', 'F.', 'Arias'], ['Marina', '', 'Escalera-Zamudio'], ['Mar\xc3\xada', 'de los Dolores Soto-Del', 'R\xc3\xado'], ['Ana', 'Georgina', 'Cobi\xc3\xa1n-G\xc3\xbcemes'], ['Pavel', '', 'Isa'], ['Susana', '', 'L\xc3\xb3pez']]",Archives of Medical Research,2009,"[u'http://www.sciencedirect.com/science/article/pii/S0188440909001969', u'http://linkinghub.elsevier.com/retrieve/pii/S0188440909001969']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Baek, Y., Pascua, P., Song, M., et. al, Surveillance and characterization of low pathogenic H5 avian influenza viruses isolated from wild migratory birds in Korea, Virus Research, 2010",cited-by,10.1016/j.virusres.2010.03.002,Surveillance and characterization of low pathogenic H5 avian influenza viruses isolated from wild migratory birds in Korea,"[['Yun', 'Hee', 'Baek'], ['Philippe', 'Noriel Q.', 'Pascua'], ['Min-Suk', '', 'Song'], ['Kuk', 'Jin', 'Park'], ['Hyeok-il', '', 'Kwon'], ['Jun', 'Han', 'Lee'], ['Seok-Yong', '', 'Kim'], ['Ho-Jin', '', 'Moon'], ['Chul-Joong', '', 'Kim'], ['Young', 'Ki', 'Choi']]",Virus Research,2010,"[u'http://www.sciencedirect.com/science/article/pii/S0168170210001024', u'http://linkinghub.elsevier.com/retrieve/pii/S0168170210001024']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Hurt, A., Barr, I., Durrant, C., et. al, Surveillance for neuraminidase inhibitor resistance in human infl uenza viruses from Australia, , 0",cited-by,10724121Surveillance for neuraminidase inhibitor resistance in human infl uenza viruses from Australia,Surveillance for neuraminidase inhibitor resistance in human infl uenza viruses from Australia,"[['Aeron', 'C', 'Hurt'], ['Ian', 'G', 'Barr'], ['Christopher', 'J', 'Durrant'], ['Robert', 'P', 'Shaw'], ['Helen', 'M', 'Sjogren'], ['Alan', 'W', 'Hampson']]",,0,"[u'http://www.healthemergency.gov.au/internet/main/publishing.nsf/content/cda-2003-cdi2704-pdf-cnt.htm/$file/cdi2704x.pdf', u'http://www.sport.gov.au/internet/main/publishing.nsf/Content/cda-2003-cdi2704-pdf-cnt.htm/$file/cdi2704x.pdf', u'http://www.carers.health.gov.au/internet/main/publishing.nsf/Content/cda-2003-cdi2704-pdf-cnt.htm/$file/cdi2704x.pdf', u'http://www.foodsecretariat.health.gov.au/internet/main/publishing.nsf/Content/cda-2003-cdi2704-pdf-cnt.htm/$FILE/cdi2704x.pdf']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Cohen-Daniel, L., Zakay-Rones, Z., Resnick, I., et. al, Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient, Journal of Clinical Virology, 2009",cited-by,10.1016/j.jcv.2008.11.014,Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient,"[['Leonor', '', 'Cohen-Daniel'], ['Zichria', '', 'Zakay-Rones'], ['Igor', 'B.', 'Resnick'], ['Michael', 'Y.', 'Shapira'], ['Marina', '', 'Dorozhko'], ['Nurith', '', 'Mador'], ['Evgenia', '', 'Greenbaum'], ['Dana', 'G.', 'Wolf']]",Journal of Clinical Virology,2009,"[u'http://www.sciencedirect.com/science/article/pii/S138665320800406X', u'http://linkinghub.elsevier.com/retrieve/pii/S138665320800406X']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Sitohy, M., Besse, B., Billaudel, S., et. al, Antiviral Action of Methylated β-Lactoglobulin on the Human Influenza Virus A Subtype H3N2, Probiotics and Antimicrobial Proteins, 2010",cited-by,10.1007/s12602-010-9036-5,Antiviral Action of Methylated β-Lactoglobulin on the Human Influenza Virus A Subtype H3N2,"[['Mahmoud', '', 'Sitohy'], ['Bernard', '', 'Besse'], ['Sylviane', '', 'Billaudel'], ['Thomas', '', 'Haertl\xc3\xa9'], ['Jean-Marc', '', 'Chobert']]",Probiotics and Antimicrobial Proteins,2010,"[u'http://www.springerlink.com/content/n403772h07224148', u'http://www.springerlink.com/index/n403772h07224148.pdf', u'http://www.springerlink.com/index/10.1007/s12602-010-9036-5', u'http://www.springerlink.com/index/pdf/10.1007/s12602-010-9036-5']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Nedyalkova, M., Hayden, F., Webster, R., et. al, Accumulation of segment 6 sgRNAs of influenza A viruses in the presence of neuraminidase inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00398-3,Accumulation of segment 6 sgRNAs of influenza A viruses in the presence of neuraminidase inhibitors,"[['Marina', 'S', 'Nedyalkova'], ['Frederick', 'G', 'Hayden'], ['Robert', 'G', 'Webster'], ['Larisa', 'V', 'Gubareva']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003983', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003983']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"McKimm-Breschkin, J., Sahasrabudhe, A., Blick, T., et. al, Mechanisms of resistance of influenza virus to neuraminidase inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00364-8,Mechanisms of resistance of influenza virus to neuraminidase inhibitors,"[['Jennifer', '', 'McKimm-Breschkin'], ['Anjali', '', 'Sahasrabudhe'], ['Tony', '', 'Blick'], ['Mandy', '', 'McDonald']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101003648', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101003648']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Herlocher, M., Fenton, R., Merry, A., et. al, Influenza resistance to zanamivir generated in ferrets, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00365-X,Influenza resistance to zanamivir generated in ferrets,"[['M.', 'Louise', 'Herlocher'], ['Rob', '', 'Fenton'], ['Andrew', '', 'Merry'], ['Stephanie', '', 'Elias'], ['Arnold', 'S.', 'Monto']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S053151310100365X', u'http://linkinghub.elsevier.com/retrieve/pii/S053151310100365X']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Tisdale, M., Daly, J., Gor, D., , Methods for determining resistance to neuraminidase inhibitors, International Congress Series, 2001",cited-by,10.1016/S0531-5131(01)00656-2,Methods for determining resistance to neuraminidase inhibitors,"[['Margaret', '', 'Tisdale'], ['Janet', '', 'Daly'], ['Dee', '', 'Gor']]",International Congress Series,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0531513101006562', u'http://linkinghub.elsevier.com/retrieve/pii/S0531513101006562']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Colacino, J., Staschke, K., Laver, W., , Approaches and strategies for the treatment of influenza virus infections, , 0",cited-by,11571009Approaches and strategies for the treatment of influenza virus infections,Approaches and strategies for the treatment of influenza virus infections,"[['Joseph', 'M', 'Colacino'], ['Kirk', 'A', 'Staschke'], ['W', 'Graeme', 'Laver']]",,0,[u'http://arbidol.org/Approaches-and-strategies-for-the-treatment-of-influenza.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Orozovic, G., Orozovic, K., Lennerstrand, J., et. al, Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds, PLOS One, 2011",cited-by,10.1371/journal.pone.0016028,Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds,"[['Goran', '', 'Orozovic'], ['Kanita', '', 'Orozovic'], ['Johan', '', 'Lennerstrand'], ['Bj\xc3\xb6rn', '', 'Olsen'], ['Ralph', '', 'Tripp']]",PLOS One,2011,"[u'http://adsabs.harvard.edu/abs/2011PLoSO...616028O', u'http://dx.doi.org/10.1371/journal.pone.0016028']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Weight, A., Haldar, J., Cienfuegos, L., et. al, Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus, Journal of Pharmaceutical Sciences, 2010",cited-by,10.1002/jps.22338,Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus,"[['Alisha', 'K.', 'Weight'], ['Jayanta', '', 'Haldar'], ['Luis', '\xc3\x81lvarez de', 'Cienfuegos'], ['Larisa', 'V.', 'Gubareva'], ['Terrence', 'M.', 'Tumpey'], ['Jianzhu', '', 'Chen'], ['Alexander', 'M.', 'Klibanov']]",Journal of Pharmaceutical Sciences,2010,[u'http://doi.wiley.com/10.1002/jps.22338']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Ilyushina, N., Seiler, J., Rehg, J., et. al, Effect of Neuraminidase Inhibitor–Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in Ferrets, PLOS Pathogens, 2010",cited-by,10.1371/journal.ppat.1000933,Effect of Neuraminidase Inhibitor–Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in Ferrets,"[['Natalia', 'A.', 'Ilyushina'], ['Jon', 'P.', 'Seiler'], ['Jerold', 'E.', 'Rehg'], ['Robert', 'G.', 'Webster'], ['Elena', 'A.', 'Govorkova']]",PLOS Pathogens,2010,[u'http://dx.doi.org/10.1371/journal.ppat.1000933']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Hurt, A., Holien, J., Parker, M., et. al, Running Title: Zanamivir-Resistant Influenza Viruses, , 2009",cited-by,13402849Running Title: Zanamivir-Resistant Influenza Viruses,Running Title: Zanamivir-Resistant Influenza Viruses,"[['Aeron', 'C.', 'Hurt'], ['Jessica', 'K', 'Holien'], ['Michael', '', 'Parker'], ['Anne', '', 'Kelso'], ['Ian', 'G.', 'Barr']]",,2009,[u'http://jvi.asm.org/cgi/reprint/JVI.01200-09v1.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Nagachinta, T., Sawanpanyalert, N., Chanprasert, P., , A Review of Influenza, , 2009",cited-by,13575225A Review of Influenza,A Review of Influenza,"[['Tippavan', '', 'Nagachinta'], ['Narumol', '', 'Sawanpanyalert'], ['Puangpen', '', 'Chanprasert']]",,2009,[u'http://www.idthai.org/Publication/pdf/Vol26-3/p.115-132.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Sui, H., Zhao, G., Huang, J., et. al, Small Interfering RNA Targeting M2 Gene Induces Effective and Long Term Inhibition of Influenza A Virus Replication, PLOS One, 2009",cited-by,10.1371/journal.pone.0005671,Small Interfering RNA Targeting M2 Gene Induces Effective and Long Term Inhibition of Influenza A Virus Replication,"[['Hong-Yan', '', 'Sui'], ['Guang-Yu', '', 'Zhao'], ['Jian-Dong', '', 'Huang'], ['Dong-Yan', '', 'Jin'], ['Kwok-Yung', '', 'Yuen'], ['Bo-Jian', '', 'Zheng'], ['Ding', 'Xiang', 'Liu']]",PLOS One,2009,"[u'http://adsabs.harvard.edu/abs/2009PLoSO...4.5671S', u'http://dx.doi.org/10.1371/journal.pone.0005671']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Gassenmeier, K., Daniher, A., Furrer, S., , 1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor, , 2006",cited-by,10.1016/S0167-4501(06)80073-7,1-Ethoxy-1-(1-ethoxy-ethoxy)-ethane: a new acetaldehyde precursor,"[['Klaus', '', 'Gassenmeier'], ['Andrew', '', 'Daniher'], ['Stefan', '', 'Furrer']]",,2006,[u'http://www.sciencedirect.com/science/article/pii/S0167450106800737']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Tremblay, C., , Antiviral agents against respiratory viruses, Clinical Microbiology Newsletter, 2001",cited-by,10.1016/S0196-4399(01)89050-4,Antiviral agents against respiratory viruses,"[['Cecile', 'L.', 'Tremblay']]",Clinical Microbiology Newsletter,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0196439901890504', u'http://linkinghub.elsevier.com/retrieve/pii/S0196439901890504']"
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Ferraris, O., Kessler, N., Lina, B., , Short communication Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice, , 0",cited-by,10760728Short communication Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice,Short communication Sensitivity of influenza viruses to zanamivir and oseltamivir: A study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice,"[['O.', '', 'Ferraris'], ['N.', '', 'Kessler'], ['B.', '', 'Lina']]",,0,[u'http://download.thelancet.com/flatcontentassets/H1N1-flu/treatment/treatment-11.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Wenzel, R., , Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor, , 0",cited-by,12398370Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,Controlled Trial Oseltamivir in Treating Acute Influenza: A Randomized Efficacy and Safety of the Oral Neuraminidase Inhibitor,"[['Richard', 'P.', 'Wenzel']]",,0,[u'http://jama.ama-assn.org/cgi/reprint/283/8/1016.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Mittelholzer, C., , Influenza virus - Protection and Adaptation, , 0",cited-by,13885593Influenza virus - Protection and Adaptation,Influenza virus - Protection and Adaptation,"[['Camilla', 'Maria', 'Mittelholzer']]",,0,[u'http://diss.kib.ki.se/2006/91-7140-656-5/thesis.pdf']
13142809Catalytic and Framework Mutations in the Neuraminidase Active Site of Influenza Viruses That Are Resistant to 4-Guanidino-Neu5Ac2en,"Tisdale, M., , Influenza M2 Ion-Channel and Neuraminidase Inhibitors, , 0",cited-by,10.1007/978-1-59745-180-2_31,Influenza M2 Ion-Channel and Neuraminidase Inhibitors,"[['Margaret', '', 'Tisdale']]",,0,"[u'http://www.springerlink.com/index/th812t5r62661uh4.pdf', u'http://www.springerlink.com/content/th812t5r62661uh4']"
10.1001~jama.283.8.1016,"Gubareva LV, Matrosovich MN, Brenner MK, Bethell RC, Webster RG. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis. 1998;178:1257-1262. TREATMENT OF INFLUENZA WITH ORAL OSELTAMIVIR 1024 JAMA, February 23, 2000—Vol 283, No. 8 ©2000 American Medical Association. All rights reserved. Downloaded From: http://jama.jamanetwork.com/ by a University of New South Wales User on 09/02/2014",references,NOT found in MAS
